Department of Energy
Established Program to Stimulate Competitive Research (DOE EPSCOR) Implementation Grants
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310335
Application Deadline: March 27, 2019
Department of Energy's Established Program to Stimulate Competitive Research (DOE EPSCoR) seeks applications for research in key science and technology areas related to DOE missions. Grants awarded under this program are intended to improve research capability through the support of a group of scientists and engineers, including graduate students and post-doctoral fellows, working on a common scientific theme in one or more than one EPSCoR jurisdictions. A Pre-Application is required and is due December 20, 2018.

DOD
Research Interests of the Air Force Office of Scientific Research
https://www.fbo.gov/index?s=opportunity&mode=form&id=d8bfeaf2e38a1e4aeb9908190fc2e0f2&tab=core&_cview=1
Proposals will be evaluated as received on an open basis. 

Kansas Science Communication Initiative and the University of Nebraska-Lincoln
SciComm 2019
https://myemail.constantcontact.com/SciComm-2019-Conference--Register-now-.html?soid=1128260340769&aid=aOd1PcuWYdY
The Kansas Science Communication Initiative is co-hosting SciComm 2019 with the University of Nebraska-Lincoln March 22-24 in Manhattan, Kansas. The conference is dedicated to understanding and promoting effective communication of science to diverse audiences - including students of all levels as well as the general public- across all venues. This year's conference will focus on informal STEM learning, science communication research, k-12 STEM, disciplinary-based education research, science and media, and broader impacts. The keynote speakers will be Danielle Lee and Kevin Folta.

NIH
Administrative Supplements to National Cancer Institute (NCI) Grant and Cooperative Agreement Awards to Support Collaborations with the Patient-Derived Xenograft (PDX) Development and Trial Centers Research Network (PDXNet)
https://grants.nih.gov/grants/guide/pa-files/PA-19-174.html
Application Deadline: March 28, 2019
As part of the Cancer Moonshot initiative, NCI created PDXNet, a collaborative network of centers of excellence focused on using patient-derived xenografts and other patient-derived models to accelerate the development of NCI investigational new drug agents (i.e., those that the NCI is developing in collaboration with pharmaceutical partners) in NCI-sponsored early phase clinical trials. This opportunity supports supplemental funds to current NCI-funded research projects for new interdisciplinary collaborations between non-PDXNet investigators and PDXNet investigators to perform research within the scientific scope(s) of the parent grant and/or cooperative agreement award(s) that will lead to improved pre-clinical evaluations of novel therapeutic concepts using the large-scale PDX model collections of PDXNet and that could ultimately be tested in NCI-sponsored clinical trials. 

NIH
Animal and Biological Material Resource Centers (P40)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-006.html
This announcement encourages applications for national Animal Model, and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs), and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, national and international basis. Support for Centers is limited to those that span the interests of two or more categorical NIH Institutes/Centers/Offices. This funding opportunity is designed to both support continuation of existing resources, and to develop new ones when appropriate. 

NIH
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-177.html
Application Deadline: May 31, 2019
The HEI Grant Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. The minimum award is $600,001 of direct costs. The maximum award is $2,000,000 of direct costs. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.

NIH
Mechanisms, Models, Measurement, and Management in Pain Research (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-188.html
The purpose of this announcement is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at NIH and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators.

NIH
National Library of Medicine (NLM) Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-032.html
NLM Grants for Scholarly Works in Biomedicine and Health are awarded for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers, and historians of the health sciences.    

NIH
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-648.html
The purpose of this grant is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

NIH
NIH Support for Conferences and Scientific Meetings (Parent R13)
http://grants.nih.gov/grants/guide/pa-files/PA-16-294.html
The purpose of this solicitation is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

NIH
Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-926.html
The purpose of this funding opportunity is to support eligible postdoctoral scientists who maintain high productivity in an National Institute of Allergy and Infectious Diseases (NIAID)-funded laboratory while engaging in primary caregiver responsibilities. This program will provide administrative supplements to existing NIAID research grants to hire a full-time or part-time laboratory technician to work with the postdoctoral scientist on his or her project.

NIH
Research on the Health of Women of Understudied, Underrepresented, and Underreported Populations (Admin Supp Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-205.html
Application Deadline: April 8, 2019
The Office of Research on Women's Health announces the availability of administrative supplements to support interdisciplinary, transdisciplinary, and multidisciplinary research focused on the effect of sex/gender influences at the intersection of several social determinants, including but not limited to: race/ethnicity, socioeconomic status, education, health literacy and other social determinants in human health and illness. 

NIH
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-906.html
Funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or have become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project.

NIH
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)
http://grants.nih.gov/grants/guide/pa-files/PA-16-289.html
The Office of Research on Women's Health and participating Institutes and Centers of the NIH announce the continuation of the program for administrative supplements to research grants to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances. The purpose of these supplements is to encourage such individuals to re-enter research careers within the missions of all the program areas of NIH. This program will provide administrative supplements to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals to update their existing research skills and knowledge.

NIH
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-023.html
The purpose of this funding opportunity is to encourage revision applications from currently funded NCI R01 research projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies program. 

NIH
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-179.html
Application Deadline: May 31, 2019

NSF
Faculty Early Career Development Program Webinar
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503214
This web page contains registration information for the CAREER webinar taking place May 9, 2019. 

NSF
Frequently Asked Questions for NSF 16-615: Transdisciplinary Research in Principles of Data Scienc Phase 1 (TRIPODS)
https://www.nsf.gov/pubs/2017/nsf17048/nsf17048.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
This website lists frequently asked questions and answers related to the Transdisciplinary Research in Principles of Data Scienc Phase 1 (TRIPODS) program (NSF 16-615).

NSF
Frequently Asked Questions for the Faculty Early Career Development (CAREER) Program for Submission in Years 2017 - 2019
https://www.nsf.gov/pubs/2017/nsf17050/nsf17050.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
This website lists frequently asked questions and answers related to the Faculty Early Career Development (CAREER) Program (NSF 17-537).

NSF
Integrative Strategies for Understanding Neural and Cognitive Systems (NCS)
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf18533
The NCS program focuses on four aspects of neural and cognitive systems that are current targets of converging interdisciplinary interests: (1) Neuroengineering and Brain-Inspired Concepts and Designs; (2) Individuality and Variation; (3) Cognitive and Neural Processes in Realistic, Complex Environments; and (4) Data-Intensive Neuroscience and Cognitive Science. NCS projects must advance the foundations of one or more of these focus areas. 

NSF and NIH
Smart and Connected Health: Connecting Data, People, and Systems
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf18541
The goal of this program is to accelerate the development and integration of innovative computer and information science and engineering approaches to support the transformation of health and medicine. Its purpose is to develop next-generation multidisciplinary science that encourages existing and new research communities to focus on breakthrough ideas in a variety of areas of value to health, such as networking, pervasive computing, advanced analytics, sensor integration, privacy and security, modeling of socio-behavioral and cognitive processes, and system and process modeling. 

Robert Wood Johnson Foundation
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health (E4A)
http://www.rwjf.org/en/library/funding-opportunities/2015/evidence-for-action-investigator-initiated-research-to-build-a-culture-of-health.html
This program funds research that expands the evidence base needed to build a Culture of Health, particularly rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs, and partnerships. The foundation is especially interested in research examining the health impacts of programmatic or policy interventions that address factors outside the domain of health care services or public health practice.

Applications are accepted on a rolling basis.

Universities Research Association
URA Early Career Research Award
https://www.ura-hq.org/awards/ura-early-career-award/
Application Deadline: April 10, 2019
Universities Research Association, Inc.  makes an award for outstanding work conducted by an early career researcher at Fermilab or benefiting the Fermilab scientific program.

USDA
Crop Protection and Pest Management Competitive Grants Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312979
Application Deadline: April 16, 2019
This program supports projects that will ensure food security and respond effectively to other major societal pest management challenges with comprehensive approaches that are economically viable, ecologically prudent, and safe for human health.

USDA
Distance Learning and Telemedicine Grants
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312924
This program provides financial assistance to enable and improve distance learning and telemedicine services in rural areas. These grants are intended to increase rural access to education, training, and health care resources that are otherwise unavailable or limited in scope.

USDA
Farm Business Management and Benchmarking Grant
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312723
Application Deadline: April 9, 2019
This program provides funds for improving the farm management knowledge and skills of agricultural producers by maintaining and expanding a national, publicly available farm financial management database to support improved farm management.

USDA
Federal-State Marketing Improvement Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312596
Application Deadline: April 5, 2019
This program offers grants with a one-to-one dollar match to assist in exploring new market opportunities for U.S. food and agricultural products, and to encourage research and innovation aimed at improving the efficiency and performance of the marketing system.

USDA
Methyl Bromide Transition Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313360
Application Deadline: April 15, 2019
This program focuses on integrated commercial-scale research on methyl bromide alternatives and associated extension activity that will foster the adoption of these solutions. Projects should cover a broad range of new methodologies, technologies, systems, and strategies for controlling economically important pests for which methyl bromide has been the only effective pest control option.

USDA
Minor Crop Pest Management Program Interregional Research Project #4
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313272
Application Deadline: April 3, 2019
This program aims to enable the crop protection industry to provide safe, effective, and economical crop protection products for growers and consumers of minor/specialty crops by providing the assistance needed to ensure that new and more effective crop protection products are developed and made available to minor/specialty crop producers. These efforts require effective collaborations among federal agencies, the crop protection industry, and land-grant colleges and universities.

USDA
Organic Agriculture Research and Extension Initiative
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313810
This initiative aims to solve critical organic agriculture issues, priorities, or problems through the integration of research, education, and extension activities.

USDA
Potato Breeding Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314099
Application Deadline: May 21, 2019
This grant program supports regional potato research and extension that focuses on the development, testing, and release of superior commercial potato varieties using classical breeding and advanced molecular and biotechnological approaches. 

USDA
Women and Minorities in STEM Fields
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314081
Application Deadline: May 21, 2019
The purpose of this program is to support research, education/teaching, and extension projects that increase participation by women and underrepresented minorities from rural areas in STEM, with a focus on addressing educational needs within broadly defined areas of food, agriculture, natural resources, and human sciences. 

Cornell University Library
John Nolen Research Fund
http://rmc.library.cornell.edu/collections/john_nolen_research_fund.php
Application Deadline: April 30, 2019
The John Nolen Research Fund provides assistance to scholars to conduct research in the John Nolen Papers and allied collections in the Division of Rare and Manuscript Collections of the Cornell University Library. Any qualified researcher interested in the history of city and regional planning before 1950 with a project that can be augmented by using the Nolen Papers is eligible to apply.

Gerald R. Ford Presidential Foundation
Research Travel Grants Program
http://www.fordlibrarymuseum.gov/library/foundationgrants.asp
Application Deadline: September 15, 2019
These grants support research in the holdings of the Gerald R. Ford Library. Library collections focus on Federal policies, U.S. foreign relations, and national politics in the 1960s and 1970s. There are earlier and later materials depending upon your topic.

Hagley Center for the History of Business, Technology and Society
Exploratory Research Grants and Henry Belin du Pont Research Grants
http://www.hagley.org/library-grants
These grants support study and research at the Hagley Museaum and Library, which focuses on the unfolding history of American business, technology, and innovation and its impact on the world. Exploratory Research Grants support one-week visits by scholars who need the opportunity to explore the collections on-site to determine if a Henry Belin du Pont Research Grant application is warranted, which enable scholars to pursue advanced research in Hagley's collections for periods of up to eight weeks.

Applications are due June 30, October 31, or March 31.

Harpo Foundation
Grants for Visual Artists
http://www.harpofoundation.org/apply/grants-for-visual-artists/
Application Deadline: April 19, 2019
These grants provide direct support to under-recognized artists 21 years or older.

Humanities Nebraska
Major Grants
http://humanitiesnebraska.org/grants/opportunities/
Application Deadline: August 1, 2019
Major Grants are given for projects or programs in the humanities that take place in Nebraska and/or have direct significance to Nebraska. Major Grants are for projects or programs costing more than $2,000.

Humanities Nebraska
Media and Website/Digital Grants
http://humanitiesnebraska.org/grants/opportunities/
Application Deadline: June 17, 2019
Humanities Nebraska is offering grants in support of media (i.e., film, radio, and/or television) and website/digital projects related to the humanities. Grants are given only for projects or programs that take place in Nebraska and/or have direct significance to Nebraska.

Humanities Nebraska
Mini Grants
http://humanitiesnebraska.org/grants/opportunities/
Mini Grants are given for projects or programs in the humanities that take place in Nebraska and/or have direct significance to Nebraska. Mini Grants are for projects or programs costing $2,000 or less.

Applications are due January 2, 2019; March 1, 2019; May 1, 2019; July 1, 2019; September 2, 2019, and November 1, 2019.

IHS Grant for Free Speech and Open Inquiry
Institute for Humane Studies at George Mason University
https://theihs.org/ihs-grant-for-free-speech-open-inquiry/
This program supports faculty who are interested in fostering free speech and civil discourse in academia as they undertake research, plan campus events, or develop student curricula exploring the past, present, and future of free speech. Applications are currently being accepted on a rolling basis for the 2019-2020 academic year.

J.M. Kaplan Fund
Furthermore Grants in Publishing
http://www.furthermore.org/apply.html
Application Deadline: September 1, 2019
Furthermore grants assist nonfiction books having to do with art, architecture, and design; cultural history, the city, and related public issues; and conservation and preservation. Funds apply to such specific publication components as writing, research, editing, indexing, design, illustration, photography, and printing and binding.

Japan Foundation
JFNY Grant for Arts and Culture
http://www.jfny.org/arts_and_culture/smallgrant.html
These grants support projects that will further understanding of Japanese arts and culture. Applications accepted on a rolling basis.

Japan Foundation
JFNY Grant for Japanese Studies
http://www.jfny.org/japanese_studies/smallgrant.html
These grants support projects that will enhance further understanding of Japan through academic exploration. Such projects generally take the form of conferences, colloquia, symposia, presentations, and lectures within the United States. Applications are accepted on a rolling basis and must be received at least three months prior to the project's starting date.

Nebraska Arts Council
Artists in Schools and Communities Sponsor Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/aisc-artist-residency-program-sponsor-grants.html
This program supports Nebraska Arts Council Roster Artist residencies that include at least 20 contact hours with participants. During residencies, artists share their expertise and work with teachers or staff to help students achieve educational goals in the arts and other academic disciplines. College- and university-based projects may be funded only when participation by the public is sought in significant numbers.

For grant requests of up to $2,500 per artist, applications are accepted on a rolling basis. For grant requests of over $2,500 per artist, the deadline is October 1, 2019.

Nebraska Arts Council
Nebraska Touring Program Sponsor Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/nebraska-touring-program-sponsor-grants.html
Nebraska Touring Program Sponsor Grants help organizations fund performances or exhibits selected from the Nebraska Arts Council (NAC) Artist Directory, available on the NAC website. Grants applications are accepted on a rolling basis, are due six weeks before the event, and are processed on a first-come, first-served basis.

NEH
Institutes for Advanced Topics in the Digital Humanities
http://www.neh.gov/grants/odh/institutes-advanced-topics-in-the-digital-humanities
Application Deadline: March 26, 2019
These NEH grants support national or regional (multistate) training programs for scholars, humanities professionals, and advanced graduate students to broaden and extend their knowledge of digital humanities.

NSF
Antarctic Artists and Writers Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314007
This program facilitates writing and artistic projects designed to increase the public's understanding and appreciation of the Antarctic and human endeavors on the southernmost continent.

Proposals are due June first, 2019 and annually thereafter.

The D. Kim Foundation for the History of Science and Technology in East Asia
Conference/Workshop Grants
http://dkimfoundation.org/wp1/fellowships/
The D. Kim Foundation supports graduate students and young scholars who are working in the history of science and technology in modern East Asia. Comparative studies of East Asia and the West as well as studies in related fields (mathematics, medicine and public health) are also welcome. These grants will support scholars who plan to present papers at international conferences or workshops. The next deadlines are May 1, 2019 and December 1, 2019.

The Kress Foundation
Grant Programs
http://www.kressfoundation.org/grants/main/
This program supports scholarly projects that promote the appreciation, interpretation, preservation, study, and teaching of European art from antiquity to the early 19th century in the following areas:

• History of Art: Supports scholarly projects that will enhance the appreciation and understanding of European art and architecture;
• Conservation: Supports the professional practice of art conservation; and
• Digital Resources: Supports efforts to integrate new technologies into the practice of art history and the creation of important online resources for art history.

The next three application deadlines are January 15, 2019 (excluding Digital Resources projects), April 1, 2019, and October 1, 2019.

The Kurt Weill Foundation for Music
College/University Performance Grants
http://www.kwf.org/pages/grant-program.html
Application Deadline: June 1, 2019
Grants are awarded to colleges and universities in support of general production expenses for performances of Kurt Weill's and/or Marc Blitzstein's stage works and to cover musical expenses in connection with performances of Weill's or Blitzstein's concert works.

The Lyndon Baines Johnson Foundation
Moody Research Grant
http://www.lbjlibrary.org/page/foundation/initiatives/moody-research-grant
Application Deadline: September 15, 2019
The LBJ Foundation awards a limited number of grants for research at the LBJ Library. Grants may be used for research for dissertations, theses, senior papers, publications, and other projects.

The Terra Foundation for American Art
Academic Workshop and Symposium Grants
http://www.terraamericanart.org/grants/academic-program-grants/
Funding is available for in-person exchanges such as workshops, symposia, and colloquia that advance scholarship in the field of American art (circa 1500-1980) that take place: 1) in Chicago or outside the United States or 2) in the United States and that examine American art within an international context, with at least half of the participants coming from outside the United States.

Letters of Inquiry (LOI) are required, followed by invited full proposals. The next deadlines are December 7, 2018 for the LOI and March 1, 2019 for the full proposal and March 15, 2019 for the LOI and June 17, 2019 for the full proposal.

The Vilcek Foundation
The Vilcek Prizes for Creative Promise in Literature
http://www.vilcek.org/prizes/creative-promise/arts.html
Application Deadline: June 10, 2019
The Vilcek Foundation will award three prizes of $50,000 each to foreign-born writers who have demonstrated outstanding achievement early in their careers. Eligible genres include fiction, nonfiction, and poetry.

The William Nelson Cromwell Foundation
William Nelson Cromwell Foundation Grants
http://cromwellfoundation.org/prizes-fellowships-grants/grants/
Application Deadline: September 1, 2019
These grants support: 1) historical monographs on major questions in American law and legal development, as well as biographies of important legal figures, 2) the publication of important legal documents in American History, and 3) the digitization of materials that are important to American legal history, particularly but not only materials from the late colonial or early national periods.

Truman Library Institute
Research Grants
http://trumanlibraryinstitute.org/research-grants/research-grants/
Application Deadline: April 1, 2019
Research grants enable graduate students, post-doctoral scholars, and other researchers to research at the Harry S. Truman Library and Museum for one to three weeks. The grants provide assistance to scholars whose contributions illuminate the critical issues of Truman's presidency and legacy.

W. Eugene Smith Memorial Fund
Howard Chapnick Grant
http://smithfund.org/howard-chapnick-grant
Application Deadline: April 20, 2019
This program encourages and supports leadership in fields ancillary to photojournalism, such as editing, research, education, and management. The grants may be used to finance any of a range of qualified undertakings, which might include a program of further education, research, a special long-term sabbatical project, or an internship to work with a noteworthy group or individual.

W. Eugene Smith Memorial Fund
W. Eugene Smith Grant for Student Photographers
http://smithfund.org/the-w-eugene-smith-grant-for-student-photographers
Application Deadline: April 20, 2019
This program supports student projects that use exemplary and compelling photojournalism (possibly supplemented by or incorporating multi-media) to address an issue of import and impact related to the human condition; social change; humanitarian concern; armed conflict or interpersonal, psychological, cultural, social environmental, scientific, medical, and/or political significance. Ideally, projects will express an underlying acknowledgement of our common humanity.

W. Eugene Smith Memorial Fund
W. Eugene Smith Grant in Humanistic Photography
http://smithfund.org/eugene-smith-grant
Application Deadline: April 20, 2019
This program supports projects that use exemplary and compelling photojournalism (possibly supplemented by or incorporating multi-media) to address an issue of import and impact related to the human condition; social change; humanitarian concern; armed conflict or interpersonal, psychological, cultural, social environmental, scientific, medical, and/or political significance. Ideally, projects will express an underlying acknowledgement of our common humanity.

Women's Studio Workshop
Studio Residency Grant
http://www.wsworkshop.org/residencies/studio-residency-grant/
Application Deadline: June 30, 2019
The Studio Grant is a six- to eight-week residency for artists to create new work in any of the studio's disciplines: intaglio, letterpress, papermaking, screenprinting, photography, or ceramics. The Women's Studio Workshop invites applications from artists at any stage in their careers.

NIH
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-833.html
The National Institute of Mental Health (NIMH) Division of AIDS Research encourages applications for Center Core grants (P30) to support Developmental AIDS Research Centers (D-ARC). The D-ARC is intended to provide infrastructural support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This FOA intends to support innovative, interdisciplinary research in several areas, including basic, neurological (i.e., neuro-HIV), behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.

NIH
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-225.html
NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. 

NIH
NIDA Core "Center of Excellence" Grant Program (P30)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-121.html
NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators, and share findings, data and their resources, consistent with achieving the goals of the program. 

NIH
NIDA Program Project Grant Applications (P01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-393.html
This solicitation announces the availability of support for collaborative research by multi-disciplinary teams that is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. Funds will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA. 

NIH
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-168.html
This announcement encourages applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers working at different levels of analysis and employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience research or in translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research that will uncover and dissect the underlying mechanisms that will ultimately provide the foundation for understanding mental disorders, (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses, and/or (c) advancing our understanding of the neurobehavioral developmental mechanisms and trajectories of psychopathology that begin in childhood and adolescence. 

Department of Defense
Defense University Research Instrumentation Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312961
Application Deadline: May 17, 2019
The Department of Defense (DoD) announces the Fiscal Year 2020 Defense University Research Instrumentation Program (DURIP). DURIP is designed to improve the capabilities of accredited United States (U.S.) institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment or instrumentation.

Department of Defense
Department of Defense Advanced Computing Initiative
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313198
Application Deadline: May 31, 2019
This opportunity seeks to increase the Department's intellectual capital in computing systems and improve its ability to address future challenges and build bridges between the Department and the computing research community. Targeted areas of interest include: 1) Novel Methods of Computing; 2) Hardware and Software Systems Components; 3) Exploration of System Concepts; and 4) Algorithms and Architectures. Concept papers are required and are due March 25, 2019.

Department of Defense
ERDC Broad Agency Announcement
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312615
Application Deadline: January 31, 2020
The U.S. Army Engineer Research and Development Center (ERDC) has issued a Broad Agency Announcement (BAA) for various research and development topic areas. The ERDC is responsible for conducting research in the broad fields of hydraulics, dredging, coastal engineering, instrumentation, oceanography, remote sensing, geotechnical engineering, earthquake engineering, soil effects, vehicle mobility, self-contained munitions, military engineering, geophysics, pavements, protective structures, aquatic plants, water quality, dredged material, treatment of hazardous waste, wetlands, physical/mechanical/chemical properties of snow and other frozen precipitation, infrastructure and environmental issues for installations, computer science, telecommunications management, energy, facilities maintenance, materials and structures, engineering processes, environmental processes, land and heritage conservation, and ecological processes.

Department of Defense
Long Range BAA
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311508
Application Deadline: September 30, 2019
This is an announcement to declare Office of Naval Research's broad role in competitive funding of meritorious research across a spectrum of science and engineering disciplines.

Department of Defense
Military Burn Research Program
https://cdmrp.army.mil/funding/mbrp
Application Deadline: July 10, 2019
The Military Burn Research Program is currently accepting applications for two awards: an Idea Development Award and a Clinical and Translational Research Award. The program seeks to address capability gaps for treating combat burn injuries. Pre-applications are required and due April 17, 2019.

Department of Defense
Military Medical Photonics Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313509

Department of Defense
Naval Air Systems Command Digital Office Office-Wide Broad Agency Announcement
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310499
Application Deadline: November 18, 2019
The Naval Air Systems Command (NAVAIR) Digital Office is interested in receiving white papers for Science and Technology Projects which offer potential for advancements and improvements applicable to the digitization of NAVAIR / U.S. Naval Operations.

Department of Defense
Neurofibromatosis Research Program (NFRP)
https://cdmrp.army.mil/funding/nfrp
The Neurofibromatosis Research Program (NFRP) is currently accepting applications for five award mechanisms: Clinical Trial Award, Exploration - Hypothesis Development Award, Investigator-Initiated Research Award, New Investigator Award, and Early Investigator Research Award. The mission of NFRP is to promote research directed toward the understanding, diagnosis, and treatment of NF1, NF2 and schwannomatosis to enhance the quality of life for persons with these disorders. Pre-applications are required. Deadlines vary by award.

Department of Defense
Ovarian Cancer Research Program
https://cdmrp.army.mil/funding/ocrp

Department of Defense
Peer Reviewed Medical Research Program
https://cdmrp.army.mil/funding/prmrp
The Peer Reviewed Medical Research Program supports research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military Service members, Veterans, retirees, and their family members. Opportunities are available through five award mechanisms: 1) Discovery Award; 2) Clinical Trial Award; 3) Focused Program Award; 4) Investigator-Initiated Research Award; and 5) Technology/Therapeutic Development Award. Pre-applications are required. Deadlines vary by award program.

Department of Defense
Special Program Announcement for Office of Naval Research Task Force Ocean
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311177
Under Task Force Ocean, Office of Naval Research plans to initiate new research to better understand and exploit the ocean environment. FY19 objectives include improved ocean and acoustic sensing, signal processing, and data analysis capabilities. White papers should be submitted no later than January 31, 2019.

Department of Defense
Strengthening Teamwork for Robust Operations in Novel Groups
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310010
The U.S. Army Research Laboratory has established this new collaborative program, Strengthening Teamwork for Robust Operations in Novel Groups (STRONG), with the goal of developing the foundation for enhanced teamwork within heterogeneous human-intelligent agent teams. STRONG will be executed through a series of eight annual program cycles (i.e., Cycles 1-8). The FOA will be amended annually to identify a specific problem statement, or topic, for that specific Cycle.

Department of Defense
Structural Integrity Research Collaborations for Aircraft
https://www.grants.gov/web/grants/view-opportunity.html?oppId=309814
The objective of the Structural Integrity Research Collaborations for Aircraft program is to enable collaborative research partnerships between the Air Force Research Laboratory, Academia, and Industry, in areas relevant to aircraft structural integrity including, but not limited to, risk and reliability, metal fatigue and fracture, and composite damage modeling. White papers are required and will be accepted until October 23, 2023.

Department of Defense
Tuberous Sclerosis Complex Research Program
https://cdmrp.army.mil/funding/tscrp
Application Deadline: May 9, 2019
The FY19 Tuberous Sclerosis Complex Research Program (TSCRP) is currently accepting applications for three award mechanisms: Exploration Hypothesis Development Award, Idea Award, and Clinical Translational Research Award. The mission of TSCRP is to fund exploratory, pioneering and transformative science that promotes discoveries in TSC, from mechanistic insights to clinical application. Letters of Intent are due April 18, 2019.

DOD
Advanced Research and Development of Mission-Focused Analytics for a Decision Advantage Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=0b63dcb943df55562b36808852570b23&tab=core&_cview=1
This mechanism seeks to provide research and development for forming a revolutionary approach to information fusion and analysis by leveraging service-oriented architecture, open standards, and cutting-edge fusion and analytical algorithms to provide real-time (or near real-time) intelligence for decision makers. 

DOD
Behavioral and Social Sciences Broad Agency Announcement for Basic, Applied, and Advanced Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=304462
The U.S. Army Research Institute for the Behavioral and Social Sciences (ARI) announces the ARI FY18-23 Broad Agency Announcement for Basic, Applied, and Advanced Scientific Research. Those contemplating submission of a proposal are encouraged to contact the ARI Technical Point of Contact for the respective topic area cited in the BAA.  If the R&D warrants further inquiry and funding is available, submission of a proposal will be entertained. The recommended three-step sequence is (1) telephone call to the ARI TPOC or responsible ARI Manager, (2) white paper submission, (3) full proposal submission.

DOD
Decentralized Classification and Coordination with Non-Permissive Communications
https://www.fbo.gov/index?s=opportunity&mode=form&id=b5cacb6f8b8c8049bdb23159b6d66005&tab=core&_cview=0
Applications may be submitted on a rolling basis until September 30, 2021. Only concept papers will be accepted as initial submissions; formal proposals will be accepted by invitation only.

DOD
Domain Agnostic Technologies for Automated Indications and Warning Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=4e1c9e7628839fe3ac9cee4ad59843cf&tab=core&_cview=1
This program seeks proposals to research, develop, demonstrate, integrate, and test innovative technologies for both tactical and strategic automated indications and warnings. 

DOD
Extensible End-to-End Machine Learning System and Advanced Learning Algorithm Development
https://www.fbo.gov/index?s=opportunity&mode=form&id=f69d3f60b2097e8aa88211f68e5b4ab5&tab=core&_cview=1
The Information Directorate of the Air Force Research Laboratory, Rome Research Site, is seeking innovative research proposals for the development of an open, end-to-end machine learning framework to revolutionize how the Department of Defense designs, develops, trains, evaluates, and deploys machine learning capabilities. 

DOD
Extramural Biomedical Research and Development
https://www.grants.gov/web/grants/view-opportunity.html?oppId=307754
Application Deadline: July 31, 2023
A primary emphasis of the program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care, human performance optimization, and canine medicine/performance. This Broad Agency Announcement (BAA) is continuously open for a 5-year period, from August 1, 2018 to July 31, 2023. A pre-proposal/pre-application is required and may be submitted at any time prior to the BAA closing date.

DOD
Forensic Analysis of Organic and Inorganic Compounds Associated with Microelectronics
https://www.grants.gov/web/grants/view-opportunity.html?oppId=298549&utm_source=Funding+Supplement&utm_campaign=e9875060b9-EMAIL_CAMPAIGN_2017_11_15&utm_medium=email&utm_term=0_8d6cbefc3d-e9875060b9-212708225
Application Deadline: December 8, 2017
This program is interested in the research and development of advanced microelectronics screening techniques for counterfeit detection. In particular, research using mass spectrometry for forensic analyses of organic and inorganic compounds associated with microelectronics, especially the compounds and materials associated with plastic-encapsulated microelectronics. 

DOD
Naval Air Warfare Center Aircraft Division
https://www.grants.gov/web/grants/view-opportunity.html?oppId=306292
The Naval Air Warfare Center Aircraft Division (NAWCAD) is interested in receiving proposals for Science and Technology  projects that offer potential for advancement and improvement of NAWCAD operations.

White Papers are required and may be submitted at any time up until June 14, 2019.

DOD
NRL Long Range BAA for Basic and Applied Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=304904

DOD
Research and Development Projects Leading to Defense Threat Reduction
https://www.fbo.gov/index?s=opportunity&mode=form&id=ad159f2bda69d90e735610c0c6cc76e1&tab=core&_cview=1
Applications will be accepted on a rolling basis until October 31, 2021. 

DOD
Research and Development Projects on Emerging Computing Architectures and Applications
https://www.fbo.gov/spg/USAF/AFMC/AFRLRRS/BAA-RIK-14-05/listing.html
This program seeks proposals that can provide revolutionary computational capabilities which enable greater system adaptability, autonomy and intelligence while improving information availability throughout the command, control, communications, computers, intelligence, surveillance, and reconnaissance enterprise. 

DOD
Research Interests of the Air Force Office of Scientific Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=305996
The focus of the Air Force Office of Scientific Research is on research areas that offer significant and comprehensive benefits to our national war fighting and peacekeeping capabilities. These areas are organized and managed in two scientific Departments: Engineering and Information Science (RTA) and Physical and Biological Sciences (RTB). You may submit proposals at any time; however, some specific topic instructions may recommend submission by specific dates that align with funding expectations.

DOD
Research Projects in the Areas of Engineering and Information Science and Physical and Biological Sciences
https://www.grants.gov/web/grants/view-opportunity.html?oppId=298498&utm_source=Funding+Supplement&utm_campaign=e9875060b9-EMAIL_CAMPAIGN_2017_11_15&utm_medium=email&utm_term=0_8d6cbefc3d-e9875060b9-212708225
This program seeks proposals related to research areas that offer significant and comprehensive benefits to our national war fighting and peacekeeping capabilities. These areas are organized and managed in two scientific departments: 1) Engineering and Information Science; and 2) Physical and Biological Sciences. 

DOD
Strategic Environmental Research and Development Core Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=6c6924838b43d23dcd43b6983527a004&tab=core&_cview=1
Application Deadline: January 4, 2018
This program seeks pre-proposals for research related to the areas of environmental restoration, munitions response, resource conservation and resiliency, and weapons systems and platforms technologies.

Full applications may be submitted after invitation only.

NIH
Cancer Research Education Grants Program - Curriculum or Methods Development (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-476.html
The goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. This announcement will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer; rehabilitation from cancer; and the continuing care of cancer patients and the families of cancer patients.

NIH
Cancer Research Education Grants Program - Research Experiences (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-478.html
The goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. This announcement will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer; rehabilitation from cancer; and the continuing care of cancer patients and the families of cancer patients, in accordance with the overall mission of the NCI.

NIH
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-345.html
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHGRI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in genomics. This funding opportunity announcement seeks to expose underrepresented students at the undergraduate, postbaccalaureate, and graduate levels to the foundational sciences relevant to genomics to enable them to pursue careers that span all areas of interest to NHGRI--genome sciences, genomic medicine, and genomics and society. 

NIH
National Cancer Institute Youth Enjoy Science Research Education Program (R25)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-059.html
The NIH Research Education Program supports research education activities in the mission areas of NIH. The overarching goal of this NCI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce. 

NIH
NIAID Research Education Program (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-455.html
 The overarching goal of this NIAID R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs in NIAID mission areas. To accomplish this goal, this announcement will support creative educational activities with a primary focus on Courses for Skills Development, Research Experiences, and Mentoring Activities related to NIAID's mission areas. 

NIH
NICHD Research Education Programs (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-183.html
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NICHD R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral, and clinical research needs. 

NIH
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-030.html
The over-arching goal of this NIDDK R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. To accomplish the stated over-arching goal, this opportunity will support creative educational activities with a primary focus on courses for skills development and research experiences.

NIH
NIMH Mentoring Networks for Mental Health Research Education (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-080.html
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIMH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.

NIH
NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-485.html
The NIH Research Education Program supports research education activities in the mission areas of the NIH. The overarching goal of this National Institute of Mental Health R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral, and clinical research needs and advance the priorities outlined in the Office of AIDS Research Annual Strategic Plan and the research program priorities of the NIMH Division of AIDS Research.

NIH
NIMH Short Courses for Mental Health-Related Research Education (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-082.html
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIMH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral, and clinical mental health-related research needs.

NIH
NINDS Research Education Opportunities (R25 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-782.html
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. Specifically, this announcement will support creative educational activities with a primary focus on Courses for Skills Development and Research Experiences.

NIH
Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program (T32)
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-011.html
Application Deadline: May 25, 2019
This opportunity solicits applications for new Behavioral and Social Sciences Research (BSSR) predoctoral training programs that focus on innovative computational and/or data science analytic approaches and their incorporation into training for the future BSSR health research workforce. The vision of the Advanced Data Analytics for BSSR training program is to support the development of a cohort of specialized predoctoral candidates who will possess advanced competencies in data science analytics to apply to an increasingly complex landscape of behavioral and social health-related big data.

NIH
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-197.html
This funding opportunity will support creative educational activities with a primary focus on research experiences for high school or undergraduate students or science teachers during the summer academic break. 

NSF
Dear Colleague Letter: Non-Academic Research Internships for Graduate Students (INTERN) Supplemental Funding
https://www.nsf.gov/pubs/2017/nsf17091/nsf17091.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
NSF will provide support for supplements to current NSF grants awarded by the Directorate for Education and Human Resources, Directorate for Engineering, and Office of Advanced Cyberinfrastructure within the Directorate for Computer and Information Science and Engineering to enhance professional development opportunities for graduate students. Supplements to existing NSF awards will enable the PIs of grants to request up to six months of additional support for graduate students to pursue new activities aimed at acquiring professional development experience that will enhance their preparation for multiple career pathways after graduation.

NSF
EHR Core Research (ECR): Building Capacity in STEM Education Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313510
This program supports activities that enable early and mid-career researchers to acquire the requisite expertise and skills to conduct rigorous fundamental research in STEM education, with a special emphasis through this solicitation on development and implementation of an ECR Data Resource Hub.

NSF
EHR Core Research: Production Engineering Education and Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312893
Application Deadline: May 15, 2019
This program invites proposals to design, develop, deploy, and study the effectiveness of online courses focusing on any of the five areas of model-based systems engineering, software engineering, mechatronics, data science, and artificial intelligence.

NSF
Improving Undergraduate STEM Education: Computing in Undergraduate Education
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312673
Application Deadline: May 9, 2019
This solicitation aims to support teams of Institutions of Higher Education (IHEs) in re-envisioning the role of computing in interdisciplinary collaboration within their institutions. Proposals must comprise a multi-institutional partnership, with a lead IHE and two to four additional IHE partners.

NSF
Improving Undergraduate STEM Education: Education and Human Resources (IUSE: EHR)
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf17590
Multiple deadlines apply. See the solicitation for details.

NSF
Webinar: How to Use InformalScience.org to Make Your Case
https://www.nsf.gov/events/event_summ.jsp?cntn_id=242924&WT.mc_id=USNSF_13&WT.mc_ev=click
InformalScience.org is a curated collection of project, research, and evaluation resources designed to support the informal STEM education community working in a variety of learning environments. This session will provide useful tips and suggestions for using the site while developing proposals, from conducting literature searches to identifying potential collaborators.

NSF
Webinar: How to Write a Competitive AISL Proposal
https://www.nsf.gov/events/event_summ.jsp?cntn_id=242925&WT.mc_id=USNSF_13&WT.mc_ev=click
In this webinar, program officers from the Advancing Informal STEM Learning (AISL) program will highlight: (1) essential elements that should be in every strong AISL proposal, (2) proposal deficiencies to avoid, and (3) key differences between a highly competitive proposal and a proposal that is not competitive. This will also be an opportunity to ask questions and receive responses from AISL program officers in real time.

The National Education Association (NEA) Foundation
Learning and Leadership Grants
http://www.neafoundation.org/pages/learning-leadership-grants/
These grants are given to NEA members for one of the following two purposes: (1) individual grants to fund participation in high-quality professional development experiences, such as summer institutes, conferences, seminars, travel abroad programs, or action research; or (2) group grants to fund collegial study, including study groups, action research, lesson plan development, or mentoring experiences for faculty or staff.  

Applications may be submitted at any time and are reviewed three times per year after February 1, June 1, and October 15.

The NEA Foundation
Student Achievement Grants
http://www.neafoundation.org/pages/nea-student-achievement-grants/
This program supports projects that enable educators to improve student learning and help students learn how to think critically and solve problems.

Applications may be submitted at any time and are reviewed three times per year after October 15, February 1, and June 1.

University of Nebraska Foundation
Women Investing in Nebraska Grant
https://womeninvestinginnebraska.org/apply-for-grants
Women Investing in Nebraska is seeking interest from University of Nebraska programs that address issues important to the state for its annual grant awards program. Eligible categories include Arts and Culture, Health and Human Services, Education and Environment, and Community and Civic Engagement.

USDA
Secondary Agriculture Education Challenge Grant Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312949
Application Deadline: April 16, 2019
This program seeks to promote and strengthen secondary education and two-year postsecondary education in the food, agriculture, natural resources and human (FANH) sciences and promote complementary and synergistic linkages among secondary, two-year postsecondary, and higher education programs in the FANH sciences.

Department of Energy
Solicitation on Topics Informing New Program Areas
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311427
Application Deadline: December 19, 2019
The Advanced Research Projects Agency - Energy (ARPA-E) of the Department of Energy is soliciting topics under this opportunity that will explore new areas of technology development. Applications to this solicitation must have the potential for high impact - if successful, it could create a new class or new trajectory for an energy technology, with the potential to make a significant impact on ARPA-E's mission areas.

Department of Energy
Solutions to Improve the Energy Efficiency of U.S. Small and Medium Commercial Buildings
https://eere-exchange.energy.gov/#FoaIdd77384ed-97f9-49e9-ba00-94ac05201041
Through this program, the Department of Energy seeks to fund the scale-up of promising solutions to the market barriers that hinder the growth of energy efficiency in small and medium commercial buildings and tenant spaces. The objective of this funding is to build a path for market-ready solutions to be used at scale across the United States to improve commercial building energy efficiency. 

Concept papers (required) are due December 4, 2015.

Applicants may submit only one concept paper and one full application for consideration under this funding opportunity announcement.

DOD
AFRL/RXM Manufacturing Technology Open BAA
http://www.grants.gov/web/grants/view-opportunity.html?oppId=258475

This BAA solicits white papers and potentially technical and cost proposals that focus on strengthening defense manufacturing capabilities and efficiencies and transitioning capability to the factory floor. Descriptors of manufacturing technology interests are presented in two contexts: that of manufacturing technology competencies and that of Air Force application area needs.

White papers may be submitted at any time prior to June 24, 2019.

DOD
AFRL/RXM Manufacturing Technology Open BAA
https://www.fbo.gov/spg/USAF/AFMC/AFRLWRS/BAA-RQKM-2014-0020/listing.html

The Air Force Research Laboratory invites proposals to support research and developmetn projects on manufacturing technologies that focus on strengthening defense manufacturing capabilities through the discovery of new manufacturing capabilities and efficiencies and transitioning capability to the factory floor are of interest. Research areas of interest are described in the announcement.

Whitepapers will be accepted on a continuing basis until June 24, 2019. 

DOD
Agent Based Systems
https://www.fbo.gov/index?s=opportunity&mode=form&id=dce3a52a2d901591300feb89eec02feb&tab=core&_cview=0
Application Deadline: September 30, 2022
Concept papers are being accepted on a rolling basis by the Air Force Research Laboratory for innovative research, development, integration, testing, and evaluation of technologies/techniques to rapidly design, build, and field autonomous systems.

DOD
Army Research Laboratory Broad Agency Announcement for Basic and Applied Scientific Research (FY 2017 - 2022)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=292896
The program seeks proposals for basic research in the fields of computational science, materials research, sciences for maneuver, information science, science for lethality and protection, human sciences, and assessment and analysis. 

DOD
Deep Learning for Actionable Intelligence Discovery and Exploitation
https://www.fbo.gov/index?s=opportunity&mode=form&id=91eb6450e655c1d1f90c6201e06d5fc5&tab=core&_cview=1
The goal of this broad agency announcement is to develop and demonstrate a time-dominant data fusion and closed-loop intelligence, surveillance, and reconnaissance system for intelligence customers. The system will automate threat detection and classification with speed and precision and in a tactically relevant timeframe, automate the generation of in-mission intelligence reports, and be responsive to intelligence squadron needs. 

DOD
Defense Threat Reduction Agency Science and Technology New Initiatives Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=228413edcd329a1561ec6039e2040c09&tab=core&_cview=1
This program seeks to discover and accelerate innovations through three broad technical approaches that contribute to safeguarding America and its allies from weapons of mass destruction and provide capabilities to reduce, eliminate, and counter their effects. 

DOD
Directed Energy and Space Vehicles Cooperative Agreement
http://www.grants.gov/web/grants/view-opportunity.html?oppId=280237
Application Deadline: November 23, 2020
The objective of this effort is to establish a combined cooperative agreement vehicle to efficiently award research funds to investigate new concepts as well as the ancillary supporting technologies for directed energy and space vehicles and to enhance theoretical analyses, exploratory studies, or experiments conducted by educational institutions.

DOD
Emergent II Research and Development
https://www.fbo.gov/spg/DLA/J3/DSCP-PB/BAA-0002-14/listing.html

The Defense Logistics Agency invites applications to support projects on emergent logistics and procurement methods and technologies in four technical areas or projects focused on increasing knowledge or understanding of the logistic and procurement processes.

Applications will be accepted on a continuing basis until April 29, 2019.

DOD
Emerging Computing Architectures and Applications
https://www.fbo.gov/index?s=opportunity&mode=form&id=e10fb45d00b2e070cca27c4494140fb6&tab=core&_cview=1

The Air Force Research Laboratory invites proposals for research projects on innovative technologies in six technical areas that explore and develop cutting-edge computational capabilities with greater sophistication, autonomy, intelligence, and assurance.

White papers are due June 16, 2014; March 2, 2015; March 1, 2016; March 1, 2017; March 1, 2018; and September 30, 2019.

 

DOD
Enabling Technologies for High-speed Operable Systems
https://www.fbo.gov/index?s=opportunity&mode=form&id=6720537f5592c2528055f12d20966c8b&tab=core&_cview=1
Required concept papers are accepted on a rolling basis until January 18, 2024. Full proposals will be solicited upon request after concept paper review.

DOD
Fundamental Research to Counter Weapons of Mass Destruction
http://www.grants.gov/web/grants/view-opportunity.html?oppId=275322
Pre-application white papers are required and can be submitted on an open basis until September 1, 2024. Full applications may be submitted only after sponsor invitation.

DOD
Global Operational Tactical Information Technology
https://www.fbo.gov/index?s=opportunity&mode=form&id=5346f250a4f5c8a3f53907c7bc54168a&tab=core&_cview=1
This program funds research on innovative technologies to enable the effective management of information for military operations. Applications will be accepted in the four technical areas described in the announcement. 

DOD
High-Powered Electromagnetics (HPEM) Research Program
https://www.fbo.gov/spg/USAF/AFMC/AFRLPLDED/BAA-RVKD-2014-0003/listing.html

AFRL invites proposals for the HPEM Research Program to support research in six technical areas described in the announcement. 

Applications will be accepted on a continuing basis until May 5, 2020.

DOD
Intelligence and Information Warfare BAA
https://www.fbo.gov/notices/e2855aca8cabab2207d5797c04bb38c7

The Communications-Electronics, Research Development and Engineering Center invites proposals to support research and development in areas related to intelligence and information warfare.

Applications will be accepted until August 25, 2019.

DOD
Methods and Technologies for Personalized Learning, Modeling and Assessment
http://www.grants.gov/web/grants/view-opportunity.html?oppId=271531

This program deals with science and technology development, experimentation, and demonstration in the areas of improving and personalizing individual, team, and larger group instructional training methods for airmen. The approaches relate to competency definition and requirements analysis, training and rehearsal strategies, and models and environments that support learning and proficiency achievement and sustainment during non-practice of under novel contexts. This effort focuses on measuring, diagnosing, and modeling airman expertise and performance, rapid development of models of airman cognition and specifying and validating, both empirically and practically, new classes of synthetic, computer-generated agents and teammates.

The closing date for submission of white papers is November 17, 2019.

DOD
Multi-Domain Aerial Warfighting Network Capabilities
https://www.fbo.gov/index?s=opportunity&mode=form&id=e831159ec0fa9b0ac27c732801a0bfb5&tab=core&_cview=0
Application Deadline: September 30, 2022
Concept papers are being solicited on a rolling submission basis for research to develop and demonstrate innovative and affordable technologies that provide agile and secure information transmission, network, and dissemination capabilities to aerial platforms that enable the sharing of quality information within resource and policy constraints. 

DOD
Open Innovation and Collaboration
https://www.fbo.gov/spg/USAF/AFMC/AFRLWRS/BAA-RQKD-2014-0001/listing.html

The Air Force Research Laboratory invites proposals for the Open Innovation Program to Overcome Technology and/or New Product Barriers for Solutions to Air Force Problems. 

Proposals will be accepted on a continuing basis until July 12, 2019.

DOD
Radio Frequency Communications Systems Research, Development, Test, and Evaluation
https://www.fbo.gov/index?s=opportunity&mode=form&id=019233dec6007bc134fdda0b8c3d63ae&tab=core&_cview=1
The Air Force Research Laboratory Information Directorate is soliciting white papers under this broad agency announcement for research, design, development, concept testing, evaluation, and experimentation in the area of radio frequency communications systems for command, control, communications, and computers/intelligence. Efforts in this area may include technologies and techniques to control, monitor, configure, and analyze the radio frequency and spectrum environment as well as assessment, instrumentation, configuration, and control of experimental systems. 

DOD
Unmanned Aircraft System Airspace Integration
http://www.grants.gov/web/grants/view-opportunity.html?oppId=261268

The objective of this effort is to conduct basic, applied, advanced, and demonstration/validation research to develop, demonstrate, integrate, and transition new unmanned aircraft system airspace integration technologies to the warfighter.

Applications will be accepted until August 6, 2019.

DOD
Very Low Frequency/Low Frequency Communications Technologies Research
https://www.fbo.gov/index?s=opportunity&mode=form&id=ba864ca7ba6d0bcf01acde0d05d5f9ba&tab=core&_cview=1
This program's objective is solicit research resulting in significant advances in science and technology that could solve urgent problems in very low frequency communications technologies. 

FDA
Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies (U01)
http://www.grants.gov/web/grants/view-opportunity.html?oppId=276023

The goal of this program is to support the advancement of regulatory science that can facilitate the implementation and the assessment of emerging manufacturing technology in the pharmaceutical sector. Emerging manufacturing technology can be viewed as a technology that has the potential to modernize the pharmaceutical manufacturing body of knowledge to support more robust, predictable, and/or cost-effective processes and with which the FDA has limited review or inspection experiences due to its relative novelty. Examples of such elements include an innovative or novel: (1) product manufacturing technology, such as the dosage form; (2) manufacturing process (e.g., design, scale-up, and/or commercial scale); and/or (3) testing technology.    

Application dates vary. See solicitation for details.

NIH
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-530.html
The purpose of this announcement is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. 

NIH
Academic-Industrial Partnerships to Translate and Validate In Vivo Cancer Imaging Systems (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-093.html
The purpose of this announcement is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem.

NIH
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-023.html

NIH
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-024.html
The purpose of this opportunity is to encourage grant applications from the scientific community that develop and test tools to address symptoms in caregivers. The key to this announcement is the focus on the caregiver, regardless of patient symptoms or conditions. Research is needed to enhance symptom recognition and assessment in caregivers and to promote technological strategies to alleviate distress in caregiver symptoms. 

NIH
Bioengineering Research Grants (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-158.html
The purpose of this announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem and 2) integrate, optimize, validate, translate, or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science.

NIH
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-148.html
This funding opportunity intends to accelerate the integration and use of scalable technologies and tools to enhance brain cell census research, including the development of technology platforms and/or resources that will enable a swift and comprehensive survey of brain cell types and circuits. 

NIH
BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-020.html
Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This solicitation seeks applications for proof-of-concept testing and development of new technologies and novel approaches for large-scale recording and manipulation of neural activity to enable transformative understanding of dynamic signaling in the nervous system. 

NIH
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-001.html
This opportunity seeks applications to assemble diverse, integrated, multi-disciplinary teams that cross boundaries of interdisciplinary collaboration to investigate high-impact questions in human neuroscience. Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to brain recording and stimulating from invasive surgical procedures. 

NIH
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-006.html
This opportunity supports efforts to disseminate resources and to integrate them into neuroscience research practice. Projects should engage in one or more of the following activities: distribution of tools and reagents; user training on the usage of new technologies or techniques; providing access to existing technology platforms and specialized facilities; minor improvements to increase the scale/efficiency of resource production and delivery; minor adaptations to meet the needs of a user community. 

NIH
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-003.html
This opportunity will support integrated, interdisciplinary research teams from prior BRAIN technology and/or integrated approaches teams, and/or new projects from the research community that focus on examining circuit functions related to behavior using advanced and innovative technologies. 

NIH
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-113.html
This announcement will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported will establish and collectively participate in the Cancer Tissue Engineering Collaborative Research Program.

NIH
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-266.html
This announcement invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. 

NIH
Exploratory Research for Technology Development (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-046.html
This initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high risk approaches with potential for significant impact. Projects will entail a high degree of risk or novelty, which will be offset by a correspondingly high potential impact. However, the possible impact is likely to be far off. Application of the proposed technology to specific biomedical questions is considered beyond the scope of the program. Preliminary data demonstrating feasibility of the proposed approach indicates that the project is beyond the scope of this program. 

NIH
Exploratory/Developmental Bioengineering Research Grants (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-149.html
The purpose of this engineering-oriented funding opportunity announcement is to encourage submissions of exploratory/developmental Bioengineering Research Grant applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.    

NIH
Focused Technology Research and Development (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-045.html
This initiative will support projects that focus solely on development of technologies with the potential to enable biomedical research. Projects should be justified in terms of potential biomedical impact, but should not include any application to specific biomedical research questions.

NIH
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-18-003.html

NIH
ImmuneChip: Engineering Microphysiological Immune Tissue Platforms (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-138.html
The purpose of this funding opportunity is to promote the development of in vitro platforms that recapitulate components of the human immune system. Applications that qualify for this funding will focus on engineering 3-D in vitro microphysiological immune system tissues, adding immune system responsiveness to existing in vitro platforms, and/or in vitro modeling of autoimmune diseases and inflammation.

NIH
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-021.html
This funding opportunity announcement solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. 

NIH
Innovative Measurement Tools for Community Engaged Research Efforts (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-13-209.html

Standard deadline dates apply. See solicitation for details.

NIH
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-019.html
This funding opportunity announcement solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research.

NIH
Innovative Research in Cancer Nanotechnology (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-240.html
This announcement encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is a component of a broader program that is the NCI Alliance for Nanotechnology in Cancer. IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. 

NIH
Medical Simulators for Practicing Patient Care Providers: Skill Acquisition, Outcomes Assessment, and Technology Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-065.html
The purpose of the funding opportunity is to promote the assessment and further development of simulation technologies intended to improve patient safety and healthcare outcomes provided by practicing patient care providers and experienced (not trainee) physicians. 

NIH
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-907.html
The purpose of this opportunity is to support the development of advanced computational, bioinformatic, and statistical tools to determine the functional relevance of genetic variants associated with mental disorders of complex etiologies identified through genome-wide association or sequencing studies. The overarching goal of this initiative is to support the development of innovative computational methods that facilitate the elucidation of the functionality of genetic variants associated with mental illness, taking into account the added complexities and nuances of brain diseases, and to ultimately inform novel treatment development based on human biology. This opportunity should be used when two or more sites are needed to complete the study. 

NIH
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-908.html
The purpose of this opportunity is to support the development of advanced computational, bioinformatic, and statistical tools to determine the functional relevance of genetic variants associated with mental disorders of complex etiologies identified through genome-wide association or sequencing studies. The overarching goal of this initiative is to support the development of innovative computational methods that facilitate the elucidation of the functionality of genetic variants associated with mental illness, taking into account the added complexities and nuances of brain diseases, and to ultimately inform novel treatment development based on human biology.

NIH
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-209.html
The objective of this funding opportunity announcement is to support the development of new and innovative on-demand, event-driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages.

NIH
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-533.html
This announcment is intended to provide an avenue for basic scientists, clinicians, and clinical scientists to jointly initiate and conduct translational research projects that translate basic research findings into clinical tools for better human health. 

NIH
NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-542.html
This announcement supports the development of therapeutic biotechnology products and biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging therapies) for disorders identified under the NINDS mission. 

NIH
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-896.html
This announcement is designed to support innovative research in biomedical informatics and data science. The scope of interest in the research domain of informatics is broad and interdisciplinary.

Standard application dates apply. See solicitation for details.

NIH
Novel Genomic Technology Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-777.html
This announcement seeks grant applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency or comprehensiveness (individually or in combination). This announcement explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing. Those projects should respond to a parallel set of announcements (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).

Application dates vary. See solicitation for details.

NIH
Novel Genomic Technology Development (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-778.html
This announcement seeks applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today, or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency, or comprehensiveness (individually or in combination). This announcement explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing. Those projects should respond to a parallel set of announcements (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).

Application dates vary. See solicitation for details.

NIH
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-001.html
This announcement solicits R01 applications to develop novel technologies that will enable no less than one order of magnitude improvement in DNA sequencing and practical methods for direct RNA sequencing.

Application dates vary. See solicitation for details.

NIH
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-002.html
This announcement solicits R21 applications to develop novel technologies that will enable substantive (no less than an order of magnitude) improvement in DNA sequencing and practical methods for direct RNA sequencing.

Application dates vary. See solicitation for details.

NIH
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-128.html
This announcement encourages research project applications under the cooperative agreement mechanism to address the development, optimization, and validation of quantitative imaging software tools and methods for prediction and/or measurement of response to cancer therapies or for planning and validating radiation therapy treatment strategies in clinical trials.

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-146.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. Of particular interest is research designed to maintain functional capabilities in such conditions as cardiac and respiratory insufficiency, movement impairment associated with arthritis, chronic back pain, stroke, and other physical or cognitive disabilities.

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-012.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities, and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. 

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-164.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities, and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. Of particular interest is research designed to maintain functional capabilities in such conditions as cardiac and respiratory insufficiency, movement impairment associated with arthritis, chronic back pain, stroke, and other physical or cognitive disabilities.

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-011.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. 

NIH
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-434.html
This announcement invites applications to conduct research to advance the understanding and application of synthetic biology for human health. It will support 1) the development of innovative tools and technologies in synthetic biology and 2) their application in biomedical research and human health. An integrative research plan based on collaborations of synthetic biologists with computational scientists, cell biologists, engineers, and/or physician scientists is strongly recommended. Early Stage Investigators in synthetic biology are especially encouraged to apply.

NIH
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-145.html
This announcement seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others. Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation. Research projects that a) incorporate emerging and cutting edge technologies to explain and predict patient trajectories, b) inform interventions, c) support real-time clinical decision making, and d) facilitate effective long-term management of chronic illness are especially needed. Proposed research should identify specific patient outcomes expected to improve from technological approaches. The specific tools or interventions proposed should clearly indicate how they will enhance patient benefits in environments, such as clinical settings, and/or in the home and community.

NIH
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-163.html
This announcement seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others. Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation. Research projects that a) incorporate emerging and cutting-edge technologies to explain and predict patient trajectories, b) inform interventions, c) support real-time clinical decision making, and d) facilitate effective long-term management of chronic illness are especially needed. Proposed research should identify specific patient outcomes expected to improve from technological approaches. The specific tools or interventions proposed should clearly indicate how they will enhance patient benefits in environments, such as clinical settings, and/or in the home and community.

NIH
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-009.html
This announcement seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others. Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation. 

NSF
Advanced Manufacturing
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505572
The Advanced Manufacturing program accelerates advances in manufacturing technologies with emphasis on multidisciplinary research that fundamentally alters and transforms manufacturing capabilities, methods, and practices. Proposals should address issues related to national prosperity and security, and advancing knowledge to sustain global leadership.

NSF
Biological and Environmental Interactions of Nanoscale Materials
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505553
The goal of the Biological and Environmental Interactions of Nanoscale Materials program is to support research to advance fundamental and quantitative understanding of the interactions of nanomaterials and nanosystems with biological and environmental media.

NSF
Broadening Participation in Engineering
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314104
This program aims to support the development of a diverse and well-prepared engineering workforce by supporting research activities will provide scientific evidence that engineering educators, employers, and policy makers need to make informed decisions to design effective programs that broaden the participation of persons from historically underrepresented groups in the engineering workforce

NSF
Cyber-Physical Systems
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312827
This program aims to develop the core research needed to engineer systems that are built from, and depend upon, the seamless integration of computation and physical components.

NSF
Cyberinfrastructure for Emerging Science and Engineering Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311402
This program aims to catalyze new science and engineering discovery pathways through early-stage collaborative activities between disciplinary scientists and engineers as well as developers/implementers of innovative cyberinfrastructure (CI) capabilities, services, and approaches.

NSF
Cyberinfrastructure for Sustained Scientific Innovation (CSSI): Elements and Framework Implementations
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312713
The CSSI umbrella program seeks to enable funding opportunities that are flexible and responsive to the evolving and emerging needs in cyberinfrastructure. This program continues the CSSI program by removing the distinction between software and data elements/framework implementations, and instead emphasizing integrated cyberinfrastructure services, quantitative metrics with targets for delivery and usage of these services, and community creation.

NSF
Dear Colleague Letter - Collaborative Supplemental Funding Opportunity in Graphene and 2D Layered Materials and Devices under the U.S. NSF/ENG - US-EC International Opportunity
http://www.nsf.gov/pubs/2016/nsf16102/nsf16102.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
This Dear Colleague Letter (DCL) invites applications for supplemental funding requests to support collaborations in graphene and 2D layered materials and devices between the U.S. and international research communities.

NSF
Dear Colleague Letter: Removal of Deadlines for the Biological and Environmental Interactions of Nanoscale Materials Program in the Division of Chemical, Biological, Environmental, and Transport Systems (CBET) in the Directorate for Engineering
https://www.nsf.gov/pubs/2017/nsf17085/nsf17085.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
The Biological and Environmental Interactions of Nanoscale Materials Program in the CBET Division has, as of April 2017, eliminated target dates and will accept proposals for consideration at any time. To allow time to adapt to the "open submission - no deadline" guidelines, new proposals will be considered for review after July 20, 2017.

NSF
Dear Colleague Letter: Stimulating Collaboration Between U.S. and European Union Robotics Researchers
http://www.nsf.gov/pubs/2015/nsf15011/nsf15011.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
Application Deadline: January 1, 2015

In order to stimulate collaboration between U.S. and EU robotics researchers, this Dear Colleague Letter announces NSF's intention to provide supplemental funding to existing Robust Intelligence and National Robotics Initiative awards that are focused on robotics. Funds will be used to pay for the travel of U.S. researchers, as well as stipends and travel support for graduate students and postdocs visiting their EU collaborators. Funds can also be used to pay stipends of visiting EU students and postdocs who have visiting appointments at U.S. institutions.

NSF
Distributed Array of Small Instruments
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311540
Application Deadline: April 19, 2019
This solicitation addresses the increasing need for high spatial and temporal resolution measurements to determine the local, regional, and global scale processes essential for addressing the fundamental questions in solar and space physics. 

NSF
Emerging Frontiers in Research and Innovation 2019 (EFRI-2019)
https://www.nsf.gov/pubs/2019/nsf19502/nsf19502.pdf
EFRI seeks proposals with transformative ideas that represent an opportunity for a significant shift in fundamental engineering knowledge with a strong potential for long-term impact on national needs or a grand challenge. For this solicitation, we will consider proposals that aim to investigate emerging frontiers in one of the following two research areas: Chromatin and Epigenetic Engineering (CEE) or Continuum, Compliant, and Configurable Soft Robotics Engineering (C3 SoRo). Required letters of intent are due by November 29, 2018. Required preliminary proposals are due by January 7, 2019, and full applications are due by April 25, 2019.

NSF
Enabling Quantum Leap: Quantum Idea Incubator for Transformational Advances in Quantum Systems
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310478
Application Deadline: May 24, 2019

NSF
Expeditions in Computing
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503169
The Expeditions in Computing (Expeditions) aims to tap the great reservoir of opportunities that fundamental research advances in computer and information science and engineering promise for the future. The program is designed to inspire the computer and information science and engineering research and education community to be as creative and imaginative as possible in the design of bold Expeditions projects that explore new scientific frontiers.

NSF
Growing Convergence Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312774
This program supports team research that crosses directorate or division boundaries and is currently not supported by NSF programs, initiatives and research-focused Big Ideas. This research should address a specific challenge or opportunity, whether it arises from deep scientific questions or pressing societal needs.

Proposal due dates are May 8, 2019, February 3, 2020, and the first Monday in February annually thereafter.

NSF
Harnessing the Data Revolution: Institutes for Data-Intensive Research in Science and Engineering - Frameworks
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312714
Application Deadline: May 7, 2019
This program seeks to create an integrated fabric of interrelated institutes that can accelerate discovery and innovation in multiple areas of data-intensive science and engineering. 

NSF
Harnessing the Data Revolution: Institutes for Data-Intensive Research in Science and Engineering - Ideas Labs
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311121
Ideas Labs are intensive workshops focused on finding innovative and bold transdisciplinary solutions to grand challenge problems. This solicitation aims to support one or more Ideas Labs focused on Data-Intensive Research in Science and Engineering.

NSF
Harnessing the Data Revolution: Transdisciplinary Research in Principles of Data Science Phase I
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312753
This program aims to bring together the electrical engineering, mathematics, statistics, and theoretical computer science communities to develop the theoretical foundations of data science through integrated research and training activities. Phase I will support the development of small collaborative Institutes.

NSF
Ideas Lab: Cross-cutting Initiative in CubeSat Innovations
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310453
Application Deadline: May 30, 2019

NSF
Mechanics of Materials and Structures
https://www.grants.gov/web/grants/view-opportunity.html?oppId=306172
The Mechanics of Materials and Structures program supports fundamental research in mechanics as related to the behavior of deformable solid materials and structures under internal and external actions. The program supports a diverse spectrum of research with emphasis on transformative advances in experimental, theoretical, and computational methods. Proposals accepted anytime.

NSF
Mid-scale Research Infrastructure-2
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311063
This program supports implementation of projects that comprise any combination of equipment, instrumentation, computational hardware and software, and the necessary commissioning and human capital in support of implementation of the same. 

NSF
Mind, Machine, and Motor Nexus
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505402

NSF
Molecular Separations
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505559
The Molecular Separations program supports research focused on novel methods and materials for separation processes, such as those central to the chemical, biochemical, bioprocessing, materials, energy, and pharmaceutical industries.

NSF
National Robotics Initiative 2.0: Ubiquitous Collaborative Robots
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310513
Application Deadline: November 19, 2019
This program builds upon the original National Robotics Initiative (NRI) program to support fundamental research in the United States that will accelerate the development and use of collaborative robots (co-robots) that work beside or cooperatively with people. The focus of the NRI-2.0 program is on ubiquity, which in this context means seamless integration of co-robots to assist humans in every aspect of life.

NSF
Next Generation Networks for Neuroscience
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313460
The goal of this solicitation is to support collaborative networks comprised of international teams of disciplinarily diverse experimentalists, theorists, and research resource (including technology and cyberinfrastructure) developers working on a common foundational question in neuroscience.

NSF
Operations Engineering
https://www.grants.gov/web/grants/view-opportunity.html?oppId=306167
The Operations Engineering (OE) program supports fundamental research on advanced analytical methods for improving operations in complex decision-driven environments. Analytical methods include, but are not limited to, deterministic and stochastic modeling, optimization, decision and risk analysis, data science, and simulation.

NSF
Planning Grants for Engineering Research Centers (ERC)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313291
Application Deadline: June 3, 2019
The ERC program intends to support planning activities leading to convergent research team formation and capacity-building within the engineering community. This planning grant solicitation is designed to foster and facilitate the engineering community's thinking about how to form convergent research collaborations.

NSF
Quantum Leap Challenge Institutes
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313033
Quantum Leap Challenge Institutes are large-scale interdisciplinary research projects that aim to advance the frontiers of quantum information science and engineering. Two types of awards will be supported under this program: (i) 12-month Conceptualization Grants to support teams envisioning subsequent Institute proposals and (ii) 5-year Challenge Institute awards to establish and operate Quantum Leap Challenge Institutes.

NSF
Real-Time Machine Learning (RTML)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313511
Application Deadline: June 6, 2019
This solicitation seeks to lay the foundation for next-generation co-design of RTML algorithms and hardware, with the principal focus on developing novel hardware architectures and learning algorithms in which all stages of training (including incremental training, hyperparameter estimation, and deployment) can be performed in real time.

NSF
Signals in the Soil
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312894
Application Deadline: May 15, 2019
This program supports research concepts that integrate fundamental science and engineering knowledge in different disciplines in a convergent approach with the aim of developing the next generation of sensors capable of in-situ measurement of dynamic soil biological, physical, and chemical variables. 

NSF
Smart and Connected Communities
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313513
This program supports integrative research that addresses fundamental technological and social science dimensions of smart and connected communities and pilots solutions together with communities.

Required letters of intent are due August 6, 2019. Full proposals are due September 6, 2019.

NSF and FDA
NSF/FDA Scholar-in-Residence at FDA
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf18556
The NSF/FDA Scholar-in-Residence Program at FDA comprises an interagency partnership for the investigation of scientific and engineering issues concerning emerging trends in medical device technology. This partnership is designed to enable investigators in science, engineering, and computer science to develop research collaborations within the intramural research environment at the FDA. 

Centers for Disease Control and Prevention
Grants to Support New Investigators in Addressing Cross-Cutting Violence Prevention and Opioid Overdose Prevention
https://www.grants.gov/web/grants/view-opportunity.html?oppId=309557
Application Deadline: April 1, 2019
The National Center for Injury and Prevention Control intends to provide support for an intensive, supervised (mentored) career development experience to develop new researchers in the fields of opioid overdose prevention and cross-cutting violence prevention. Investigators focused on opioid overdose prevention must propose a research project to investigate risk factors for and strategies to prevent opioid overdose.

Department of Defense
Air Force Young Investigator Research Program (YIP)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313523
Application Deadline: June 3, 2019
The Air Force Young Investigator Research Program (YIP) intends to support young in career scientists and engineers who have received their Ph.D. or equivalent degrees by April 1, 2012, or later and who show exceptional ability and promise for conducting basic research. The program objective is to foster creative basic research in science and engineering; enhance early career development of outstanding young investigators; and increase opportunities for the young investigator to recognize the Air Force mission and related challenges in science and engineering.

Department of Energy
Early Career Research Program
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002019.pdf
Application Deadline: April 29, 2019
Department of Energy's Office of Science invites grant applications for support under the Early Career Research Program in the following program areas: Advanced Scientific Computing Research (ASCR); Biological and Environmental Research (BER); Basic Energy Sciences (BES), Fusion Energy Sciences (FES);
High Energy Physics (HEP), and Nuclear Physics (NP). The purpose of this program is to support the development of individual research programs of outstanding scientists early in their careers and to stimulate research careers in the areas supported by the Office of Science. Pre-applications are required and due February 6, 2019.

Department of Energy
Nuclear Energy University Programs - Fellowship and Scholarship Support
https://nugrant.unl.edu/fundingOpps/singleOpportunity?VCRFundingOpID=7839
Application Deadline: January 31, 2021
The purpose of this Funding Opportunity Announcement is to award multiple cooperative agreements to accredited U.S. two- and four-year colleges and universities to receive and administer scholarship and fellowship funding provided through the Integrated University Program and administered by the Department of Energy on behalf of selected students attending these universities.

For a copy of this solicitation, please contact Tiffany Lee at tlee9@unl.edu.

Department of Justice
Graduate Research Fellowship in Science, Technology, Engineering, and Mathematics
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312095
Application Deadline: April 17, 2019
The Graduate Research Fellowship in Science, Technology, Engineering, and Mathematics opportunity provides grants to accredited academic institutions to support graduate research leading to doctoral degrees in topic areas that are relevant to preventing and controlling crime, and ensuring the fair and impartial administration of criminal justice in the United States.

Department of Justice
Graduate Research Fellowship Program in the Social and Behavioral Sciences
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312643
Application Deadline: April 8, 2019
This program provides awards to accredited academic institutions to support graduate research leading to doctoral degrees in areas that are relevant to ensuring public safety, preventing and controlling crime, and ensuring the effective administration of criminal justice in the United States.

Department of the Interior
BLM National Interagency Fire Center (NIFC) Joint Fire Science Program (JFSP) Graduate Research Innovation (GRIN)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313753
Application Deadline: May 16, 2019
The Graduate Research Innovation (GRIN) award is for current master and doctoral students enrolled at colleges or universities within the United States in the field of wildland fire and related physical, biological, and social sciences, to enhance student exposure to the management and policy relevance of their research to achieve beneficial outcomes of funded work.

Gerald R. Ford Presidential Library and Museum
Gerald R. Ford Scholar Award
http://www.fordlibrarymuseum.gov/library/fsa.asp
Application Deadline: March 31, 2019
The award is given to a doctoral student to support dissertation research and writing in any field related to any aspect of the United States' political process and public policy during the last half of the 20th century.

J.M. Kaplan Fund
The J.M.K. Innovation Prize
https://www.jmkfund.org/funds/innovation-prize/
This prize supports those addressing our country's most pressing needs through social innovation. Specifically, the prize supports innovators who are spearheading transformative early-stage projects in the fields of the environment, heritage conservation, and social justice. Application is a two-step process. The first-round application is due April 30, 2019, and select applicants will be invited to submit a more detailed second-round application in late spring.

John F. Kennedy Library Foundation
Research Fellowships
http://www.jfklibrary.org/About-Us/Job-Volunteer-Internships/Research-Grants-and-Fellowships.aspx
Application Deadline: August 15, 2019
Several research fellowships are offered, which are intended to support scholars and students who wish to make use of the archival holdings (including audiovisual materials) of the John F. Kennedy Presidential Library and Museum. Topics of interest include foreign intelligence and the presidency or a related topic; the foreign policy of the Kennedy Presidency or the Kennedy Administration's domestic policy; immigration, naturalization, or refugee policy; and domestic policy, political journalism, polling, or press relations.

Library of Congress
David B. Larson Fellowship in Health and Spirituality
https://www.loc.gov/programs/john-w-kluge-center/chairs-fellowships/fellowships/larson-fellowship-in-health-and-spirituality/
Application Deadline: April 17, 2019
This fellowship provides an opportunity for a period of six to 12 months of concentrated use of the collections of the Library of Congress, through full-time residency in the Library's John W. Kluge Center, to conduct scientific study of the relation of religiousness and spirituality to physical, mental, and social health.

Library of Congress
Kluge Fellowships
https://www.loc.gov/programs/john-w-kluge-center/chairs-fellowships/fellowships/kluge-fellowships/
Application Deadline: July 15, 2019
These fellowships allow scholars to conduct research at the Kluge Center using the Library of Congress collections and resources for a period of four to eleven months. The Kluge Center especially encourages humanistic and social science research that makes use of the Library's large and varied collections.

NASA
ROSES 2018: Early Career Fellowship Start-up Program for Named Fellows
https://www.grants.gov/web/grants/view-opportunity.html?oppId=300800
The Early Career Fellowship program supports the development of individual research programs of outstanding scientists early in their careers and stimulates research careers in the areas supported by the Planetary Sciences Division. 

NEH
Fellowships
http://www.neh.gov/grants/research/fellowships
Application Deadline: April 10, 2019
These fellowships are granted to individual scholars pursuing projects that embody exceptional research, rigorous analysis, and clear writing. Applications must clearly articulate a project's value to humanities scholars, general audiences, or both. Applicants interested in research projects that are either born digital or require mainly digital expression and digital publication are encouraged to apply instead for NEH-Mellon Fellowships for Digital Publication. Applicants for NEH Fellowships may not also apply to the NEH Fellowship Program for Advanced Social Science Research on Japan or the NEH-Mellon Fellowships for Digital Publication program.

NEH
NEH-Mellon Fellowships for Digital Publication
https://www.neh.gov/grants/research/neh-mellon-fellowships-digital-publication
Application Deadline: April 10, 2019
These fellowships support individual scholars pursuing interpretive research projects that require digital expression and digital publication. To be eligible for this special opportunity, an applicant's plans for digital publication must be essential to the project's research goals. Applicants for NEH-Mellon Fellowships for Digital Publication may not also apply to the NEH Fellowship Program for Advanced Social Science Research on Japan or the NEH Fellowships program.

NEH and the Japan-U.S. Friendship Commission
Fellowships for Advanced Social Science Research on Japan
http://www.neh.gov/grants/research/fellowships-advanced-social-science-research-japan
Application Deadline: April 24, 2019
Awards support research on modern Japanese society and political economy, Japan's international relations, and U.S.-Japan relations. Applicants to the Fellowship Program for Advanced Social Science Research on Japan may not also apply to the NEH Fellowships or the NEH-Mellon Fellowships for Digital Publication programs.

New York Public Library
Fordham-NYPL Research Fellowships in Jewish Studies
https://www.nypl.org/fordham-nypl-fellowship
Application Deadline: March 31, 2019
This fellowship program is open to scholars in all fields of Jewish Studies seeking to conduct on-site research in the New York Public Library, especially the Dorot Jewish Division. Short-term and mid-term fellowships are available.

NIH
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-916.html
This funding opportunity seeks to facilitate the entry of both newly independent and early career investigators to the area of drug use and use disorder research and HIV/AIDS. This opportunity encourages Small Research Grant (R03) applications to support research projects on drug misuse and/or use disorder and HIV/AIDS that can be carried out in a short period of time with limited resources. 

NIH
Alcohol Research Resource Awards (R24)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-170.html
This funding opportunity announcement encourages non-hypothesis-driven grant applications to support investigator-initiated research projects that will maintain and expand the availability of resources to serve biomedical research within NIAAA's priority areas.

NIH
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-004.html
The Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators proposing highly innovative studies that address NIH HIV/AIDS Research Priorities. Specifically, the program will support research approaches, both basic and clinical, that have the potential to benefit substance using populations with or at risk for HIV/AIDS by reducing HIV incidence, improving therapies for HIV, reducing the impact of comorbid conditions, and ultimately eradicating HIV.

NIH
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-813.html
The purpose of this program is to increase workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators by enhancing the pool of individuals from nationally underrepresented groups in BRAIN Initiative research areas. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track, or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

See solicitation for application due dates.

NIH
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-814.html
The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers. Funds are specifically for applicants proposing research that does not involve leading a clinical trial, a clinical trial feasibility study, or ancillary clinical trial.

See solicitation for application due dates.

NIH
Chemical Discovery (CHEM) Award (R21/R33)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-384.html
The purpose of this announcement is to support the development of chemical probes that aid basic research investigations on substance use disorders (SUDs) or identify new lead chemical scaffolds with potential for structure activity relationship (SAR) studies on SUDs. In the long term, it is hoped that these lead chemical scaffolds will provide a greater number of pharmacological tools for basic research and possible drug candidates for medications development.

NIH
Chemistry Science Track Award for Rapid Transition (C/START) (R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-383.html
NIDA seeks to facilitate the entry of new/early stage investigators (ESIs) into substance use disorder (SUD) research. ESIs are invited to submit applications for small scale, innovative chemical/pharmacological pilot research projects. Importantly, the C/START award is intended to enable an ESI the opportunity to gather preliminary data in support of subsequent research grants (e.g., R21/R33 [CHEM], R21 or R01) or drug development funding opportunities that, in the long term, help to launch the ESIs scientific career. 

NIH
Cutting-Edge Basic Research Awards (R21-Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-437.html
This award is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders.

NIH
Genomic Innovator Award (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-006.html
This program aims to support researchers to do highly innovative work on important problems in genomics. The PD/PIs should be creative investigators, early in their careers, who are part of consortia, large research groups, or other team-science efforts. They should have New Investigator status and have shown the potential to make important contributions to the field of genomics. PD/PIs will have flexibility to take their research in novel directions as scientific opportunities arise during this award. 

NIH
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-918.html
This opportunity encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs to enable the conduct of small "proof of concept" studies. 

NIH
K01 Mentored Research Scientist Development Award
https://grants.nih.gov/grants/guide/pa-files/PAR-18-799.html
The purpose of the K01 grant program is to provide support and dedicated time for a supervised (mentored) career development experience in occupational safety and health research, leading to research independence. This grant program also is to help ensure the availability of adequate numbers of highly trained scientists and educators to address critical issues in occupational safety and health.

NIH
Maximizing Investigators' Research Award (R35)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-094.html
The Maximizing Investigators' Research Award is a grant to provide support for the program of research in an investigator's laboratory that falls within the mission of NIGMS. 

NIH
Maximizing Investigators' Research Award for Early Stage Investigators (R35)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-190.html
The Maximizing Investigators' Research Award (MIRA) is a grant to provide support for the program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. A program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. 

NIH
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-894.html
The purpose of this funding opportunity is to enhance the diversity of the mental health research workforce by providing dissertation awards in all research areas within the strategic priorities of the NIMH to individuals from groups underrepresented in biomedical, behavioral, clinical, and social sciences research. This award supports the completion of the doctoral research project.

NIH
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-026.html

NIH
Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)
https://grants.nih.gov/grants/guide/pa-files/PA-19-124.html
The purpose of this award is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.

NIH
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-18-005.html
The purpose of this award is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in research in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence.

NIH
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-126.html
The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and "protected time" (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. 

NIH
National Heart, Lung, and Blood Institute (NHLBI) Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-012.html
The purpose of the NHLBI EIA is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrate their ability to make major contributions to heart, lung, blood and sleep research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards.

NIH
National Heart, Lung, and Blood Institute (NHLBI) Outstanding Investigator Award (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-011.html
The purpose of the NHLBI Outstanding Investigator Award is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood, and sleep research.

NIH
NCMRR Early Career Research Award (R03)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-161.html
This award is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The proposed research should be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems; repair and recovery of motor and cognitive function; functional plasticity, adaptation, and windows of opportunity for rehabilitation interventions; rehabilitative strategies involving pharmaceutical, stimulation, neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices. The NCMRR ECR Award supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new technology. Irrespective of the type of project, the intent of the award is for PIs to obtain sufficient preliminary data for a subsequent R01 application. 

NIH
NIA Academic Leadership Career Award (K07)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-287.html
The objective of this award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

NIH
NIAID Career Transition Award (K22)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-434.html
The purpose of this program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.

NIH
NIBIB Trailblazer Award for New and Early Stage Investigators (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-390.html
This award is an opportunity for new and early stage investigators to pursue research programs of high interest to NIBIB that integrate engineering and the physical sciences with the life and behavioral sciences. Applications are invited from researchers who are at the early stage of their independent careers or those who have not had substantial prior NIH funding. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Applicants are expected to propose research approaches for which there are minimal or no preliminary data.

NIH
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-019.html
This program supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. 

NIH
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-001.html
The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. 

NIH
NIDCD Early Career Research Award (R21 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-487.html
This award is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. 

NIH
NIDCD Research Career Enhancement Award for Established Investigators (K18)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-346.html
The purpose of this award is to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech, and language sciences. 

NIH
NIDDK Mentored Research Scientist Development Award (K01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-211.html
The purpose of the NIDDK Mentored Research Scientist Development Award is to provide support and protected time for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. The NIDDK invites K01 applications from experienced postdoctoral (two years minimum) and/or recently appointed early career faculty (usually with a Ph.D. degree) in biomedical, behavioral, or clinical sciences who are pursuing careers in research areas supported by NIDDK.

NIH
NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-011.html
The purpose of the NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award is to support a defined pathway across career stages for outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical and behavioral sciences. This two-phase award will facilitate completion of the doctoral dissertation and transition of talented graduate students to strong neuroscience research postdoctoral positions and will provide career development opportunities relevant to their long-term career goal of becoming independent neuroscience researchers.

NIH
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-18-200.html
This award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers and who plan to make a long term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic, or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders. 

NIH
NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-469.html
This award is designed to enhance the participation of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. 

NIH
NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-220.html
This award is designed to enhance the participation of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. 

NIH
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-219.html
The purpose of this award is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time, and career stage appropriate professional development mentorship in neuroscience research. 

NIH
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-685.html
The purpose of this award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. 

NIH
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-686.html
The purpose of this award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. 

NIH
NINDS Postdoctoral Mentored Career Development Award (K01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-145.html
The purpose of this award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. 

NIH
Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-052.html
This program invites applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer's Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD or AD-related dementias (ADRD). This award will also allow data scientists to redirect their expertise toward the study of AD and ADRD.

NIH
Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship (Parent F32)
https://grants.nih.gov/grants/guide/pa-files/PA-19-188.html
The purpose of this fellowship is to enhance the research training of promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers.

NIH
Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship (Parent F31)
https://grants.nih.gov/grants/guide/pa-files/PA-19-195.html
The purpose of this fellowship award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the applicants dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist.

NIH
Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31 - Diversity)
http://grants.nih.gov/grants/guide/pa-files/PA-16-308.html
The purpose of this award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from population groups that have been shown to be underrepresented in the biomedical, behavioral, or clinical research workforce, including underrepresented racial and ethnic groups and those with disabilities. Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist.

NIH
Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)
https://grants.nih.gov/grants/guide/pa-files/PA-19-196.html
The purpose of this award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds, including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce.

NIH
Ruth L. Kirschstein National Research Service Award Individual Senior Fellowship (Parent F33)
https://grants.nih.gov/grants/guide/pa-files/PA-19-187.html
NIH awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. This announcement is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

NIH
Ruth L. Kirschstein National Research Service Award Individual Senior Fellowship (Parent F33)
http://grants.nih.gov/grants/guide/pa-files/PA-16-310.html
NIH awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.

NIH
Short-term Mentored Career Enhancement Awards for Mid-career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-692.html
This announcement encourages applications for short-term mentored career development awards that improve synergies among researchers in basic and applied behavioral-social sciences, human subjects, and model animals settings as well as biomedical and behavioral-social sciences. 

NIH
Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the Intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-881.html
The goal of the program is to support the development of research capability in mobile and wireless health technology (e.g., wearable devices, mobile applications, electronic health records, data analytics). Special emphasis will be given to independent behavioral and social sciences investigators who seek to train in a STEM discipline (e.g., big data analysis, computational modeling, engineering, computer science, and mathematics) or to STEM scientists who which to train in a behavioral and social science discipline.

NIH
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-467.html
This announcement represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial three years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.

NIH
Transition to Independent Environmental Health Research Career Transition Award (K01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-360.html
This award is a three-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences. At the conclusion of the career development period the candidates are expected to demonstrate they can successfully compete for research funding in the environmental health sciences.

Science History Institute
Library Travel Grants
https://www.sciencehistory.org/fellowships
These travel grants are given for periods of up to two weeks for research using the primary research materials of the Othmer Library, an independent research library encompassing the history of chemistry and related sciences and industries.

Applications are accepted on a rolling basis.

Simons Foundation
Simons Fellowship in Mathematics
https://www.simonsfoundation.org/grant/simons-fellows-in-mathematics/
Application Deadline: September 27, 2018
The Simons Foundation's Mathematics and Physical Sciences division invites applications for the Simons Fellows in Mathematics program, which is intended to make sabbatical leaves more productive by extending them to a full academic year for those that hold a tenured position within a mathematics department.

The Gilder Lehrman Institute of American History
Scholarly Fellowships
https://www.gilderlehrman.org/content/scholarly-fellowships
Application Deadline: May 13, 2019
These short-term research fellowships support doctoral candidates and university faculty at every rank working in the field of American history who intend to conduct research at archives in New York City.

The Kurt Weill Foundation for Music
Kurt Weill Prize
https://www.kwf.org/pages/call-for-nominations.html
Application Deadline: April 30, 2019
The 2019 Kurt Weill Prizes will be given for distinguished scholarship in music theater since 1900 (including opera) for works first published in calendar years 2017 and 2018. Two prizes will be awarded: one to the author of the winning book entry and another to the author of the winning article entry.

The Lyndon Baines Johnson Foundation
Harry Middleton Fellowship in Presidential Studies
http://www.lbjlibrary.org/page/foundation/initiatives/harry-middleton-fellowship-in-presidential-studies
Application Deadline: September 15, 2019
The Harry Middleton Fellowship supports scholarly work in presidential studies for doctoral students and postdoctoral fellows. Fellowship recipients must conduct research at the LBJ Library and at least one other facility of the National Archives and Records Administration.

The MacDowell Colony
MacDowell Fellowship
https://www.macdowellcolony.org/application-guidelines
These fellowships consist of exclusive use of a studio, accommodations, and three prepared meals a day for up to eight weeks at the MacDowell Colony. The Colony accepts applications from artists working in the following disciplines: architecture, film/video arts, interdisciplinary arts, literature, music composition, theatre, and visual arts.

The next two deadlines are April 15, 2019 and September 15, 2019.

U.S. Department of Education
Fulbright-Hays Doctoral Dissertation Research Abroad Fellowships
https://www2.ed.gov/programs/iegpsddrap/applicant.html?utm_content=&utm_medium=email&utm_name=&utm_source=govdelivery&utm_term=
Application Deadline: March 25, 2019
The Fulbright-Hays Doctoral Dissertation Research broad Fellowship Program provides opportunities to doctoral candidates to engage in full-time dissertation research abroad in modern foreign languages and area studies. The program is designed to deepen research knowledge and increase the study of modern foreign languages, cultural engagement, and area studies not generally included in U.S. curricula.

Vermont Studio Center
Vermont Studio Center Fellowships
http://vermontstudiocenter.org/fellowships
These residential fellowships are open to artists and writers living and working anywhere in the world.

There are three annual fellowship deadlines: October 1, February 15, and June 15.

Virginia Center for the Creative Arts
Residencies
https://vcca.com/main/apply
Application Deadline: May 15, 2019
This center offers working retreats for exceptional national and international artists, writers, and composers. For anywhere from two weeks to two months (depending on the fellowship), awardees come to the center for intense periods of work, free from the distractions of day-to-day life.

Department of Justice
Measuring the Impact of Victim Services: Instrument Development
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313301
Application Deadline: May 16, 2019
This opportunity seeks the development of a validated instrument for users of victim services to assess outcomes such as, but not limited to, satisfaction, needs addressed, additional needs identified and referrals. This solicitation is focused on the development of a validated, multi-lingual tool, as well as a platform for easy distribution.

Department of Justice
Office on Violence Against Women Research and Evaluation Solicitation
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312343
Application Deadline: March 25, 2019
The purpose of the Office on Violence Against Women's Research and Evaluation (R&E) Initiative is to research and evaluate approaches to combating domestic violence, sexual assault, dating violence, and stalking. R&E is designed to support researcher-practitioner partnerships and a broad range of research and evaluation methods, including qualitative, mixed-method, and quasi-experimental designs.

Department of Justice
Research and Development in Forensic Science for Criminal Justice Purposes
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312114
Application Deadline: April 11, 2019
The forensic science research and development grant program supports a discrete, specified, circumscribed project that will: (1) increase the body of knowledge to guide and inform forensic science policy and practice, or (2) lead to the production of useful material(s), device(s), system(s), or method(s) that have the potential for forensic application.

Department of Justice
Research and Evaluation in Safety, Health, and Wellness in the Criminal Justice System
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313637
Application Deadline: May 28, 2019
This opportunity seeks applications for funding of multidisciplinary research projects addressing three topics: 1) The impact of fatigue and stress on officer performance; 2) Enhancing strategies for officer interaction with mentally ill individuals; and 3) Advancing Resiliency for the Forensic Workforce- Understanding the Impact and Management of Stress, Burnout, and Vicarious Trauma.

Department of Justice
Research and Evaluation on Drugs and Crime
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312887
Application Deadline: May 6, 2019
This opportunity supports rigorous applied research on evidence-based tools, protocols, and policies that focus on criminal investigation, prosecution, drug intelligence, and community surveillance relevant to narcotics law enforcement, forensic science, and/or medicolegal death investigation. The FY2019 solicitation drug priorities are: 1) fentanyl and its illicit analogues, 2) methamphetamine, and 3) illegal marijuana markets.

Department of Justice
Research and Evaluation on Policing
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312707
Application Deadline: May 7, 2019
This opportunity seeks to fund investigator-initiated, randomized controlled trial (RCT) studies to inform policing at the State, local, and tribal levels.

Department of Justice
Research and Evaluation on Promising Reentry Initiatives
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312096
Application Deadline: May 13, 2019
This opportunity seeks to build knowledge on best practices in offender reentry initiatives with a focus on juveniles, young adults (aged 18-24), and adults that have a moderate-to-high risk of reoffending.

Department of Justice
Research and Evaluation on Terrorism Prevention
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312830
Application Deadline: April 22, 2019
The Domestic Radicalization and Terrorism program strives to better understand the primary drivers of radicalization and what can be done to prevent or intervene during the radicalization process through programmatic efforts.

Department of Justice
Research and Evaluation on the Administration of Justice
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312654
Application Deadline: April 19, 2019
This opportunity seeks to fund investigator-initiated, interdisciplinary research and evaluation projects related to the administration of justice in three areas: (1) eyewitness evidence; (2) police deflection strategies; and (3) forensic science testimony.

Department of Justice
Research and Evaluation on Trafficking in Persons
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313255
Application Deadline: May 8, 2019
This opportunity seeks to build upon previous research and evaluation efforts to better understand, prevent, and respond to trafficking in persons in the United States. Research responding to the following priority areas is of particular interest: 1) labor trafficking; 2) phased evaluation, not to exceed a 24-month period of performance; 3) outcome evaluation of trafficking focused on victim service providers; and 4) developing a better understanding of traffickers.

Department of Justice
Research and Evaluation on White Collar Crime: Health Care and Elder Fraud
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312947
Application Deadline: May 2, 2019

This opportunity supports scientifically rigorous research and evaluation projects that will advance our understanding of white collar crime and effective approaches for identifying, preventing, investigating and prosecuting white collar crime related to health care fraud, cyber crime against individuals, and elder fraud and financial exploitation.

Department of Justice
Research into Desistance from Crime
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312829
Application Deadline: April 29, 2019
This solicitation seeks to build upon research efforts to understand and aid in accelerating the process of desistance from crime. Applicants should propose research projects that have clear implications for criminal justice policy and practice in the United States.

Department of Justice
Research on Immigration and Crime
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313333
Application Deadline: May 20, 2019
This is a new solicitation undertaken this year to address the Department of Justice's interest in better understanding the nexus of crime and immigration, both legal and illegal.

Department of Energy
Systems Biology Enabled Research on the Roles of Microbiomes In Nutrient Cycling Processes
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002059.pdf
Application Deadline: May 17, 2019
This funding opportunity solicits applications for: i.) systems biology studies on regulatory, metabolic, and signaling networks of microbes, microbial consortia, and microbe-plant interactions involved in biogeochemical cycling of nutrients; and ii.) development and application of -omics approaches to investigate microbial community processes involved in biogeochemical nutrient cycling in terrestrial ecosystems. Pre-applications are required and due March 13, 2019.

DOD
Broad Agency Announcement for Extramural Medical Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=297726&utm_source=Funding+Supplement&utm_campaign=cbe3e60740-EMAIL_CAMPAIGN_2017_10_11&utm_medium=email&utm_term=0_8d6cbefc3d-cbe3e60740-212708225
The United States Army Medical Research Acquisition Activity invites applications for extramural medical research projects to provide solutions to medical problems of importance to the American service member at home and abroad, as well as to the general public at large. 

National Psoriasis Foundation
Psoriatic Arthritis Diagnostic Test Grant
https://www.psoriasis.org/sites/default/files/2019_psa_diagnostictest_loi_0.pdf
The National Psoriasis Foundation is seeking researchers to submit grant applications that aim to develop a clinically applicable diagnostic test for psoriatic arthritis that may improve detection of psoriatic arthritis in a highly sensitive, specific, and non-invasive manner. The Psoriatic Arthritis Diagnostic Test

National Psoriasis Foundation
Psoriatic Arthritis Diagnostic Test Grant
https://www.psoriasis.org/grants
The National Psoriasis Foundation is seeking researchers to submit grant applications that aim to develop a clinically applicable diagnostic test for psoriatic arthritis that may improve detection of psoriatic arthritis in a highly sensitive, specific, and non-invasive manner. The Psoriatic Arthritis Diagnostic Test Grant will fund research initiatives that have the potential to achieve this goal within five years. Projects will occur in two phases, with one year of support to establish proof-of-concept data followed by up to four additional years to complete research, development and validation.

NIH
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-426.html
The purpose of this announcement is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. 

NIH
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-425.html
The purpose of this announcement is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies that are now a leading cause of death in HIV-infected individuals. 

NIH
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-077.html
The purpose of this funding opportunity is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.

NIH
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-162.html
The ABCD Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood. These data will be made available to the scientific community through the National Institute of Mental Health Data Archive. The purpose of this funding opportunity is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. 

NIH
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-163.html
The ABCD Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood. These data will be made available to the scientific community through the National Institute of Mental Health Data Archive. The purpose of this funding opportunity is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. 

NIH
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-172.html
This funding opportunity announcement encourages state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. 

NIH
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-173.html
This funding opportunity announcement encourages state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. 

NIH
Acute Kidney Injury in Older Adults (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-13-141.html

Standard deadline dates apply. See solicitation for details.

NIH
Addressing Chronic Wound Trajectories Through Social Genomics Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-17-492.html
The purpose of this announcement is to stimulate clinical research that applies a social genomics approach to chronic wound risk, presence, progression, and healing. The field of social genomics focuses on how the social environment influences gene expression, and how this gene expression may in turn impact health outcomes. 

NIH
Addressing Chronic Wound Trajectories Through Social Genomics Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-17-493.html
The purpose of this announcement is to stimulate clinical research that applies a social genomics approach to chronic wound risk, presence, progression, and healing. The field of social genomics focuses on how the social environment influences gene expression, and how this gene expression may in turn impact health outcomes. 

NIH
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-368.html
This announcement invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. Specifically, this announcement will use the NIH Exploratory/Developmental Grants Phase II mechanism to provide support for expanded activities. Applicants are expected to have an existing research infrastructure developed either through PA-12-064 or with other NIH or non-NIH support. Through this award, investigators will develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

NIH
Advances in Polycystic Kidney Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-159.html
The purpose of this announcement is to increase investigator interest in basic and applied investigations of the etiology and pathogenesis of Polycystic Kidney Disease (PKD), in both its autosomal dominant and autosomal recessive forms.The ultimate aim is to facilitate PKD-related research studies, which will provide the basis for new therapeutic approaches. 

NIH
Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-505.html
This announcement encourages research grant applications to develop novel, robust assays to reveal changes in neuronal and/or glial function. The goal is to adapt state-of-the-art measures of basic cellular processes or molecular events that are key mediators of nervous system function into phenotypic assays, with the intent to probe mechanisms or perturbations in an unbiased and efficient manner. These novel assays would provide opportunities to measure neurobiological endpoints to accelerate basic discovery and support target identification and therapeutic development efforts.

NIH
Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-044.html
Application Deadline: April 25, 2019
The purpose of this opportunity is to support improved cancer immunotherapy research projects that reduce the incidence and/or severity of irAEs while retaining anti-tumor efficacy. Single investigators and/or multidisciplinary teams with expertise in mechanisms of cancer immunology, immune tolerance, irAEs, autoimmunity, and/or patient characterization and selection are encouraged to propose projects that utilize appropriate model systems, clinical samples, and expertise of these research communities. The specific objectives are to generate new ideas and approaches to better understand and thereby reduce the incidence and/or severity of irAEs resulting from cancer immunotherapy.

NIH
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-080.html

NIH
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-081.html
The purpose of this funding opportunity is to support the development of rapid, sensitive, specific, simple, and cost-effective fungal diagnostics for primary health-care settings (hospitals and point-of-care).

NIH
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-002.html
This announcement supports highly innovative R01 applications on HIV/AIDS and drug abuse and complements the Avant-Garde Award Program for HIV/AIDS and Drug Use Research and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS. 

NIH
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-022.html
This solicitation supports highly innovative R01 applications on HIV/AIDS and drug abuse and complements the Avant-Garde Award Program for HIV/AIDS and Drug Use Research and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS. 

NIH
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-876.html#_3._Additional_Information
The purpose of this funding opportunity is twofold: (1) to stimulate basic and mechanistic science that facilitates the development of effective probiotics or pre-/probiotic combinations of relevance to human health and disease; and (2) to determine biological outcomes for the evaluation of efficacy of pre/probiotics in appropriate test systems and animal models. This opportunity encourages basic and mechanistic studies using in vitro, in vivo, ex vivo, and in silico models that focus on prebiotic/probiotic strain selectivity, interaction, and function. It will also encourage inter and multidisciplinary collaborations among scientists in a wide range of disciplines including nutritional science, immunology, microbiomics, genomics, other '-omic' sciences, biotechnology, and bioinformatics.

NIH
Advancing Our Understanding of the Brain Epitranscriptome (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-152.html
The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and in the associated modification proteins that act on RNA (readers, writers, and erasers) that play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders. 

NIH
Advancing our Understanding of the Brain Epitranscriptomics (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-153.html
The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and/or the associated modification proteins that act on RNA (readers, writers, and erasers) and play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders. 

NIH
Advancing Research in Augmentative and Alternative Communication (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-047.html
This funding opportunity announcement solicits applications on augmentative and alternative communication to advance our scientific knowledge in the evaluation and treatment of individuals with complex communication needs or with severe speech and physical impairments.

NIH
Advancing Research in Augmentative and Alternative Communication (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-046.html
This funding opportunity announcement solicits applications on augmentative and alternative communication to advance our scientific knowledge in the evaluation and treatment of individuals with complex communication needs or with severe speech and physical impairments. 

NIH
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-902.html
The purpose of this funding opportunity is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. 

NIH
Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-031.html
The purpose of this announcement is to stimulate investigations, including translational, epidemiologic and clinical studies and trials, that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. 

NIH
Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-032.html
The purpose of this announcement is to stimulate investigations, including translational, epidemiologic and clinical studies and trials, that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. 

NIH
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-738.html
The overall purpose of this opportunity is to assess the role of the microbiome in health and disease during aging. 

NIH
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-739.html
The overall purpose of this announcement is to assess the role of the microbiome in health and disease during aging. 

NIH
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-863.html
The purpose of this funding announcement issued by the National Institute on Alcohol Abuse and Alcoholism is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

NIH
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-861.html
The purpose of this funding announcement issued by the National Institute on Alcohol Abuse and Alcoholism is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

NIH
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-862.html
The purpose of this funding announcement issued by the National Institute on Alcohol Abuse and Alcoholism is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

NIH
Alcohol-Induced Effects on Tissue Injury and Repair (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-297.html
This announcement encourages R01 applications to study molecular and cellular mechanisms of tissue injury and repair associated with alcohol use in humans. 

NIH
Alcohol-Induced Effects on Tissue Injury and Repair (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-296.html
This announcement encourages R21 applications to study molecular and cellular mechanisms of tissue injury and repair associated with alcohol use in humans. 

NIH
Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-823.html
The National Institute on Aging (NIA) invites applications for research projects (R01) involving secondary analyses of data and/or stored biospecimens from the CALERIE (Comprehensive Assessment of Long- term Effects of Reducing Intake of Energy) trial. The goal of this funding opportunity announcement (FOA) is to encourage analyses that will lead to a more detailed understanding of the effects of caloric restriction (CR) on risk factors for chronic diseases, as well as, the cellular/molecular mechanisms mediating the effects of sustained CR in humans.

Standard application dates apply. See solicitation for details.

NIH
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-046.html
The overarching purpose of this funding opportunity is to promote the validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-opioid pain therapeutics from discovery through Phase II clinical trials.  

NIH
Archiving and Documenting Child Health and Human Development Data Sets (R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-149.html
The purpose of this announcement is to invite applications to support archiving and documenting existing data sets in order to enable secondary analysis of these data by the scientific community. The priority of this program is to archive data sets within the scientific mission of the NICHD; highest priority will be given to archive data collected with NICHD support. 

NIH
Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-538.html
This announcement invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease.

NIH
Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-544.html
This announcement invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease.

NIH
Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-119.html
This announcement encourages applications from investigators that propose to study the developing brain or brain areas that play significant roles in mediating emotional and motivated behavior and in substance use and dependence. All stages of brain development are of interest, but a new emphasis of the current reissue of this initiative is to support basic neuroscience research on fundamental mechanisms of brain development during prepuberty and the adolescent period in relation to the problems of substance abuse and co-morbidity with psychiatric disorders. 

NIH
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-654.html
This announcement encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. 

NIH
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-655.html
This announcement encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. 

NIH
Biology of Bladder Cancer (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-183.html
This funding opportunity announcement encourages applications investigating the biology and underlying mechanisms of bladder cancer.

NIH
Biology of Bladder Cancer (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-184.html
This funding opportunity announcement seeks applications investigating the biology and underlying mechanisms of bladder cancer.

NIH
Biology of Lung, and Head and Neck Preneoplasias (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-459.html
This announcement seeks applications investigating mechanistic and biological aspects of preneoplasia leading to lung and head and neck (HN) cancers. Despite improved therapies and a deeper molecular understanding of lung and HN cancers, these tumors remain a major health problem. While molecular markers of early injury to the aerodigestive epithelial field have been found, relatively little is known about the molecular mechanisms that initiate these preneoplasias and drive their progression to invasive cancer. A functional understanding of the key molecular changes involved in the formation and progression of lung and HN preneoplasias will enhance our knowledge of oncogenic progression and accelerate development of effective preventive and therapeutic strategies.

NIH
Biology of Lung, and Head and Neck Preneoplasias (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-460.html
This announcement seeks applications investigating mechanistic and biological aspects of preneoplasia leading to lung and head and neck (HN) cancers. Despite improved therapies and a deeper molecular understanding of lung and HN cancers, these tumors remain a major health problem in the United States and globally. While molecular markers of early injury to the aerodigestive epithelial field have been found, relatively little is known about the molecular mechanisms that initiate these preneoplasias and drive their progression to invasive cancer. A functional understanding of the key molecular changes involved in the formation and progression of lung and HN preneoplasias will enhance our knowledge of oncogenic progression and accelerate development of effective preventive and therapeutic strategies.

NIH
Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-123.html
This announcement will provide support for assays (and associated data analysis) of repository-held samples for studies focused on an NIDDK relevant disease. 

NIH
Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-169.html
This announcement encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy. 

NIH
BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-149.html
This funding opportunity intends to support a group of specialized collaboratories that will adopt scalable technology platforms and streamlined workflows to accelerate progress towards establishing comprehensive molecular and anatomical reference cell atlases of human brain and/or non-human primate brains. A central goal of this opportunity is to build a brain cell census resource that can be widely used throughout the research community. 

NIH
BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-018.html
A central goal of the BRAIN Initiative is to develop new and improved perturbation technologies suitable for controlling specified cell types and circuits to modulate function in the central nervous system. This solicitation seeks applications to systematically characterize, model, and validate the membrane, cellular, circuit, and adaptive-biological responses of neuronal and non-neuronal cells to various types of stimulation. 

NIH
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-145.html
This funding opportunity announcement (FOA) solicits applications to develop web-accessible data archives to capture, store, and curate data related to BRAIN Initiative activities. The data archives will work with the research community to incorporate tools that allow users to analyze and visualize the data, but the creation of such tools is not part of this FOA. The data archives will use appropriate standards to describe the data, but the creation of such standards is not part of this FOA. A goal of this program is to advance research by creating a community resource data archive with appropriate standards and summary information that is broadly available and accessible to the research community for furthering research.

NIH
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-135.html
The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative funding opportunity is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits in large brains. Neuroscience has experienced an impressive influx of exciting new research tools in the past decade, especially since the launch of the BRAIN Initiative. However, the majority of these cutting-edge tools have been developed for use in model organisms, primarily rodents, fish, and flies. These cutting-edge tools, such as viral delivery of genetic constructs, are increasingly adaptable to larger mammalian brains and more importantly are emerging as potential human therapeutic strategies for brain disorders. A pressing need to develop tools for use in large brains or those that are more directly relevant to the human brain is the focus of this initiative. 

NIH
BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-029.html
This announcement promotes the integration of experimental, analytic, and theoretical capabilities for large-scale analysis of neural systems and circuits. Specifically, this announcement seeks applications for exploratory research studies that use new and emerging methods for large-scale recording and manipulation of neural circuits across multiple brain regions. Applications should propose to elucidate the contributions of dynamic circuit activity to a specific behavioral or neural system. Applications should seek to understand circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating relevant dynamic patterns of neural activity and by measuring the resulting behaviors and/or perceptions. Studies should incorporate rich information on cell-types, on circuit functionality and connectivity, and should be performed in conjunction with sophisticated analysis of complex, ethologically relevant behaviors. Applications should propose teams of investigators that seek to cross boundaries of interdisciplinary collaboration by bridging fields and linking theory and data analysis to experimental design. Exploratory studies supported by this FOA are intended to develop experimental capabilities and quantitative, theoretical frameworks in preparation for a future competition for larger-scale, multi-component, Team-Research BRAIN Circuit Programs (U19).

NIH
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-147.html
This funding opportunity solicits applications to develop informatics tools for analyzing, visualizing, and integrating data related to the BRAIN Initiative or to enhance our understanding of the brain.

NIH
BRAIN Initiative: New Concepts and Early-stage Research for Large-scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-18-001.html
This announcement seeks applications for unique and innovative technologies that are in an even earlier stage of development than that sought in other announcements under the BRAIN Initiative, including new and untested ideas that are in the initial stages of conceptualization. In addition to experimental approaches, the support provided under this announcement might enable calculations, simulations, computational models, or other mathematical techniques for demonstrating that the signal sources and/or measurement technologies are theoretically capable of meeting the demands of large-scale recording or manipulation of circuit activity in humans or in animal models. The support might also be used for building and testing phantoms, prototypes, in-vitro, or other bench-top models in order to validate underlying theoretical assumptions in preparation for future announcement aimed at testing in animal models.

NIH
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-146.html
This funding opportunity solicits applications to develop standards that describe experimental protocols that are being conducted as part of the BRAIN Initiative. It is expected that applications will solicit community input at all stages of the process. It is recommended that the first step of standard development will involve sharing data between different key groups in the experimental community in order to ensure that the developing standard will cover the way that all of those groups are collecting data. The developed standard is expected to be made widely available.

NIH
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-17-005.html
This solicitation requests new theories, computational models, and statistical tools to derive understanding of brain function from complex neuroscience data. 

NIH
Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-15-358.html
Application Deadline: December 10, 2015
The goal of this announcement is to support innovative research focused on understanding the molecular and cellular mechanisms underlying the heterogeneity and multifactorial nature of Alzheimer's Disease (AD) with the potential to create new or challenge existing scientific paradigms. This announcement encourages individual or collaborative research projects that propose innovative approaches to understand the complex biology of AD aimed to fill critical knowledge gaps. 

NIH
Cellular and Molecular Biology of Complex Brain Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-309.html
This announcement encourages applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. 

NIH
Cellular and Molecular Biology of Complex Brain Disorders (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-310.html
This announcement encourages research grant applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. 

NIH
Changes in Cellular Architecture During Aging (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-442.html
This announcement seeks applications that propose innovative research strategies aimed at increasing the understanding of the changes in cellular architecture that occur during the aging process. 

NIH
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-923.html
The purpose of this opportunity is to support innovative studies to identify and understand the immunological responses that mediate protection from Mycobacterium tuberculosis infection or following vaccination with Bacillus Calmette-Guérin or investigational vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected or uninfected individuals. Development of novel functional assays to assess host response and inclusion of immune profiling and systems biology approaches are encouraged.

NIH
Characterization of the Adolescent Reproductive Transition (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-314.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of puberty and the trajectory of sexual development. Research using new technologies and approaches is needed to fill knowledge gaps and advance understanding of normative sexual development in both males and females. It is anticipated that the findings of studies supported by this announcement will advance knowledge of puberty and the establishment of reproductive competence. 

NIH
Characterization of the Adolescent Reproductive Transition (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-316.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of puberty and the trajectory of sexual development. New technologies and approaches are needed to fill knowledge gaps and advance understanding of normative sexual development in both males and females. It is anticipated that the findings of studies supported by this announcement will advance knowledge of puberty and the establishment of reproductive competence.

NIH
Characterization of the Adolescent Reproductive Transition (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-315.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of puberty and the trajectory of sexual development. New technologies and approaches are needed to fill knowledge gaps and advance understanding of normative sexual development in both males and females. It is anticipated that the findings of studies supported by this announcement will advance knowledge of puberty and the establishment of reproductive competence.

NIH
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-029.html
This announcement invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias. 

NIH
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-038.html
This announcement invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias (ADRD). Specifically sought is research focusing on understanding why persons with ADRD are at increased risk to develop delirium, often with a worse prognosis compared to those without antecedent ADRD, and why patients who experience delirium are at higher risk to develop subsequent short- and/or long-term mild cognitive impairment or ADRD, often with an accelerated rate of cognitive decline compared to those without preceding delirium. 

NIH
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-181.html
This announcement invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias (ADRD). Specifically sought is research focusing on understanding why persons with ADRD are at increased risk to develop delirium, often with a worse prognosis compared to those without antecedent ADRD, and why patients who experience delirium are at higher risk to develop subsequent short- and/or long-term mild cognitive impairment or ADRD, often with an accelerated rate of cognitive decline compared to those without preceding delirium. 

NIH
Clinical and Biological Measures of Traumatic Brain Injury (TBI)-related Dementia Including Chronic Traumatic Encephalopathy (CTE) (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-026.html
Application Deadline: April 15, 2019
This opportunity invites investigation of biological and clinical measures of TBI-related progressive neurodegeneration and neurocognitive decline associated with increased risk for dementia and /or traumatic encephalopathy syndrome (clinicopathologic diagnostic counterpart to the neuropathological diagnosis of CTE). 

NIH
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-952.html
This opportunity invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare disease research by enabling efficient and effective movement of candidate therapeutics or diagnostics toward clinical trials and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.

NIH
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-953.html

NIH
Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-664.html
The purpose of this announcement is to support rigorous clinical validation of a candidate biomarker using retrospective and/or prospective methods in a manner that is consistent with the purpose of the biomarker. This announcement assumes that: (1) a candidate biomarker has already been identified, (2) an analytical method has been developed and validated that is consistent with the purpose of the biomarker, and (3) a working hypothesis regarding context of use is in place. The goal of this announcement is to facilitate the advancement of robust and reliable biomarkers of neurological disease for use in multi-site clinical trials and clinical practice.

NIH
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-895.html
The purpose of this funding opportunity is to support studies with a focus on developing drug delivery strategies that target the Central Nervous System for better suppression of Human Immunodeficiency Virus and reservoir reduction. 

NIH
Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 - Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-781.html
The purpose of this announcement is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune responses. Research areas supported by this announcement include: immune system development, function, or regulation; mechanisms governing immune response to infectious pathogens, vaccines, or adjuvants; host susceptibility factors and mechanisms of pathogen-induced immunopathology; and immune mechanisms involved in the development and progression of immune-mediated diseases, such as allergy/asthma, autoimmunity, primary immunodeficiency, inflammation, and cell/organ/tissue transplant rejection or tolerance.

NIH
Comparative Biology of Neurodegeneration (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-039.html
This announcement invites exploratory comparative biology research projects assessing how different animal species respond to challenges and damage to cellular physiology pathways that might influence the onset of Alzheimer's and other neurodegenerative diseases as well as resilience to them, such as adaptation to stress, macromolecular damage, proteostasis, and stem cell function and regeneration. 

NIH
Comparative Genomics Research Program (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-482.html
Application Deadline: January 8, 2021
Applications for research developing comparative approaches that can be used to understand genome structure and function and the relationship between genomic features and phenotypes. This program supports studies that enable the use of a diverse array of species to advance our ability to understand basic biological processes related to human health and disease, as well as studies that develop novel analytical tools and resources for the comparative genomics research community. 

NIH
Complex Integrated Multi-Component Projects in Aging Research (U19)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-143.html
This announcement requests applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.

NIH
Computational Models of Immunity (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-011.html
Application Deadline: June 10, 2019
This funding opportunity announcement solicits applications developing computational models of immunity that advance understanding of the mechanisms required to induce and/or maintain protective immunity to infectious pathogens, other than HIV, and/or vaccines against such pathogens. 

NIH
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-096.html

NIH
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-039.html
This opportunity encourages applications for CounterACT Cooperative Agreement Research Projects for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development.

NIH
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-040.html
This opportunity encourages applications for CounterACT Cooperative Agreement Research Projects for research on the optimization of small molecule or biologic compounds that are excellent candidates for therapeutic development.

NIH
Detection of HIV for Self-Testing (R61/R33)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-471.html
The purpose of this announcement is to support bi-phasic developmental, discovery-driven, or hypothesis-driven research focused on innovative strategies to detect HIV either within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy. Applications should propose simple diagnostic tools that would be feasible for a self-testing platform to allow untrained individuals to detect HIV. Interdisciplinary collaborations that include biomedical, physical, and behavioral sciences are highly encouraged. 

NIH
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-307.html
The purpose of this announcement is to fund highly innovative and promising research aimed at developing multi-level physical activity intervention programs acting on at least two levels of the socioecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity and 2) that could be made scalable and sustainable for broad use across the nation. This announcement provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for optimizing the intervention and conducting larger-scale feasibility studies. 

NIH
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 -Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-917.html
The purpose of this funding opportunity is to support projects that will elucidate the therapeutic potential of the cannabinoids and endocannabinoid system in the development of mechanism-based therapies for pain. 

NIH
Development of Animal Models and Related Biological Materials for Research (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-141.html
This announcement encourages highly innovative research to develop, characterize or improve animal models and related biological materials for human health and disease or to improve diagnosis and control of diseases that might interfere with animal use for biomedical research purposes. The proposed project must fall within the categorical interests of two or more NIH institutions/centers. Applications to develop models that relate strictly to a specific disease or category of research will not be accepted and should be proposed to the appropriate categorical Institute or Center of the NIH.

NIH
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-856.html

NIH
Diet and Physical Activity Assessment Methodology (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-167.html
This announcement encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications are encouraged to include the development of novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including children and older adults; improved technology or applications of existing technology; statistical methods/modeling to improve assessment and/or to correct for measurement errors or biases; methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors. 

NIH
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html
This announcement encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications may include development of novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including children and older adults; improved technology or applications of existing technology; statistical methods/modeling to improve assessment and/or to correct for measurement errors or biases; methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors.

NIH
Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-120.html
This announcement encourages applications for research projects that identify, validate, and/or functionally characterize loci, genetic variations, and haplotypes that are associated with vulnerability to addiction and that potentially inform the likelihood of responsiveness to treatment. 

NIH
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html
The purpose of this funding opportunity is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this opportunity is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system, or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. 

NIH
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-042.html
This program announcement is intended to encourage new exploratory and developmental research projects to discover and validate novel targets for pain treatment.

NIH
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-041.html
The purpose of this funding opportunity is to support the discovery of promising candidate biomarkers that will facilitate the development of non-opioid therapeutic options for the treatment of pain conditions. The goal of this opportunity is to encourage a biomarker discovery process that will result in the development of pain biomarkers that can withstand rigorous clinical and analytical validation. It is hoped that an increased availability of rigorous biomarkers for pain will facilitate the discovery and development of transformational non-opioid therapeutics for pain.

NIH
Discovery of cell-based Chemical Probes for Novel Brain Targets (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-335.html
This announcement will support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. 

NIH
Discovery of in vivo Chemical Probes for Novel Brain Targets (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-336.html
This announcement will support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. 

NIH
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-331.html
The purpose of this announcement is to promote the discovery of novel small molecules that may enhance the ability of the immune system to selectively recognize and attack cancer cells. 

NIH
Drug Abuse Dissertation Research (R36)
http://grants.nih.gov/grants/guide/pa-files/PA-16-443.html
The goal of this announcement is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. 

NIH
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-147.html
This funding opportunity intends to support investigators who have interest and capability in the discovery of novel compounds for the prevention and treatment of nervous system disorders. This opportunity is designed to stimulate research in: 1) identification, design, synthesis, and pre-clinical testing of compounds of candidate therapeutics; 2) initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) later stage lead optimization to improve efficacy and pharmacokinetics; and 4) initial drug metabolism and pharmacokinetics. Emphasis will be placed on projects that provide novel approaches to identify potential therapeutic agents 

NIH
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-146.html
This funding opportunity intends to support investigators who have interest and capability in the discovery of novel compounds for the prevention and treatment of nervous system disorders. This opportunity is designed to stimulate research in: 1) identification, design, synthesis, and pre-clinical testing of compounds of candidate therapeutics; 2) initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) later stage lead optimization to improve efficacy and pharmacokinetics; and 4) initial drug metabolism and pharmacokinetics. Emphasis will be placed on projects that provide novel approaches to identify potential therapeutic agents 

NIH
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-853.html
The purpose of this funding opportunity is to support in vivo research to elucidate the chemical features of non-native molecules that facilitate passage across the blood-testis and/or blood-epidydimal barriers. 

NIH
Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-029.html
This announcement encourages research projects on the role of aging-related changes in systemic, peripheral, and/or non-neuronal factors individually or in combination to the pathogenesis, presentation, and/or progression of Alzheimers disease (AD). The goal of this FOA is to support innovative multidisciplinary research that will integrate the AD science with the basic biology of aging and clinical aging research. 

NIH
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-529.html
The purpose of this announcement is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. 

NIH
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-531.html
The purpose of this announcement is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. 

NIH
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-532.html
The purpose of this announcement is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. 

NIH
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-121.html
The overarching goal of this announcement is to translate basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the NIDDK. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, hematology, and specific aspects of cystic fibrosis. 

NIH
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-845.html
The purpose of this funding opportunity is to support basic research examining how Electronic Nicotine Delivery Systems aerosols affect normal and disease states relevant to human cells, tissues, and organs.

NIH
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-846.html
The purpose of this funding opportunity is to support basic research examining how Electronic Nicotine Delivery Systems aerosols affect normal and disease states relevant to human cells, tissues, and organs.

NIH
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical, and Applied Prevention of Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-847.html
The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems that examine population-based, clinical, and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, and benefits and impacts on other tobacco use behavior among different populations. 

NIH
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical, and Applied Prevention Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-848.html
The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, and benefits and impacts on other tobacco use behavior among different populations.

NIH
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-898.html
This opportunity seeks to generate scientific advancements addressing the role of the autonomic nervous system in the regulation of peripheral metabolism and its role in diabetes, obesity, and related metabolic disease. 

NIH
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html
The purpose of this opportunity is to stimulate research to examine the multi-dimensional foundations, experiences and management of complex, advanced signs and symptoms at the end of life.

NIH
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html
The purpose of this opportunity is to stimulate research to examine the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life.  

NIH
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-153.html

NIH
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-398.html
This announcement encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems with improved fidelity to complex human brain, spinal, peripheral nervous system, and/or sensory end organ circuit physiology in vivo, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system disorders.

Standard application dates apply. See solicitation for details.

NIH
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-397.html
This announcement encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems with improved fidelity to complex human brain, spinal, peripheral nervous system, and/or sensory end organ circuit physiology in vivo, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system disorders.

Standard application dates apply. See solicitation for details.

NIH
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-263.html
The purpose of this announcement is to encourage interdisciplinary research aimed at promoting health, preventing and limiting symptoms and disease, and reducing health disparities across the lifespan for those living or spending time in non-traditional settings (i.e. playgrounds and nursing homes). 

NIH
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-273.html
The purpose of this announcement is to encourage interdisciplinary research aimed at promoting health, preventing and limiting symptoms and disease, and reducing health disparities across the lifespan for those living or spending time in non-traditional settings (i.e. playgrounds and nursing homes). 

NIH
Eradication of HIV-1 from Central Nervous System Reservoirs (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-084.html
This announcement invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 

NIH
Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-178.html
The purpose of this Research Demonstration and Dissemination Projects (R18) announcement is to support research to evaluate large scale policies or programs related to healthcare delivery that are expected to influence diabetes prevention and care. This announcement is not intended to support the initiation and delivery of new policies or programs. Research support is for the evaluation of the effectiveness of healthcare programs and/or policies implemented independent of NIH grant funding. The goal is to support research that meaningfully informs clinical practice and health policy related to prevention or management of diabetes. 

NIH
Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-175.html
This announcement invites applications for research on cancer epidemiology, genomics, and risk assessment. 

NIH
Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-333.html
This announcement will support innovative exploratory/developmental investigations on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. 

NIH
Extracellular Vesicles and Substance Use Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-250.html
The purpose of this announcement is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.

NIH
Extracellular Vesicles and Substance Use Disorders (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-242.html
The purpose of this announcement is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.

NIH
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-113.html
The purpose of this announcement is to stimulate and support investigator-driven collaborative research to: 1) probe how vaccine-elicited antibodies protect against viral acquisition via Fc receptor-mediated mechanisms and 2) determine the functional profiles of Fc receptor engagement in the context of immune responses elicited by protective vaccines, to inform advancement of similarly promising HIV vaccine candidates.

NIH
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-020.html
This opportunity invites applications for studies that address knowledge gaps in mechanisms of Fc-dependent, antibody-mediated killing of infected cells or aberrant cells or antibody-mediated therapeutic ablation of cells implicated in immune pathologies, including autoimmune and allergic diseases.

NIH
Fertility Status as a Marker for Overall Health (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-091.html
The purpose of this announcement is to support research that explores the premise that fertility status can be a marker for overall health.

NIH
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-727.html
The purpose of this announcement is to promote research on food specific molecular signatures and biomarkers of dietary consumption and to promote collaborative interactions among NIH- and USDA-supported nutrition researchers.

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-252.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. 

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-176.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. 

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-253.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. 

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-179.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology.

NIH
Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-155.html
Genetic and genomic studies have identified genes and gene variants that may impact the fundamental biological mechanisms underpinning substance use disorders (SUDs). Discovery of these genes/variants, while extremely valuable, is only the first step in understanding the molecular processes that influence SUDs. This announcement encourages basic functional genetic and genomic research in two areas: (1) functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in SUDs and (2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in SUDs. 

NIH
Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-157.html
Genetic and genomic studies have identified genes and gene variants that may impact the fundamental biological mechanisms underpinning substance use disorders (SUDs). Discovery of these genes/variants, while extremely valuable, is only the first step in understanding the molecular processes that influence SUDs. This announcement encourages basic functional genetic and genomic research in two areas: (1) functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in SUDs, and (2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in SUDs.

NIH
Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/rfa-es-19-001.html
Application Deadline: May 16, 2019
The National Institute of Environmental Health Sciences seeks to solicit innovative, mechanistic research applications that are focused on how environmental exposures are associated and involved with the functional activities of RNA modifications and pathways that may be modified or misregulated, associated with adverse health outcomes, and/or be useful as biomarkers of exposure and/or exposure induced pathologies. 

NIH
Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-002.html
Application Deadline: May 16, 2019
Chemical modifications of proteins, DNA and RNA nucleoside moieties play critical roles in regulating gene expression. Emerging evidence suggests these RNA modifications (epitranscriptomics) have substantive roles in basic biological processes. Recent studies in yeast, Drosophila, and rodent models demonstrate stressors can induce RNA modifications, with specific epitranscriptomic reprogramming of some regulatory RNAs. The purpose of this funding opportunity is to solicit and support R21 applications that propose innovative, high risk, high reward research addressing how environmental exposures impact this layer of cellular regulation.

NIH
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-380.html
The purpose of this announcement is to encourage projects to generate fundamental knowledge of affective processes. Basic affective science projects should have key consequences for single (e.g., cancer screening) and multiple (e.g., adherence to oral chemotherapy regimen) event decisions and behaviors across the cancer prevention and control continuum. 

NIH
Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-323.html
This announcement encourages research grant applications to investigate the fundamental science of mind and body approaches, including mind/brain-focused practices (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), meditative exercise (e.g., yoga, tai chi, qi gong), art and music therapies, or integrative approaches combining several components. 

NIH
Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-322.html
This announcement encourages exploratory /developmental research grant applications to investigate the fundamental science of mind and body approaches, including mind/brain-focused practices (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), meditative exercise (e.g., yoga, tai chi, qi gong), art and music therapies, or integrative approaches combining several components. 

NIH
Gene Fusions in Pediatric Sarcomas (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-251.html
The overall goal of this announcement is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

NIH
Gene Fusions in Pediatric Sarcomas (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-252.html
The overall goal of this announcement is to encourage research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

NIH
Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-725.html
The purpose of this announcement is to advance select areas of research recognized as critical in the National Action Plan for Combating Antibiotic-Resistant Bacteria, including research focused on understanding the nature of microbial communities, how antibiotics affect them, and how they can be harnessed to prevent disease, as well as research exploring combination therapies to address the emergence of resistance.

Standard application dates apply. See solicitation for details.

NIH
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-724.html
The purpose of this announcement is to advance select areas of research recognized as critical in the National Action Plan for Combating Antibiotic-Resistant Bacteria, including research focused on understanding the nature of microbial communities, how antibiotics affect them, and how they can be harnessed to prevent disease, as well as research exploring combination therapies to address the emergence of resistance.

Standard application dates apply. See solicitation for details.

NIH
Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-660.html
The goal of this announcement is to develop new hypotheses and common experimental framework(s) between human - animal model studies to better understand the genetic, genomic, and epigenetic factors contributing to and underlying biological bases for the development of tolerance and the progression to alcohol dependence.

NIH
Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-435.html
The purpose of this announcement is to expand the use of high-throughput genotyping, genomic sequencing, and related genomic technologies, and generate resulting data resources widely available for research use to improve the efficacy and safety and ease of use of HIV/AIDS therapies and of non-HIV drugs used to treat HIV/AIDS patients and reduce HIV/AIDS-related comorbidities, coinfections, and complications.

NIH
Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-013.html
Application Deadline: July 2, 2019
This funding opportunity announcement invites applications proposing research on the specific role of aging biology in the development, etiology, and treatment of Alzheimer's disease. 

NIH
Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-014.html
Application Deadline: July 2, 2019
This funding opportunity announcement invites applications proposing research on the specific role of aging biology in the development, etiology, and treatment of Alzheimer's disease. 

NIH
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-411.html
The purpose of this announcement is to support grants to improve measurement and understanding of viral suppression and HIV transmission in the U.S. using population-level epidemiology and novel tools from Big Data science approaches and m/eHealth. The outcome of this research will uncover new knowledge from data to build more effective and context-specific HIV control strategies for the U.S. epidemic.

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-835.html
This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects between U.S. and low- and middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs (including neurological, mental, behavioral, alcohol and substance use disorders and spanning the full range of science from basic to implementation research). Scientists in upper middle-income countries are also eligible to partner directly with scientists at other LMIC institutions with or without out a U.S. partner.

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-835.html
This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects between U.S. and low- and middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs (including neurological, mental, behavioral, alcohol and substance use disorders and spanning the full range of science from basic to implementation research). Scientists in upper middle-income countries are also eligible to partner directly with scientists at other LMIC institutions with or without out a U.S. partner.

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-836.html
This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, proposing the development of innovative, collaborative research projects on brain and other nervous system function and disorders throughout life, relevant to low- and middle-income countries (LMICs). Research on neurological, mental, behavioral, alcohol and substance use disorders may span the full range of science from basic to implementation research. Scientists in the United States or upper-middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Scientists in UMICs are also eligible to partner directly with scientists at other LMIC institutions with or without out a U.S. partner. 

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-313.html
This announcement encourages exploratory/developmental research grant applications proposing the development of innovative, collaborative research projects on brain and other nervous system function and disorders throughout life relevant to low- and middle-income countries.

NIH
Grand Opportunity in Medications Development for Substance-Use Disorders (U01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-431.html
The purpose of this announcement is to accelerate the development of medication for the treatment of Substance-Use Disorders by encouraging research applications to support a diverse array of pre-clinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. 

NIH
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-764.html
The purpose of this announcement is to promote research that transforms understanding of HIV transmission, the HIV care continuum, and HIV comorbidities using Big Data Science. This announcement will support projects to assemble diverse big data sources, conduct robust and reproducible analyses, and create meaningful visualizations of big data, as well as engage ethical experts where appropriate to ensure the development of this scientific area is guided by ethical principles.

Standard AIDS applications due dates apply. See solicitation for details.

NIH
Hearing Health Care for Adults: Improving Access and Affordability (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-202.html
This announcement encourages applications for research on hearing health care in adults in support of improving access and affordability. Further research is needed to strengthen the evidence base with a goal of delivering better hearing health care outcomes in adults.

NIH
Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-382.html
This announcement encourages exploratory and developmental research applications for research on hearing health care in adults in support of improving access and affordability. Further research is needed to strengthen the evidence base with a goal of delivering better health care outcomes in adults.

NIH
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAS-18-698.html
This announcement seeks to stimulate HIV/AIDS research within the mission of the NIDDK that addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research. These priorities are described in NOT-OD-15-137: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding.

NIH
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-319.html
The purpose of this announcement is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included.

NIH
HIV-1 infection of the Central Nervous System (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-100.html
This announcement invites research grant applications focused on defining and understanding the pathogenic mechanisms involved in HIV-1 induced CNS dysfunction within the context of viral suppression and antiretroviral therapy. The announcement further supports research to identify therapeutic targets against which treatments may be developed to prevent neurobehavioral and neurological co-morbidities in HIV-1 infected individuals. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 

NIH
Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-516.html
The goal of this announcement is to establish functional genotype-phenotype relationships of genetic variants suspected of altering the risk of Alzheimers disease (AD), in neural cells using human-induced pluripotent stem cells or other human cell reprogramming approaches. The causal linkage of AD-associated genetic variants identified in genome-wide association studies and genome sequencing studies to molecular and biological cell phenotypes in human neural cells is expected to give greater insight into molecular targets contributing to the etiology of AD. 

NIH
Human-Animal Interaction Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-231.html
This announcement invites grant applications for research to examine 1) the impact of human-animal interaction on typical and atypical child development and health, 2) the evaluation of animal-assisted intervention for children and adults with disabilities or in need of rehabilitative services, and 3) the effects of animals on public health, including cost effectiveness of involving animals in reducing and preventing disease. 

NIH
Human-Animal Interaction Research (R21)
https://nugrant.unl.edu/fundingOpps/singleOpportunity?VCRFundingOpID=9756
This announcement invites grant applications for research to examine 1) the impact of human-animal interaction on typical and atypical child development and health, 2) the evaluation of animal-assisted intervention for children and adults with disabilities or in need of rehabilitative services, and 3) the effects of animals on public health, including cost effectiveness of involving animals in reducing and preventing disease. 

NIH
Imaging the Persistent HIV Reservoir (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-305.html
The purpose of this announcement is to support the development of imaging approaches to identify and characterize persistent HIV reservoirs in patients undergoing suppressive antiretroviral therapy and to quantify the nature and size of these reservoirs in response to therapeutic interventions.

NIH
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-860.html
The purpose of this funding opportunity is to support short-term exploratory, developmental, and transdisciplinary research to understand the immunologic events that occur during blood feeding by hematophagous arthropods. The scientific objectives of this initiative are to (1) understand the immunological events in the vertebrate host, which occur during and after blood feeding by hematophagous arthropods, at the bite site (skin), and systemically; (2) identify and characterize the immune modulatory properties of arthropod salivary components; and (3) understand the immunological events in the hematophagous arthropods following a blood meal.

NIH
Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-491.html
The goal of this announcement is to translate and adapt the most successful global, evidence-based HIV-related service provision strategies to marginalized populations in the U.S. with a substantial risk of HIV-infection and AIDS. The ultimate goal is to produce improvements in HIV-related health outcomes in these key populations through strategies that successfully and durably reach them with timely HIV testing, prevention, and treatment technologies that lead to the achievement of the UNAIDS 90-90-90 benchmarks.

NIH
Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-490.html
The goal of this announcement is to translate and adapt the most successful global, evidence-based HIV-related service provision strategies to marginalized populations in the U.S. with a substantial risk of HIV-infection and AIDS. The ultimate goal is to produce improvements in HIV-related health outcomes in these key populations through strategies that successfully and durably reach them with timely HIV testing, prevention, and treatment technologies that lead to the achievement of the UNAIDS 90-90-90 benchmarks.

NIH
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-093.html
This announcement encourages applications proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions.The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems, 2) development of new technologies for stem cell characterization and transplantation, and 3) improvement of animal disease models for stem cell-based therapeutic applications.

NIH
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-094.html
This announcement encourages applications proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions.The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems, 2) development of new technologies for stem cell characterization and transplantation, and 3) improvement of animal disease models for stem cell-based therapeutic applications.

NIH
Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-287.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech, and language.

NIH
Improving Outcomes for Disorders of Human Communication (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-139.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language.

NIH
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-288.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech, and language.

NIH
Improving Outcomes for Disorders of Human Communication (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-140.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language.

NIH
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-19-112.html
This announcement encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. 

NIH
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-19-111.html
This solicitation encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. 

NIH
Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAS-18-030.html
This announcement invites applications that address clinical and translational research gaps in the study of end-of-life care needs in order to improve quality of life at the end of life of people with Alzheimers disease and related dementias (ADRD) and their families. Research that either employs (a) secondary analysis of existing data from longitudinal cohort studies or from administrative records or (b) primary data collection for Stage I behavioral intervention development is particularly encouraged.

NIH
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-280.html
The purpose of this announcement is to (1) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug discovery/drug development in HBV/HIV co-infection and (2) stimulate and accelerate a better understanding of the immunopathogenic interactions between HBV and HIV. 

NIH
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-281.html
The purpose of this announcement is to (1) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug discovery/drug development in HBV/HIV co-infection and (2) stimulate and accelerate a better understanding of the immunopathogenic interactions between HBV and HIV. 

NIH
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-760.html
Funds through this program will support the study of in vivo synaptic structure and function in Alzheimer's and related dementia and advance development of methods to study synapses in animal models and humans.

Standard application dates apply. See solicitation for details.

NIH
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-005.html
The purpose of this announcement is to encourage applications to phenotype and/or perform research on embryonic lethal knockout mouse strains being generated through the International Mouse Phenotyping Consortium of which the NIH Knockout Mouse Phenotyping Program is a member. 

NIH
Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-079.html
This announcement encourages health services research designed to increase the public health impact of FDA-approved pharmacotherapies for the treatment of alcohol use disorder. 

NIH
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-932.html
This funding opportunity invites applications that seek to understand strategies to reduce disparities in the uptake of evidence-based screening (e.g., screening recommendations proven to be effective based on rigorous systematic review of scientific evidence by authoritative committees) across the adult lifespan. In this program announcement, screening is defined as a preventive service focused on detection of an undiagnosed disease in asymptomatic populations. 

NIH
Innovation for HIV Vaccine Discovery (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-263.html
The purpose of this announcement is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. 

NIH
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-182.html
The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this announcement could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, initial development and pilot tests of innovative approaches for intervention, and intervention efficacy trials.

NIH
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-181.html
The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this announcement could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum and initial development and pilot tests of innovative approaches for intervention.

NIH
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-947.html
This funding opportunity will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies and blood biospecimens utilized as "liquid biopsies." Extramural research funded under this opportunity may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), pleural aspirates, and blood utilized for liquid biopsies. 

NIH
Integration of Individual Residential Histories into Cancer Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-298.html
The purpose of this announcement is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes and to encourage the development of complex analytical strategies in support of such investigation.

NIH
Integration of Individual Residential Histories into Cancer Research (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-295.html
The purpose of this announcement is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes and to encourage the development of complex analytical strategies in support of such investigation.

NIH
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-033.html
This announcement invites applications that apply a cross-disciplinary, team science approach to gain comprehensive, mechanistic understanding of the impact of sex differences on the trajectories of brain aging and phenotypes of Alzheimers disease risk and on the responsiveness to pharmacologic and non-pharmacologic interventions. 

NIH
Inter-organelle Communication in Cancer (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-203.html
The purpose of this announcement is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.

NIH
Inter-organelle Communication in Cancer (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-204.html
The purpose of this announcement is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.

NIH
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-496.html
The purpose of this announcement is to encourage research to improve Native American health. Such research can include: conducting secondary analysis of existing data (such as databases that the Tribal Epidemiology Centers have collected); merging various sources of data to answer critical research questions; conducting pilot and feasibility studies; and/or assessing and validating measures that are being developed and/or adapted for use in Native American communities.

NIH
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-712.html
The purpose of this announcement is to advance the discovery and characterization of primary immunodeficiency diseases, understand the causes and mechanisms of disease, enable early detection and molecular diagnosis, and support the development of strategies to treat and eventually cure these disorders.

NIH
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-844.html
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All proposals should address how the methods would scale to address larger and larger data sets.

NIH
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-843.html

NIH
Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-008.html
This announcement invites grant applications for funding to conduct Large Research Projects that propose to advance the base of knowledge for detection, prevention, and reduction of Healthcare-Associated Infections.

NIH
Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-212.html
This announcement encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

NIH
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-605.html
This announcement encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

NIH
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-606.html
This announcement encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

NIH
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-213.html
This announcement encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

NIH
Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimer's Disease and Related Dementias (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-054.html
This announcement invites applications that will combine multiple cohorts in order to improve statistical power and clarify risk and protective factors for Alzheimers disease and related dementias.

NIH
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-289.html
The goal of this announcement is to efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. 

NIH
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-288.html
The goal of this announcement is to efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. 

NIH
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-196.html
Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. 

NIH
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-198.html
Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. 

NIH
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-197.html
Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. 

NIH
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-001.html
Application Deadline: April 17, 2019
This funding opportunity encourages applications from institutions/organizations proposing the development of targeted mass spectrometric assays (e.g., Multiple Reaction Monitoring) for proteins and peptides of primary interest to the obesity research community.

NIH
Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-776.html
This announcement encourages applications to improve health outcomes for women, infants and children by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn.

Standard and AIDS application dates apply. See solicitation for details.

NIH
Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-022.html
This announcement will support meritorious exploratory research relevant to the NHLBI mission using the existing biospecimen collections that are stored in the NHLBI Biologic Specimen Repository (Biorepository), thereby maximizing the scientific value of the stored collections and providing researchers with an opportunity to generate preliminary data for subsequent research proposals.

NIH
Mechanism for Time-Sensitive Opportunity in Environmental Health Sciences (R21)
http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-16-005.html
This announcement is intended to support environmental health research in which an unpredictable event provides a limited window of opportunity to collect human biological samples or environmental exposure data. The primary motivation is to understand the consequences of natural and man-made disasters or emerging environmental public health threats in the U.S. and abroad. A distinguishing feature of an appropriate study is the need for rapid review and funding (substantially shorter than the typical NIH grant review/award cycle) in order for the research question to be addressed and swiftly implemented. 

NIH
Mechanisms Mediating Osteoarthritis in Aging (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-239.html
This announcement invites applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms of initiation and progression of osteoarthritis and the role of aging in the process.

NIH
Mechanisms Mediating Osteoarthritis in Aging (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-240.html
This announcement invites applications intended to encourage Exploratory/Developmental applications to accelerate the characterization of new paradigms to test hypotheses that will lead to an improved understanding of the mechanisms of initiation and progression of osteoarthritis and the role of aging in the process. 

NIH
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-659.html
The intent of this announcement is two-fold: (1) develop new hypotheses about key factors and pathways in sensitivity and tolerance to alcohol and (2) develop a common framework of mechanisms underlying the development of tolerance and the progression to alcohol dependence. These objectives will be accomplished with a Phased Innovation (R21/R33) mechanism, in which secondary data analysis or pilot studies can occur during the R21 phase and research testing the hypotheses can be expanded in the R33 phase.

NIH
Mechanisms of Alcohol-associated Cancers (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-220.html
This announcement invites applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. 

NIH
Mechanisms of Alcohol-associated Cancers (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-219.html
This announcement invites applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. 

NIH
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-258.html
This announcement invites innovative pilot projects or feasibility studies to stimulate research aimed to better understand the complex interaction of biological, cognitive, behavioral, and sociocultural factors that contribute to cancer and treatment related symptoms and toxicities throughout the cancer care trajectory. 

NIH
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-151.html
The purpose of the initiative is to support multidisciplinary research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the United States.

NIH
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-150.html
The purpose of the initiative is to support multidisciplinary innovative exploratory and developmental research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the United States.

NIH
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-018.html
This initiative will support multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations. 

NIH
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-019.html
This initiative will support exploratory and developmental multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.

NIH
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/pa-19-200.html
The purpose of this opportunity is to encourage mechanistic research to investigate the impact of sleep disturbances on pain. 

NIH
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-201.html
The purpose of this opportunity is to encourage mechanistic research to investigate the impact of sleep disturbances on pain.

NIH
Mechanistic Studies on Chronic Alcohol Use and Sleep Homeostasis (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-19-006.html
Application Deadline: April 17, 2019
This funding opportunity, issued by the National Institute on Alcohol Abuse and Alcoholism, encourages applications proposing to conduct mechanistic studies on the relationships between sleep problems and alcohol dependence. The objective of this opportunity is to promote research in animal models and human subjects on the reciprocal relationships between chronic alcohol use and sleep disruptions. The major goal is to understand the underlying mechanisms that will lead to improved treatments for alcohol dependence. 

NIH
Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-051.html
This announcement invites applications for human studies to elucidate the etiology and pathogenesis of the increased risk for neurocognitive impairment associated with type 2 diabetes. 

NIH
Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-333.html
This announcement invites applications for human studies to elucidate the etiology and pathogenesis of the increased risk for neurocognitive impairment associated with type 2 diabetes. 

NIH
Metabolic Reprogramming to Improve Immunotherapy (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-228.html
The goal of this announcement is to encourage R01 grant applications to (a) generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, (b) determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and (c) then use this information to manipulate (reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy.

NIH
Metabolic Reprogramming to Improve Immunotherapy (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-229.html
The goal of this announcement is to encourage R21 exploratory/developmental grant applications to (a) generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, (b) determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and (c) then use this information to manipulate (reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy. 

NIH
Microbial-based Cancer Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-193.html
The overall purpose of this funding opportunity announcement is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages, and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex interactions between microorganisms, tumor, and immune system. 

NIH
Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-194.html
The overall purpose of this funding opportunity announcement is to stimulate exploratory development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages, and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex interactions between microorganisms, tumor, and immune system. 

NIH
Modeling of Infectious Disease Agent Study Research Projects (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-107.html
The purpose of this announcement is to support innovative research that will develop and apply computational tools and methods for modeling interactions between infectious agents and their hosts, disease spread, prediction systems, and response strategies. The models should be useful to researchers, policymakers, or public health workers who want to better understand and respond to infectious diseases. This research opportunity encourages applications from institutions/organizations that propose to provide the scientific and public health communities better resources, knowledge, and tools to improve their ability to prepare for, identify, detect, control, and prevent the spread of infectious diseases caused by naturally occurring or intentionally released pathogens, including those relevant to biodefense.

NIH
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-869.html
This funding opportunity invites applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.

NIH
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-198.html
The purpose of this funding opportunity is to support research that can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.  

NIH
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/par-19-199.html
The purpose of this funding opportunity is to support research that can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation. 

NIH
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-078.html
The purpose of this funding opportunity is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. 

NIH
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-079.html
The purpose of this funding opportunity is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. 

NIH
Multidisciplinary Research in Vulvodynia (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-102.html
The purpose of this announcement is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research. This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest.

NIH
Multidisciplinary Research in Vulvodynia (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-101.html
The purpose of this announcement is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research. This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest.

NIH
Multidisciplinary Research in Vulvodynia (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-100.html
The purpose of this announcement is to indicate a continued interest in the topic area of vulvodynia or chronic vulvar pain of unknown etiology as an integral area of branch research. This announcement is intended to encourage new research applications in the exploration of etiology, prevention, diagnosis, and therapeutics in the field of vulvodynia. Applications utilizing multidisciplinary approaches and interdisciplinary investigative teams are of particular interest.

NIH
Multidisciplinary Studies of HIV/AIDS and Aging (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-321.html
This announcement encourages applications at the intersection of HIV and aging by addressing two overarching objectives: (1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment and (2) to improve approaches for testing, prevention, and treatment of HIV infection and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. 

NIH
Multidisciplinary Studies of HIV/AIDS and Aging (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-320.html
This announcement encourages exploratory/developmental research applications at the intersection of HIV and aging by addressing two overarching objectives: (1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment and (2) to improve approaches for testing, prevention, and treatment of HIV infection and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. 

NIH
Natural History of Disorders Identifiable by Screening of Newborns (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-061.html
This announcement encourages applications that propose to develop studies that will lead to a broad understanding of the natural history of disorders that already do or could potentially benefit from early identification by newborn screening.

NIH
NCI Program Project Applications (P01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-290.html
The National Cancer Institute invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. 

NIH
NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-416.html
This announcement supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 

NIH
NEI Research Grant for Vision Related Secondary Data Analysis (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-168.html
This announcement encourages applications from institutions/organizations that propose to conduct vision-related secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. 

NIH
Neural Regulation of Cancer (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-245.html
This announcement encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the nervous system contribution to cancer. Leveraging the knowledge, tools, experimental models and reagents in neuroscience research to uncover novel mechanisms used by the nervous system to promote tumor initiation, progression and metastasis can ultimately inform key areas of cancer research including the prevention and treatment of non-central nervous system tumors.

NIH
Neural Regulation of Cancer (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-246.html
This announcement encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the nervous system contribution to cancer. Leveraging the knowledge, tools, experimental models, and reagents in neuroscience research to uncover novel mechanisms used by the nervous system to promote tumor initiation, progression and metastasis can ultimately inform key areas of cancer research including the prevention and treatment of non-central nervous system tumors.

NIH
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-060.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. 

NIH
Neuroscience Research on Drug Abuse (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-111.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this announcement are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. An understanding of the basic mechanisms underlying substance use disorders can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate.

NIH
Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-078.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this announcement are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. 

NIH
Neuroscience Research on Drug Abuse (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-112.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this announcement are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. An understanding of the basic mechanisms underlying substance use disorders can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate.

NIH
New Onset Depressive Symptoms in Acute Illness (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-17-488.html
The purpose of this announcement is to encourage research on the etiology of depressive symptoms that occur in the context of a sudden onset acute illness. Although it is known that depressive symptoms may linger and affect functional recovery long after physical recovery from an acute insult, there is a gap in knowledge about the pathobiology that may underlie these incident depressive symptoms. A greater understanding of the etiological factors that contribute to and/or mitigate a trajectory of depressive symptoms may inform a personalized, holistic approach to managing recovery from acute illness.

NIH
New Onset Depressive Symptoms in Acute Illness (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-17-487.html
The purpose of this announcement is to encourage research on the etiology of depressive symptoms that occur in the context of a sudden onset acute illness. Although it is known that depressive symptoms may linger and affect functional recovery long after physical recovery from an acute insult, there is a gap in knowledge about the pathobiology that may underlie these incident depressive symptoms. A greater understanding of the etiological factors that contribute to and/or mitigate a trajectory of depressive symptoms may inform a personalized, holistic approach to managing recovery from acute illness.

NIH
New Paradigms in Tissue Communication from Mediators to Metabolic Function (RC2 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-886.html

NIH
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-049.html
This opportunity will support pilot studies by R01-funded investigators in areas of research that advance high priority studies of normal biology and resilience as described by Objective 1 of the NHLBI Strategic Vision. The development of more effective means for diagnosing and treating heart, lung, blood, and sleep disorders is often aided by a detailed understanding of normal biology, specifically the nature and operations of the molecular systems and cells that are affected by those diseases. Areas of research interest include studies of fundamental processes that explain "resilience" - the capability of some individuals to maintain or restore normal function despite aging or exposure that causes disease in others.

NIH
NHLBI Program Project Applications (P01 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-405.html
This grant supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and blood, including transfusion medicine, blood resources, and sleep disorders, as well as other programs including implementation science, health disparities, and translation research that address the mission of the Institute. This announcement requires a minimum of three interrelated research projects that investigate a complex biomedical theme or research question. The projects may be supported by core units to facilitate economy of effort, space, and equipment.

NIH
NIA Late Onset of Alzheimer's Disease Family-Based Study (U24)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-205.html
This announcement invites applications specific to infrastructure to support the Alzheimer's Disease Sequencing Project related to the collection, longitudinal follow-up, ascertainment of antecedent risk factors, and the characterization of additional relatives from families multiply affected with Alzheimer's disease (AD) in order to expand the existing NIA late onset of AD family-based study sample set.

NIH
NIA Program Project Applications (P01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-297.html
The National Institute on Aging (NIA) invites the submission of investigator-initiated program project applications. The applications should address scientific areas relevant to the NIA mission. Each application must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.

NIH
NIA Program Project Applications (P01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-358.html
The National Institute on Aging (NIA) invites the submission of investigator-initiated program project applications. The applications should address scientific areas relevant to the NIA mission. Each application submitted must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.

NIH
NIBIB Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-433.html
This announcement will support exploratory/developmental research projects of interest to the NIBIB. These studies are expected to lead to breakthroughs in development of innovative techniques, agents, methodologies, models, or applications. These studies may involve considerable risk that should be balanced by the potential high impact on human-health and related research. Applicants are expected to propose novel biomedical research approaches for which there is no preliminary data to demonstrate the feasibility of the proposed project. A project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven.

NIH
NICHD Exploratory-Developmental Research Grant (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-259.html
The NICHD Exploratory-Developmental Grant program supports exploratory and developmental research projects that fall within the NICHD mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

NIH
NICHD Exploratory/Developmental Research Grant (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-482.html
The NICHD Exploratory/Developmental Grant program supports exploratory and developmental research projects that fall within the NICHD mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

NIH
NICHD Laboratory of Developmental Biology (R24)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-396.html
This announcement encourages grant applications aimed at the collection, identification, staging, and distribution of conceptal tissues for use in studies to understand the underlying developmental biology of normal and abnormal human development and human pathologies. The objective of this announcement is to provide support for established resources that serve the research community.

Application dates vary. See solicitation for details.

NIH
NICHD Small Grant Program (R03 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-481.html
Application Deadline: January 8, 2021
The NICHD Investigator-Initiated Small Research Grant (R03) funding opportunity supports small research projects that can be carried out in a short period of time with limited resources. The R03 activity code supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

NIH
NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-19-001.html
This funding opportunity encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to support research and/or infrastructure needs in emerging scientific areas leading to more accessible and affordable hearing health care for adults with mild to moderate hearing loss. The proposed research aims should be milestone-driven and lead to better hearing healthcare, targeting enhanced access and affordability, in an effort to improve outcomes for adults with hearing loss.

NIH
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-184.html
This announcement provides an avenue for basic scientists, clinicians, and clinical scientists to jointly initiate and conduct translational research projects that translate basic research findings into clinical tools for better human health.  

NIH
NIDDK Program Projects (P01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-012.html
This announcement invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission, including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat, and cure these diseases, including clinical research. 

NIH
NIDDK Program Projects (P01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-127.html
This announcement invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission, including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research.

NIH
NIH Exploratory/Developmental Research Grant Program ( Parent R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-053.html
The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. 

NIH
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-056.html
The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers based on their scientific missions. 

NIH
NIH Small Research Grant Program (Parent R03 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-052.html
The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 

NIH
NINDS CREATE Bio Optimization Track for Biologics (U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-456.html
This announcement supports the optimization of potential therapeutic biotechnology products and biologics (e.g., peptides, proteins, oligonucleotides, gene, and cell therapies) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic lead(s) that showed promise as a potential therapeutic agent as evidenced by convincing animal proof-of-concept studies. Therefore, at the end of this funding period, successful projects will have delivered and optimized therapeutic candidate with demonstrated bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and should be eligible for entry into the CREATE Bio Development track. The CREATE Bio Development track is a later stage program focused on the development of optimized therapeutic candidates through Investigational New Drug (IND)-enabling studies and submission of an IND package to the Food and Drug Administration (FDA).

NIH
NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-358.html
The NINDS Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects that fall within the mission of the NINDS. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience or to the development of novel techniques, agents, methodologies, or models of high value to the neuroscience community.    

NIH
NIOSH Occupational Safety and Health Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-769.html
The purpose of the R01 grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. Applicants must concisely describe the occupational health burden(s) being addressed in their proposal while also linking the need for the proposed research activities to planned outputs that will help address or alleviate this burden. Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.

Standard application due dates apply. See solicitation for details.

NIH
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-114.html
The purpose of this announcement is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination. Secondary objectives include the development of novel technologies to allow for more definitive studies of human immune monitoring in the context of vaccine clinical trials and the recruitment of innate immunologists to the HIV vaccine field.

NIH
Non-healing Ulcerative Wounds in Aging (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-230.html
This announcement invites applications that propose basic, clinical, or translational research on non-healing ulcerative wounds and their consequences in aging and in older persons. Applications are encouraged that focus on the (1) biology, etiology and pathophysiology of non-healing ulcerative wounds in animal models and/or older adults; (2) translation of basic/clinical research into clinical practice and health decision-making; and (3) diagnosis, prevention, management and clinical outcomes of non-healing wounds in older adults. 

NIH
Non-healing Ulcerative Wounds in Aging (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-231.html
This announcement invites applications that propose basic, clinical, or translational research on non-healing ulcerative wounds and their consequences in aging and in older persons. Applications are solicited that focus on the (1) biology, etiology and pathophysiology of non-healing ulcerative wounds in animal models and/or older adults; (2) translation of basic/clinical research into clinical practice and health decision-making; and (3) diagnosis, prevention, management, and clinical outcomes of non-healing wounds in older adults.

NIH
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-868.html
Genome-wide association studies and other disease studies have found many variants that are statistically associated with disease risk, disease protection, or other traits. However, such studies do not show which variants in genomic elements cause these effects or how they result in differences in function. Similarly, clinical genomic sequencing studies have identified many variants in healthy and diseased individuals. However, the pathogenicity of such variants is often unknown, leading to their classification as variants of uncertain significance, which makes clinical implementation difficult. 

NIH
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-867.html
Genome-wide association studies and other disease studies have identified many variants that are statistically associated with disease risk, disease protection, or other traits. However, such studies do not generally show which specific variants in genomic elements cause these effects or how they result in differences in function. Similarly, genomic sequencing studies in clinical settings have identified many variants in healthy and diseased individuals. However, the pathogenicity of such variants is often unknown, leading to their classification as variants of uncertain significance, which makes clinical implementation difficult. 

NIH
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-082.html
The purpose of this funding opportunity is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; with the ultimate goal of advancing the field toward solutions for the improved detection, prevention, and treatment of select endemic mycoses.

NIH
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-083.html
The purpose of this funding opportunity is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; with the ultimate goal of advancing the field toward solutions for the improved detection, prevention, and treatment of select endemic mycoses.

NIH
Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-243.html
The purpose of this announcement is to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as (1) pathogenesis, (2) host response, (3) disease transmission, (4) vector biology and natural history, (5) vaccines, (6) diagnostics, and (7) therapeutics. 

NIH
Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-244.html
The purpose of this announcement is to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as (1) pathogenesis, (2) host response, (3) disease transmission, (4) vector biology and natural history, (5) vaccines, (6) diagnostics, and (7) therapeutics. 

NIH
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-753.html
This announcement invites R01 applications to support the development of novel biomarkers and improved HIV incidence assays and algorithms with increased specificity for distinguishing recent (within the first 12 months) from chronic HIV infections.

NIH
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-754.html
This announcement invites R21 applications to support the development of novel biomarkers and improved HIV incidence assays and algorithms with increased specificity for distinguishing recent (within the first 12 months) from chronic HIV infections.

NIH
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-034.html
The purpose of this announcement is to promote application of nutrigenetics and/or nutrigenomics approaches to nutrition research through collaborative interaction among nutrition researchers and experts in omics technologies.

NIH
Nutrition and Alcohol-Related Health Outcomes (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-211.html
This announcement encourages applications that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.

NIH
Nutrition and Alcohol-Related Health Outcomes (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-212.html
The solicitation encourages applications that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models, with the goal of stimulating a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.

NIH
Nutrition and Alcohol-Related Health Outcomes (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-213.html
This announcement encourages applications that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models, with the goal of stimulating a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.

NIH
Occupation Safety and Health Exploratory/Developmental Grant Program (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-798.html
The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. NIOSH sponsors exploratory and developmental research projects by providing support for the early and conceptual stages of projects. Applicants must concisely describe the occupational health burden(s) being addressed in their proposal while also linking the need for the proposed research activities to planned outputs that will help address or alleviate this burden. Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.

NIH
Occupational Safety and Health Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-812.html
The purpose of this program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.

Application dates vary. See solicitation for details.

NIH
Occupational Safety and Health Small Research Grant Program
https://grants.nih.gov/grants/guide/pa-files/PAR-18-797.html
The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports small occupational safety and health research projects that can be carried out with limited resources such as pilot and feasibility studies, secondary data analysis, or development of research methods.

NIH
Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-088.html
Application Deadline: May 8, 2019
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of oocyte mitochondrial function in relation to fertility, aging, and mitochondrial disease transmission to offspring. The overarching goal is to gain fundamental insight into the role of mitochondria and long-term consequences of their dysfunction in the oocyte, and to develop therapeutic or alternative approaches to treat mitochondrial dysfunction for improving oocyte quality and competency, and health of the resultant offspring.

NIH
Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-087.html
Application Deadline: May 8, 2019
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of oocyte mitochondrial function in relation to fertility, aging, and mitochondrial disease transmission to offspring. The overarching goal is to gain fundamental insight into the role of mitochondria and long-term consequences of their dysfunction in the oocyte, and to develop therapeutic or alternative approaches to treat mitochondrial dysfunction for improving oocyte quality and competency, and health of the resultant offspring. 

NIH
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-306.html
The purpose of this announcement is to support exploratory basic research to develop innovative phylodynamic approaches to identify and prioritize the most rapidly growing HIV transmission clusters within a given population of individuals in near-real time. 

NIH
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-893.html
This announcement encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. 

NIH
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-892.html
This announcement encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. 

NIH
Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-903.html
The purpose of this funding opportunity is to foster the advancement of the research mission of the Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases by inviting research concepts for clinical pilot and feasibility research studies; and translational research studies in digestive diseases and nutrition.

NIH
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications in Cancer Biology (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-177.html
This announcement encourages basic research into the role of RNA chemical modifications and their corresponding writers, readers and erasers in the initiation and progression of cancer. 

NIH
Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-615.html
This announcement invites applications for innovative basic and translational research projects examining HIV infection, persistence, and comorbidities as they relate to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases and consistent with the scientific priorities outlined by the NIH Office of AIDS Research in NOT-OD-15-137.

NIH
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-180.html
The purpose of this announcement is to encourage research applications to develop and pilot test approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive routine medical care. 

NIH
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-177.html
The purpose of this announcement is to encourage research applications to test innovative approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive their routine medical care. 

NIH
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-900.html
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This opportunity is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This opportunity intends to support disease-focused translational studies and invites research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies.

NIH
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-899.html
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This opportunity is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This opportunity intends to support disease-focused translational studies and invites research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. 

NIH
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-849.html#_3._Additional_Information
This funding opportunity announcement seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and well-being as individuals age and prevent illness and disability in later years. 

NIH
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-850.html#_3._Additional_Information
This funding opportunity announcement seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and well-being as individuals age and prevent illness and disability in later years. 

NIH
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-067.html
This funding opportunity invites applications to characterize antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands presented by classical and non-classical MHC class I and class II molecules and to determine the contribution of these unique antigenic ligands to: protective immune responses to infectious pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or in the induction/progression or prevention of immune-mediated diseases. 

NIH
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-066.html
This opportunity invites applications to determine antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands and to determine the contribution of these unique antigenic ligands to: protective immune responses against infectious disease pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or limit progression or induction of immune-mediated diseases.

NIH
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-276.html
This announcement encourages research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis, and prognosis of early cancer. This announcement will promote rigor and reproducibility research in both the isolation of exosomes as well as the computational analysis of the cargo carried in these vesicles. 

NIH
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-277.html
This announcement encourages research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer. This announcement will promote rigor and reproducibility research in both the isolation of exosomes as well as the computational analysis of the cargo carried in these vesicles.

NIH
Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-170.html
The goal of this funding opportunity is to encourage applications that propose to identify biomarkers for onset and progression of cognitive impairment in Parkinson's Disease through Parkinson's Disease Dementia. 

NIH
Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-262.html
The purpose of this announcement is to stimulate HIV/AIDS research by addressing scientific areas of primary interest to the National Institute of Child Health and Human Development, Maternal and Pediatric Infectious Disease Branch, and the Office of AIDS Research.

NIH
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-032.html
The purpose of this funding opportunity is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS). This opportunity involves a set of six PQs. Each research project proposed in response to this opportunity must be focused on addressing one particular research problem defined by one specific PQ selected from the list. 

NIH
PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (Collaborative U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-258.html
This solicitation will support research in the discovery and characterization of the full spectrum of human-specific non-coding functional genomic elements across brain regions, cell types, and developmental time periods to elucidate their role(s) in the molecular pathophysiology of mental illness. 

NIH
PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-257.html
This solicitation will support research in the discovery and characterization of the full spectrum of human-specific non-coding functional genomic elements across brain regions, cell types, and developmental time periods to elucidate their role(s) in the molecular pathophysiology of mental illness. 

NIH
Research Grants Using the Resources from the Osteoarthritis Initiative (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-409.html
This announcement encourages applications for research awards that are focused on the use of the Osteoarthritis Initiative database, clinical data, and images. 

NIH
Research Grants Using the Resources from the Osteoarthritis Initiative (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-408.html
This announcement encourages applications for research awards that are focused on the use of the Osteoarthritis Initiative database, clinical data, and images. 

NIH
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-367.html
This announcement invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. Specifically, this announcement will use the NIH Phased Innovation Award mechanism to provide up to two years of R21 support for initial developmental activities, and up to three years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions. 

NIH
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-013.html
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This opportunity is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This opportunity intends to support disease-focused translational studies and invites research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies.

NIH
Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-012.html
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This opportunity is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This opportunity intends to support disease-focused translational studies and invites research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. 

NIH
Research on Autism Spectrum Disorders (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-388.html
The purpose of this announcement is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders. 

NIH
Research on Autism Spectrum Disorders (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-387.html
The purpose of this announcement is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders. 

NIH
Research on Autism Spectrum Disorders (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-386.html
The purpose of this announcement is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders. 

NIH
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-937.html
The purpose of this funding opportunity is to encourage epidemiological, clinical, and translational research that will increase our understanding of the natural history, prevalence, biological mechanisms, psychological variables, and clinical risk factors responsible for the presence of multiple chronic pain conditions in people with pain.

NIH
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/pa-18-939.html
The purpose of this funding opportunity is to encourage epidemiological, clinical, and translational research that will increase our understanding of the natural history, prevalence, biological mechanisms, psychological variables, and clinical risk factors responsible for the presence of multiple chronic pain conditions in people with pain.

NIH
Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAS-18-557.html
HIV+ alcohol users remain at high risk for medication non-adherence and rapid disease progression, medication toxicities, organ failure, and poor viremic control, leading to increased risk of transmission and premature death. Recent advances in technology and biomedical science (e.g., new pharmacological agents, alcohol and inflammation biomarkers, internet and mobile technology) open new opportunities for strengthening the quality of HIV/alcohol-related implementation research through utilization of novel technology and biomarkers. This initiative seeks to advance knowledge on implementation and comparative effectiveness of alcohol-focused interventions among HIV+ individuals. 

NIH
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-070.html
The purpose of this funding opportunity is to invite applications proposing research on current topics in Alzheimer's disease and its related dementias.

NIH
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/par-19-071.html
The purpose of this funding opportunity is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease and its related dementias and which need additional preliminary data with broader dissemination to establish them for more general use in this research field.

NIH
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-729.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

Standard and AIDS application dates apply. See solicitation for details.

NIH
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-728.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

Standard and AIDS application dates apply. See solicitation for details.

NIH
Research on Transgender Health (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-478.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

NIH
Research on Transgender Health (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-477.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex. 

NIH
Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-20-005.html
Application Deadline: June 27, 2019
In this funding opportunity announcement, the National Center for Medical Rehabilitation Research within the National Institute of Child Health and Human Development invites applications for research project grants addressing the rehabilitation needs of children with chronic, physical disabilities.

NIH
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-260.html
This announcement encourages applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community and to implement an environmental public health action plan based on research findings. 

NIH
Research to Advance Hepatitis B Virus (HBV) Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAS-19-097.html
The purpose of this funding opportunity is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving HBV cure in the presence or absence of HIV.

NIH
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-196.html
The purpose of this announcement is to establish a program of research to advance the understanding, prevention, and treatment of pediatric multiple organ dysfunction syndrome (MODS). Possible topics of study include, but are not limited, to the epidemiology, pathophysiology, monitoring, and treatment of MODS. Studies that assess specific etiologies associated with MODS including, but not limited to, sepsis, trauma, acute respiratory distress syndrome, inborn errors of metabolism, burns, cancer, transplantation and congenital heart disease are encouraged. Applications may include any appropriate study designs ranging from basic science and animal models through prospective randomized controlled trials. 

NIH
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-197.html
The purpose of this announcement is to advance the understanding, prevention, and treatment of pediatric multiple organ dysfunction syndrome (MODS). It is hoped that this research will inform subsequent R01 applications, and ultimately translate into improved outcomes for children with MODS, both in terms of prevention and treatment.

NIH
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-195.html
The purpose of this announcement is to establish a program of research to advance the understanding, prevention, and treatment of pediatric multiple organ dysfunction syndrome (MODS). The intent of this R21 funding initiative is to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of research projects addressing these topics. These studies may incur considerable research risk in efforts to make important breakthroughs in the understanding, prevention, and treatment of MODS in children. Projects of limited cost or scope that use widely accepted approaches and methods within well-established fields are better suited for the R03 small grant activity code. It is hoped that the results of this exploratory research will translate into improved clinical outcomes for children with, and at risk for, MODS.

NIH
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-873.html
The purpose of this opportunity is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety, such as: 1) characterization of physiological and immunological responses to vaccines and vaccine components, including different adjuvants; 2) how genetic variations affect immune/physiological responses that may impact vaccine safety; 3) identification of risk factors (e.g., infection history, predisposition to or presence of allergic and/or autoimmune disease and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines; 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources, such as passive reporting systems or healthcare databases; or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety.

NIH
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-872.html
The purpose of this opportunity is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety such as 1) characterization of physiological and immunological responses to vaccines and vaccine components, including different adjuvants; 2) how genetic variations affect immune/physiological responses that may impact vaccine safety; 3) identification of risk factors e.g., infection history, predisposition to or presence of allergic and/or autoimmune disease and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines; 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems or healthcare databases; or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety. 

NIH
Research to Improve Native American Health (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-464.html
The purpose of this announcement is to encourage exploratory developmental research to improve Native American health. Such research can include conducting secondary analysis of existing data (such as databases that the Tribal Epidemiology Centers have collected); merging various sources of data to answer critical research questions; conducting pilot and feasibility studies; and/or assessing and validating measures that are being developed and/or adapted for use in Native American communities. 

NIH
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-369.html
This announcement encourages grant applications aimed at developing, characterizing, or improving animal models of human diseases; improving access to data and information about or generated from the use of animal models of human disease; or improving diagnosis and control of diseases of laboratory animals. The animal models and related materials to be developed must address the research interests of two or more of the categorical NIH Institutes and Centers. Applications to develop models that relate strictly to a specific disease or category of research will not be considered acceptable. Projects that predominantly address the research interests of one NIH Institute or Center but are peripherally related to the research interests of other Institutes and Centers will not be considered appropriate. 

NIH
Role of Age-Associated Metabolic Changes in Alzheimer's Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-031.html
This announcement encourages innovative experimental approaches to explore the molecular and cellular bases for age-related change in metabolism that impact the development of Alzheimer's disease.

NIH
Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-144.html
The purpose of this announcement is to encourage the submission of applications to examine the effects of drugs of abuse on the structural connectivity of astrocytic networks within the CNS and the generation, processing, and spatiotemporal control of activities within these networks.

NIH
Role of Astrocytes and Astrocytic Networks in Drug Abuse (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-145.html
The purpose of this announcement is to encourage the submission of applications to examine the effects of drugs of abuse on the structural connectivity of astrocytic networks within the CNS and the generation, processing, and spatiotemporal control of activities within these networks.

NIH
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living With and Without HIV (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-838.html
The purpose of this funding opportunity announcement is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reproductive and metabolic failure. 

NIH
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living With and Without HIV (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-839.html
The purpose of this funding opportunity announcement is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reproductive and metabolic failure.

NIH
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-311.html
The purpose of this announcement is to (1) promote preclinical, translational, clinical, and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments.

NIH
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-313.html
The purpose of this announcement is to (1) promote preclinical, translational, clinical, and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments. 

NIH
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-312.html
The purpose of this announcement is to (1) promote preclinical, translational, clinical, and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in the safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatment.

NIH
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-741.html
This announcement encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases.

NIH
Secondary Analyses of Alcohol and Chronic Disease (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-394.html
This announcement encourages applications that propose to conduct secondary analyses of alcohol as it relates to chronic disease etiology and epidemiology. The goal of this program is to facilitate innovative yet cost-effective research utilizing previously collected data.

Standard application dates apply. See solicitation for details.

NIH
Secondary Analyses of Existing Alcohol Research Data (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-467.html
This announcement encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption and the epidemiology and etiology, including genetics, of alcohol-related problems. 

NIH
Secondary Analyses of Existing Alcohol Research Data (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-468.html
This announcement encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption and the epidemiology and etiology, including genetics, of alcohol-related problems. 

NIH
Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-004.html
The goal of this opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. 

NIH
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-239.html
This announcement encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. 

NIH
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-243.html
This announcement encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. 

NIH
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-068.html

NIH
Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-158.html
This solicitation seeks applications that propose secondary analyses of existing clinical research data sets to investigate constructs identified in the NIMH's Research Domain Criteria Initiative and to test novel hypotheses using the Criteria framework.

NIH
Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-706.html
The goal of this announcement is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimers disease (AD). Understanding mechanisms underlying selective vulnerability from cells to networks in AD is critical to fully define the disease process and to develop effective therapies.

NIH
Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-047.html
The goal of this announcement is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimers disease (AD). Understanding mechanisms underlying selective vulnerability from cells to networks in AD is critical to fully define the disease process and to develop effective therapies. 

NIH
Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-519.html
The purpose of this announcement is to encourage applications that propose either basic, clinical, or a combination of basic and clinical studies to investigate how functional changes in the sensory and/or motor systems impact the development and progression of Alzheimers disease. 

NIH
Serious Adverse Drug Reaction Research (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-275.html
This announcement will support research grants that will advance the state of knowledge of serious adverse drug reactions. Applications across the spectrum of research are encouraged. 

NIH
Serious Adverse Drug Reaction Research (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-274.html
This announcement will support research grants that will advance the state of knowledge of serious adverse drug reactions. Applications across the spectrum of research are encouraged. 

NIH
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-222.html
The purpose of this funding opportunity announcement is to provide support for New Investigators: 1) from diverse backgrounds, including from groups nationally underrepresented in biomedical and behavioral research to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Human Genome Research Institute; and 2) who at the time of award will have/have had less than $125,000 direct cost of combined research funding (excluding NIH training and NIH career awards). 

NIH
Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-299.html
This announcement encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources. 

NIH
Small Grants on Primary Immunodeficiency Diseases (R03)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-332.html
This announcement will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying, the molecular basis of or developing innovative therapies for primary immunodeficiency diseases. 

NIH
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-069.html
This opportunity is intended to support meritorious small research projects focused on the development and analyses of childhood cancer and/or structural birth defects datasets that are part of the Gabriella Miller Kids First Data Resource or could be included in the Kids First Data Resource. Development of statistical methodology appropriate for analyzing genome-wide data relevant to childhood cancer and/or structural birth defects may also be proposed. 

NIH
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-313.html
This announcement invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a related group of cancers. 

NIH
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAS-19-105.html

NIH
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-430.html
The purpose of this announcement is to support research that advances compounds toward FDA approval by leveraging NIDA funds with the strengths and resources of outside organizations, such as for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, and small businesses. 

NIH
Symptom Cluster Characterization in Chronic Conditions (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-462.html
The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions.

NIH
Symptom Cluster Characterization in Chronic Conditions (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-461.html
The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions.

NIH
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-143.html
The announcement invites research applications focused on developing, adapting and testing innovative cost-effective strategies to prevent, identify and manage symptoms of HIV-associated Non-AIDS conditions and other comorbidities among older adults with prolonged HIV infection.

NIH
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-161.html
The announcement invites research applications focused on developing, adapting, and testing innovative cost-effective strategies to prevent, identify, and manage symptoms of HIV-associated Non-AIDS conditions and other comorbidities among older adults with prolonged HIV infection.

NIH
Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-454.html
The purpose of this announcement is to promote systems developmental biology. In the context of this announcement, systems developmental biology is defined as research focused on understanding how biological components work together to produce the complex biological phenomena encompassing embryonic development.

Applications are due December 6, 2017; December 6, 2018; and December 6, 2019.

NIH
Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-194.html
This announcement encourages implementation research projects designed in partnership with global and domestic service providers to target the particular needs in the selected community to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment, and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression. 

NIH
Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-195.html
This announcement encourages implementation research projects designed in partnership with global and domestic service providers to target the particular needs in the selected community to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment, and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression. 

NIH
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/pa-19-073.html
The purpose of this funding opportunity is to stimulate clinical research that examines the role of telomeres in wellness and disease and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

NIH
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-074.html

NIH
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-306.html
The purpose of this announcement is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity and 2) that could be made scalable and sustainable for broad use across the nation. 

NIH
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-324.html
The purpose of this announcement is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity and 2) that could be made scalable and sustainable for broad use across the nation. 

NIH
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-440.html
The purpose of this announcement is to stimulate research in the interplay between cell death pathways in nave and drug resistant cancers. 

NIH
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-449.html
The purpose of this announcement is to stimulate research in the interplay between cell death pathways in nave and drug resistant cancers. 

NIH
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-830.html
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), and the National Eye Institute (NEI).

NIH
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-831.html
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NIH
The Role of Mobile Genetic Elements in Cancer (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-227.html
The goal of this announcement is to encourage applications to investigate mechanisms regulating the expression and activity of mobile genetic elements, including long terminal repeat (LTR) and non-LTR retroelements, in cancer. 

NIH
The Role of Mobile Genetic Elements in Cancer (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-226.html
The goal of this announcement is to encourage applications to investigate mechanisms regulating the expression and activity of mobile genetic elements, including long terminal repeat (LTR) and non-LTR retroelements, in cancer. 

NIH
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-283.html
The purpose of this announcement is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection. 

NIH
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-282.html
The purpose of this announcement is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection. 

NIH
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-189.html
The purpose of this announcement is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the announcement are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. 

NIH
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-188.html
The purpose of this announcement is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the announcement are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. 

NIH
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-187.html
The purpose of this announcement is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the announcement are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. 

NIH
Trophoblast Differentiation and Function (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-445.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of trophoblast differentiation and function in relation to fertility and pregnancy, including the role of the immune system. 

NIH
Trophoblast Differentiation and Function (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-444.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of trophoblast differentiation and function in relation to fertility and pregnancy, including the role of the immune system. 

NIH
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-466.html
A rich body of evidence suggests that optimal cognitive, affective, and social processes are associated with highly coordinated neural activity. These findings suggest that oscillatory rhythms, their co-modulation across frequency bands, spike-phase correlations, spike population dynamics, and other patterns might be useful drivers of therapeutic development for treatment of cognitive, social, or affective symptoms in neuropsychiatric disorders. This funding opportunity supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. 

NIH
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-463.html
A rich body of evidence suggests that optimal cognitive, affective, and social processes are associated with highly coordinated neural activity. These findings suggest that oscillatory rhythms, their co-modulation across frequency bands, spike-phase correlations, spike population dynamics, and other patterns might be useful drivers of therapeutic development for treatment of cognitive, social, or affective symptoms in neuropsychiatric disorders. This funding opportunity supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. 

NIH
Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-032.html
This announcement invites applications from institutions/organizations that propose to characterize or identify factors in early childhood (birth-24 months) that may increase or mitigate risk for obesity and/or excessive weight gain and/or to fill methodological research gaps relevant to the understanding of risk for development of obesity in children. 

NIH
Understanding Factors in Infancy and Early Childhood that Influence Obesity Development (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-169.html
This announcement invites applications from institutions/organizations that propose to characterize or identify factors in early childhood (birth-24 months) that may increase or mitigate risk for obesity and/or excessive weight gain and/or to fill methodological research gaps relevant to the understanding of risk for development of obesity in children. 

NIH
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-333.html
The purpose of this announcement is to support studies on the very early development of the immune system and the humoral and cellular communication that exists between the mother and fetus that may shape or impact immune system development and maturation. 

NIH
Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-115.html
Application Deadline: May 2, 2019
This funding opportunity invites innovative research grant applications focused on identifying potential mechanisms and risk factors underlying HIV treatment-associated neuropsychiatric symptoms and neurological toxicities experienced by some people living with HIV infection.

NIH
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-330.html
The purpose of this announcement is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists.

NIH
Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-007.html
The purpose of the updated ViCTER program is to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts among fundamental (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers in the environmental health field. The newly established collaborative teams will come together in common interest to investigate potential linkages between human health and one or more environmental stressor(s). 

NIH
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-024.html
Application Deadline: April 4, 2019
The National Institute of Child Health and Human Development plans to establish new epidemiology cohort(s) of least 2,000 participants to stimulate research on a wide range of HIV research hypotheses pertinent to reproductive age women. The purpose of this funding opportunity announcement is to support new and innovative epidemiology research in reproductive age women living with HIV.   

NIH
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-048.html
The purpose of this announcement is to provide support for research on Zika virus and its complications. This announcement replaces PAR-16-106, which had used rolling application due dates to facilitate the rapid review and award of particularly urgent or time-sensitive projects. The last date for submitting an application to PAR-16-106 is January 13, 2017.

NIH
Zika Virus (ZIKV) Complications (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-085.html
The purpose of this announcement is to provide support for research on Zika virus (ZIKV) and its complications. This announcement replaces PAR-16-106, which had used rolling application due dates to facilitate the rapid review and award of particularly urgent or time-sensitive projects. The last date for submitting an application to PAR-16-106 was January 13, 2017.

NSF
Long Term Research in Environmental Biology
https://www.grants.gov/web/grants/view-opportunity.html?oppId=309109
The Long Term Research in Environmental Biology (LTREB) Program supports the generation of extended time series of data to address important questions in evolutionary biology, ecology, and ecosystem science. All proposals submitted through the LTREB solicitation are processed by 1 of the 3 clusters in the Division of Environmental Biology: Ecosystem Science, Population and Community Ecology, and Evolutionary Processes. Proposals must address topics supported by these clusters. 

NSF
Sustained Availability of Biological Infrastructure
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314047
This program supports the continued operation of extant infrastructure that will advance basic biological research, with a focus on awards that ensure the continued availability of mature infrastructure resources critical to sustain the ability of today's scientific community to conduct leading edge research.

Tourette Association of America
Support for Research Consortia and Collaborative Research Projects
https://tourette.org/research-medical/support-for-research-consortia-and-collaborative-research-projects/
The Tourette Association of America is offering seed funding to research consortia working on large issues relevant to Tourette Syndrome and seeks to support research efforts that crossover different scientific and medical disciplines and that encourage collaboration among researchers and institutions.

J.M. Kaplan Fund
Alice Award
http://www.furthermore.org/alice-award.html
Application Deadline: April 1, 2019

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by March 4, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NEA
Art Works
http://arts.gov/grants-organizations/art-works/grant-program-description
This program supports public engagement with, and access to, various forms of excellent art, the creation of art that meets the highest standards of excellence, learning in the arts at all stages of life, and the integration of the arts into the fabric of community life. Applications require two subsequent submissions to Grants.gov and then to NEA, and the deadlines for the first submission - the Grants.gov submission - are February 14, 2019 or July 11, 2019, depending on the artistic discipline and/or type of project for which an organization seeks support.

In most situations, an organization may submit only one application to either the Art Works program or the Challenge America program.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by January 7, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NEA
Challenge America
http://arts.gov/grants-organizations/challenge-america/grant-program-description
The Challenge America program offers support primarily to small and mid-sized organizations for projects that extend the reach of the arts to underserved populations  -  those whose opportunities to experience the arts are limited by geography, ethnicity, economics, or disability. Applying requires two successive submissions to Grants.gov and then to NEA, and the deadline for the first submission to Grants.gov is April 11, 2019.

In most situations, an organization may submit only one application to either the Art Works program or the Challenge America program.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by January 7, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

Nebraska Arts Council
Arts Project Grants and Arts Learning Project Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/
Application Deadline: October 1, 2019
Arts Project Grants support arts programming, productions, or events open to the general public. Arts Learning Project Grants support programs with a strong educational emphasis in pre-K-12 schools or in community settings.

Each college/university department may only apply for either one Arts Project Grant or one Arts Learning Project Grant per deadline.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by April 8, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

Nebraska Arts Council
Mini Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/mini-grants.html
Mini Grants are designed to provide quick access to funds supporting a variety of arts projects. Examples of projects include exhibitions, performances, poetry readings, commissions and/or support of new work development, arts festivals, community murals, and cultural heritage projects.

Applications are accepted on a rolling basis.

Organizations may submit up to two Mini Grant applications per fiscal year (July 1 to June 30).

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by July 9, 2018. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NEH
Infrastructure and Capacity Building Challenge Grants
https://www.neh.gov/grants/preservation/infrastructure-and-capacity-building-challenge-grants
Application Deadline: May 15, 2019
The mission of this Challenge Grants program is to strengthen the institutional base of the humanities by enabling infrastructure development and capacity building. Grants aim to help institutions secure long-term support for their core activities and expand efforts to preserve and create access to outstanding humanities materials.

Institutions may apply for only one NEH challenge grant per calendar year.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by March 25, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NIH
Collaborative Program Grant for Multidisciplinary Teams (RM1) (Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-340.html
Application Deadline: May 25, 2019
This opportunity is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of the National Institute of General Medical Sciences and are beyond the scope of one or two investigators. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields. Only one application per institution per review cycle is allowed.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by February 18, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NIH
Environmental Health Sciences Core Centers (P30)
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-17-003.html
This announcement invites grant applications for Environmental Health Sciences Core Centers (EHS CC). As intellectual hubs for environmental health research, EHS CCs are expected to be the thought leaders for the field and advance the goals of the NIEHS Strategic Plan (http://www.niehs.nih.gov/about/strategicplan/). 

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by March 20, 2017. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NIH
Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-178.html
Application Deadline: May 31, 2019
The SIFAR Grant Program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as a series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations. Only one SIFAR application per institution, as identified by the DUNS number, is allowed per the receipt date. 

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by February 25, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
Materials Innovation Platforms
https://www.nsf.gov/pubs/2019/nsf19526/nsf19526.htm
Application Deadline: April 26, 2019
Materials Innovation Platforms (MIP) is a mid-scale infrastructure program in the Division of Materials Research designed to accelerate advances in materials research. This MIP competition focuses on advancing convergence of materials research with biological sciences for developing new materials.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by January 16, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
NSF Scholarships in Science, Technology, Engineering, and Mathematics Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=290464
Application Deadline: March 27, 2019
This program provides awards to Institutions of Higher Education to fund scholarships and to advance the adaptation, implementation, and study of effective evidence-based curricular and co-curricular activities that support recruitment, retention, transfer (if appropriate), student success, academic/career pathways, and graduation in STEM. 

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by January 22, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
Science and Technology Centers: Integrative Partnerships
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313811
This program supports exceptionally innovative, complex research and education projects that require large-scale, long-term awards. Supported centers may involve any area of science and engineering that NSF supports and must undertake activities that facilitate knowledge transfer.

The Foundation for Food and Agricultural Research
New Innovator in Food and Agricultural Research Award
https://foundationfar.org/wp-content/uploads/2018/02/FINAL-2018-NIA-Call-for-Nominations.pdf
Application Deadline: April 24, 2019
The Foundation for Food and Agricultural Research is seeking nominations for its 2019 New Innovator in Food and Agriculture Research Award.  This award is intended to promote career advancement of highly creative and promising new scientists who intend to make a long-term career commitment to research in food and agriculture and bring innovative, ground-breaking research initiatives and thinking to bear on problems facing food and agriculture.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by February 4, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

USDA
Children, Youth and Families at Risk Sustainable Communities Projects
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313957
Application Deadline: April 22, 2019
This program aims to develop and deliver educational programs that equip limited resource families and youth who are at-risk for not meeting basic human needs with the skills they need to lead positive, productive, contributing lives.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by March 27, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

William T. Grant Foundation
Scholars Program
http://wtgrantfoundation.org/grants/william-t-grant-scholars-program?utm_source=WilliamTGrant+Website+Signup&utm_campaign=690101b05c-ENTER_GA_HERE_COPY_01&utm_medium=email&utm_term=0_a590baf297-690101b05c-1204799469
Application Deadline: July 2, 2019
The William T. Grant Scholars Program supports career development for promising early-career researchers. The program funds five-year research and mentoring plans that significantly expand researchers' expertise in new disciplines, methods, and content areas. Applicants should have a track record of conducting high-quality research and an interest in pursuing a significant shift in their trajectories as researchers.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by February 4, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

Department of Energy
Quantum Information Science Enabled Discovery (QuantISED) for High Energy Physics
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002077.pdf
Application Deadline: April 16, 2019
The Department of Energy Office of Science program in High Energy Physics (HEP) hereby announces its interest in receiving interdisciplinary applications for Pioneering Pilots proposing open scientific research on Quantum Information Science (QIS) Enabled Discovery (QuantISED) to understand how the universe works at its most fundamental level. A letter of intent is required and due March 5, 2019.

Department of Energy
Quantum Information Science Research for Fusion Energy Sciences
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002078.pdf
Application Deadline: May 9, 2019
This opportunity seeks applications for fundamental research for public benefit in the area of Quantum Information Science (QIS). Responsive applications will propose research that could have a transformative impact on Fusion Energy Sciences (FES) mission areas - including fusion and discovery plasma science - and/or advance QIS development enabled by FES-supported science. A letter of intent is required and due April 4, 2019.

Department of Energy
Research Opportunities in Accelerator Stewardship
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002069.pdf
Application Deadline: April 23, 2019
This funding opportunity focuses on three distinct activities: (1) applied research that is focused on developing a prototype in response to a specific technical challenge, (2) basic research that broadly impacts many accelerator applications, and (3) facilitating access to accelerator R&D capabilities at SC-sponsored National Laboratories for academic research. Pre-applications are required and due March 12, 2019.

Department of Energy
Subsurface Biogeochemical Research
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002035.pdf
Application Deadline: April 11, 2019
The Department of Energy Office of Science program in Biological and Environmental Research hereby announces its interest in receiving applications for research in Subsurface Biogeochemical Research (SBR). The goal of the SBR program is to advance a robust predictive understanding of how watersheds function as integrated hydro-biogeochemical systems and how these systems respond to perturbations caused by changes in water availability and quality, contaminant release, nutrient cycling, land-use, vegetation cover, and snowmelt timing. Pre-applications are required and due February 14, 2019.

Department of Energy
Terrestrial Ecosystem Science
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0002043.pdf
Application Deadline: March 29, 2019
The Terrestrial Ecosystem Science program in the Climate and Environmental Sciences Division, Biological and Environmental Research program of the Office of Science, U.S. Department of Energy, announces its interest in receiving research applications seeking to improve the understanding and representation of terrestrial ecosystems in ways that advance Earth system model parameterizations and capabilities. Pre-applications are required and due by January 24, 2019.

Department of Energy
Theoretical Research in Magnetic Fusion Energy Science
https://science.energy.gov/~/media/grants/pdf/foas/2019/sc_foa_0001973.pdf
Application Deadline: March 26, 2019
The Department of Energy Office of Science program in Fusion Energy Sciences hereby announces its interest in receiving applications for fundamental theoretical and computational research for public benefit, relevant to magnetic confinement configurations. The specific areas of interest are macroscopic stability; confinement and transport; boundary physics; plasma heating and non-inductive current drive; and energetic particles. A letter of intent is required and due February 11, 2019.

NASA
Research Opportunities in Aeronautics - 2018
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId=%7B92A96AE7-DBC9-D850-9DBA-D69E94C2027A%7D&path=open
Research Opportunities in Aeronautics - 2018 solicits foundational and system-level research in support of NASA's Aeronautics Research Mission Directorate. Specific research thrusts are outlined in the appendices.

NASA
ROSES 2017: Land-Cover/Land-Use Change
https://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId=%7b53BC4764-570A-05A6-0FC1-0FEA93AD036E%7d&path=open&utm_source=Funding+Supplement&utm_campaign=ef6712c15b-EMAIL_CAMPAIGN_2017_03_06&utm_medium=email&utm_term=0_8d6cbefc3d-ef6712c15b-212708225
Notices of intent to propose are due April 3, 2017. Full proposals are due June 8, 2017.

NASA
ROSES 2018: Carbon Monitoring System
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313154
This program element requests proposals for investigations that will advance products toward the end goal of developing a prototype carbon monitoring system from an Earth's system perspective. Geographic areas of interest include terrestrial, atmospheric, and aquatic realms.

NASA
ROSES 2018: Korea Pathfinder Lunar Orbiter Participating Scientist Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313099
This program solicits proposals that require the use of anticipated Korea Pathfinder Lunar Orbiter mission data to address outstanding science questions about, or related to, the Moon.

NASA
ROSES 2018: Planetary Mission Concept Studies
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313098
This program element solicits proposals for mission concept studies that address NASA's planetary science objectives, which are to ascertain the content, origin, and evolution of the Solar System and the potential for life elsewhere.

NASA
ROSES 2018: Planetary Protection Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312760
This program solicits proposals for new projects aimed at protecting solar system bodies from contamination by Earth life and protecting Earth from possible life forms that may be returned from other solar system bodies.

NASA
ROSES 2018: Plankton, Aerosol, Cloud, Ocean (PACE) Mission System Vicarious Calibration
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313144
This program seeks ways to provide or develop, if needed, in situ instruments, systems, and approaches for the post-launch vicarious calibration of the PACE mission system. Ocean color "vicarious" calibration refers to a final bias adjustment to the calibrated, spectral, top-of-atmosphere radiances observed by an ocean color instrument. 

NASA
ROSES 2018: Rapid Response and Novel Research in Earth Science
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId=%7bC1F3E3C6-923F-524C-3933-160AF5F195C8%7d&path=open&utm_source=Funding+Supplement&utm_campaign=6986960e15-EMAIL_CAMPAIGN_2018_05_22&utm_medium=email&utm_term=0_8d6cbefc3d-6986960e15-212708225
Rolling submissions will be accepted through March 29, 2019.

NASA
ROSES 2018: Second Astrophysics Data Analysis Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312674
The Astrophysics Data Analysis Program (ADAP) solicits research with a primary emphasis on the analysis of NASA space astrophysics data that are archived in the public domain at the time of proposal submission. This second ADAP solicitation provides support for investigations focusing on the analysis of archival data from NASA space astrophysics missions.

NASA
ROSES 2018: Second Exoplanets Research Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313205
This program element solicits basic research proposals to conduct scientific investigations focused on extrasolar planets. Broad objectives of this program include, but are not limited to: the detection and characterization of other planetary systems; characterization of individual exoplanets through exploration of their composition, dynamics, energetics, chemical behavior, etc.; and the origins of extrasolar planets.

NASA
ROSES 2018: SERVIR Applied Sciences Team
https://www.grants.gov/web/grants/view-opportunity.html?oppId=300775
The Applied Sciences Program invites proposals for membership on the third SERVIR Applied Sciences Team and Team member projects through this program element. SERVIR is a joint initiative of NASA and USAID and fosters applications of Earth observations to help developing countries assess environmental conditions to improve their planning and actions.

NASA
ROSES 2018: Topical Workshops, Symposia, and Conferences
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId=%7bDA995583-5342-7497-1A9C-7DF8A7CE6E27%7d&path=open&utm_source=Funding+Supplement&utm_campaign=6986960e15-EMAIL_CAMPAIGN_2018_05_22&utm_medium=email&utm_term=0_8d6cbefc3d-6986960e15-212708225
Rolling submissions will be accepted through March 29, 2019.

NSF
Division of Physics: Investigator-Initiated Research Projects
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf17561
This solicitation has annual deadlines that vary across programs. See the solicitation for details.

NSF
Geoinformatics
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313270
This solicitation supports efforts to develop data resources, software tools, and computational infrastructure needed to facilitate studies of the structure, dynamics, and evolution of the Earth through time, as well as the processes that act upon and within the Earth from the surface to the core. Successful projects will develop community cyberinfrastructure to advance research and education goals in Earth Science.

Proposals are due August 15, 2019 and every other year thereafter.

NSF
NSF-CBMS Regional Research Conferences in the Mathematical Sciences
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310678
Application Deadline: April 26, 2019
These five-day conferences feature a distinguished lecturer presenting on one important current research topic in the mathematical sciences. Support is provided for about 30 participants at each conference.

NSF
Probability
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5555
The full proposal deadline is September 25, annually.

Simons Foundation
Targeted Grants in Mathematics and Physical Sciences
https://www.simonsfoundation.org/grant/targeted-grants-in-mps/
The Simons Foundation's Mathematics and Physical Sciences division invites applications for its Targeted Grants in Mathematics and Physical Sciences program. This program is intended to support high-risk theoretical mathematics, physics, and computer science projects of exceptional promise and scientific importance on a case-by-case basis.

NIH
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-062.html
The purpose of this announcement is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. 

NIH
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-234.html
The purpose of this announcement is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. 

NIH
Addressing Health Disparities in NIDDK Diseases (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-021.html
This announcement invites research projects to improve understanding of the causes of high priority diseases in the United States and reducing/eliminating health disparities. Research is encouraged in the following high priority diseases within the scientific mission areas of the NIDDK: diabetes; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; sickle cell disease, specifically, studies in complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; hematologic diseases, including studies in abnormal hemoglobin synthesis; metabolic diseases; gastrointestinal, hepatic, and renal complications from infection with HIV. Clinical trials are not permitted.

NIH
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-284.html
The purpose of this announcement is to support innovative research to develop and implement effective interventions to address health disparities among U.S. immigrant populations. 

NIH
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-043.html
The purpose of this announcement is to support innovative research to develop and implement effective interventions to address health disparities among U.S. immigrant populations. 

NIH
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-285.html
The purpose of this announcement is to support and accelerate innovative exploratory and developmental research to develop and test feasibility of effective interventions to address health disparities among U.S. immigrant populations. 

NIH
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-044.html
The purpose of this announcement is to support and accelerate innovative exploratory and developmental research to develop and test feasibility of effective interventions to address health disparities among U.S. immigrant populations. 

NIH
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-747.html
This announcement seeks to support investigative and collaborative research focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder (OUD), and understanding and reducing disparities in opioid care in minority health and health disparity populations in the U.S. This initiative will also seek to identify multi-level intervention strategies at the institutional and systems level for addressing OUD in these populations.

NIH
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-745.html
The purpose of this announcement is to encourage developmental and exploratory research focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder (OUD), and understanding and reducing disparities in opioid care in minority health and health disparity populations in the U.S. This initiative will also seek to identify multi-level intervention strategies at the institutional and systems level for addressing OUD in these populations.

NIH
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-041.html
The purpose of this announcement is to support innovative research to understand uniquely associated factors (biological, behavioral, sociocultural, and environmental) that contribute to health disparities or health advantages among U.S. immigrant populations. 

NIH
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-042.html
The purpose of this announcement is to support innovative exploratory and developmental research to understand uniquely associated factors (biological, behavioral, sociocultural, and environmental) that contribute to health disparities or health advantages among U.S. immigrant populations.

NIH
Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-200.html
Application Deadline: April 10, 2019
This funding opportunity announcement invites applications on violence and the HIV care continuum, including: 1) research that will advance understanding of the role of exposure to violence on engagement and retention in HIV care, HIV medication adherence, and viral suppression; and 2) research to develop and test novel interventions to improve HIV care continuum outcomes for individuals who have experienced violence.

NIH
Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-201.html
Application Deadline: April 10, 2019
This funding opportunity announcement invites applications on violence and the HIV care continuum, including: 1) research that will advance understanding of the role of exposure to violence on engagement and retention in HIV care, HIV medication adherence, and viral suppression; and 2) research to develop and test novel interventions to improve HIV care continuum outcomes for individuals who have experienced violence.

NIH
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-014.html
The purpose of this announcement is to stimulate clinical research addressing behavioral and psychological symptoms of dementia (BPSD) and the association of BPSD with unmet physical, social, or environmental needs in persons with dementia.

NIH
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-013.html
The purpose of this announcement is to stimulate clinical research addressing behavioral and psychological symptoms of dementia (BPSD) and the association of BPSD with unmet physical, social, or environmental needs in persons with dementia.

NIH
Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-825.html
The National Institute on Aging (NIA) invites applications for research projects involving secondary analyses of data in the Computerized Tracking System (CTS) database from the CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) trial to explore behavioral and psychosocial aspects of sustained caloric restriction (CR) in humans, including the translation of the CR adherence strategies used in the trial to promote healthy behaviors, especially for the prevention of weight gain with age. CALERIE was the first trial in humans to specifically focus on the effects of sustained CR. It demonstrated feasibility of sustained human CR (for at least two years) and favorable effects on predictors of longevity, as well as on cardiometabolic risk factors. The sustained weight loss in CALERIE has not been previously attained in any clinical study in non-obese individuals.

Standard application dates apply. See solicitation for details.

NIH
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-945.html
The purpose of the funding opportunity is to encourage grant applications from the scientific community on applying a biopsychosocial perspective to self-management of chronic pain. 

NIH
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-946.html
The purpose of the funding opportunity is to encourage grant applications from the scientific community on applying a biopsychosocial perspective to self-management of chronic pain. 

NIH
Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-448.html
This announcement invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease. 

NIH
Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-449.html
This announcement invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease. 

NIH
Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-212.html
 The purpose of this funding opportunity announcement is to encourage behavioral intervention development research. Specifically, test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological treatments. 

NIH
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-944.html

NIH
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-943.html
The purpose of the funding opportunity is to encourage grant applications from the scientific community on the biobehavioral basis of chronic pain. The focus encompasses the individual phenotype, genotype, and other omic-type assessments and the associated sensory and emotional components that underpin the individual's chronic pain experience. Research relating biology and behavior is needed to better define the individual-specific burden of chronic pain and to better understand the mechanisms underlying differences in pain experiences among individuals afflicted with the same chronic illness. 

NIH
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-400.html
This opportunity seeks to support efforts addressing core ethical issues associated with research focused on the human brain and resulting from emerging technologies and advancements supported by the BRAIN Initiative.

NIH
Building Evidence: Effective Palliative/End of Life Care Interventions (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-173.html
This announcement seeks to stimulate research that tests optimal end-of-life and palliative care (EOLPC) interventions/models of care that are based on individual- and family-centered outcomes. The testing of EOLPC interventions and models of care are urgently needed that address racial, ethnic and/or cultural diversity in children and adults for those with serious, advanced illness. Trials are needed to test efficacy and effectiveness of these interventions and/or models of care.

NIH
Building Evidence: Effective Palliative/End of Life Care Interventions (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-250.html
This announcement seeks to stimulate research that tests optimal end-of-life and palliative care (EOLPC) interventions/models of care that are based on individual- and family-centered outcomes. The testing of EOLPC interventions and models of care are urgently needed that address racial, ethnic and/or cultural diversity in children and adults for those with serious, advanced illness. Trials are needed to test efficacy and effectiveness of these interventions and/or models of care.

NIH
Cancer-related Behavioral Research through Integrating Existing Data (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-256.html
This announcement invites applications that seek to integrate two or more independent data sets to answer novel cancer control and prevention questions. The goal is to encourage applications that incorporate Integrative Data Analysis (IDA) methods to study behavioral risk factors for cancer, including tobacco use, sedentary behavior, poor weight management, and lack of medical adherence to screening and vaccine uptake. 

NIH
Cancer-related Behavioral Research through Integrating Existing Data (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-255.html
This announcement invites applications that seek to integrate two or more independent data sets to answer novel cancer control and prevention questions. The goal is to encourage applications that incorporate Integrative Data Analysis (IDA) methods to study behavioral risk factors for cancer, including tobacco use, sedentary behavior, poor weight management, and lack of medical adherence to screening and vaccine uptake. 

NIH
Chronic Condition Self-Management in Children and Adolescents (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-115.html
The purpose of this announcement is to encourage research to improve self-management and quality of life in children and adolescents with chronic conditions. Managing a chronic condition is an unremitting responsibility for children and their families. Children with a chronic condition and their families have a long-term responsibility for self-management. This announcement encourages research that takes into consideration various factors that influence self-management such as individual differences, biological and psychological factors, family/caregivers and sociocultural context, family-community dynamics, healthcare system factors, technological advances, and the role of the environment.

NIH
Chronic Condition Self-Management in Children and Adolescents (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-116.html
The purpose of this announcement is to encourage exploratory/developmental research to improve self-management and quality of life in children and adolescents with chronic conditions. 

NIH
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-242.html
This funding opportunity solicits applications for research projects that will use computational approaches to test the validity of dimensional constructs in the NIMH Research Domain Criteria matrix (or similar constructs based on comparable criteria). The ultimate goal is to advance translational research that will identify novel classification approaches and/or treatment targets and lead to more effective and timely interventions for serious mental illnesses. 

NIH
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-240.html

NIH
Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-930.html
The purpose of this funding opportunity is to support the development and optimization of tasks and/or measures for constructs pertaining to functional aspects of behavior or cognitive/affective processes, for use in laboratory or population-based studies, clinical trials outcomes, or related research. 

NIH
Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-780.html
This announcement encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability, and safety of novel or adapted interventions that target HIV prevention, treatment, or services research. For the purposes of this announcement, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection or improve clinical outcomes for persons who are HIV infected.

AIDS application dates apply. See solicitation for details.

NIH
Dissemination and Implementation Research in Health (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-238.html
This announcement encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g., behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. 

NIH
Dissemination and Implementation Research in Health (R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-237.html
This announcement encourages investigators to submit research grant applications that will identify, develop, evaluate, and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services into public health, clinical practice, and community settings. 

NIH
Dissemination and Implementation Research in Health (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-236.html
This announcement encourages investigators to submit research grant applications that will identify, develop, test, evaluate, and/or refine strategies to disseminate and implement evidence-based practices (e.g., behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. 

NIH
Emotion Regulation, Aging, and Mental Disorder (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-094.html

NIH
Emotion Regulation, Aging, and Mental Disorder (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-095.html
This funding opportunity encourages applications for mechanistic research on age-related changes in emotion regulation and how they may contribute to mental disorders in middle-aged and older adults. In particular, research is sought that will advance understanding of irregularities in the integrative neural-behavioral mechanisms of emotion regulation in adult mood and anxiety disorders, and that will examine whether the irregularities are associated with typical or atypical maturational trajectories of emotion processing.